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 Introduction 
 
 
Amphiphilic peptides have recently gained much attention for the development of 
novel functional materials. The combination of hydrophobicity with hydrogen bonding  makes 
these peptides into a versatile class of molecular building blocks with respect to the ability to 
influence assembly behavior and folding. Lipidated peptides, obtained through the 
introduction of one or more aliphatic chains to a peptide, are an important and readily 
accessible subset of amphiphilic peptides. In this chapter an overview of the current work on 
lipidated amphiphilic peptides, their self-assembly and other properties is presented. 
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1.1 Introduction 
Structural proteins and protein-based materials are an important part of living systems. 
Secreted products such as silk and mussel ligation fibrils consist of well defined protein 
structures with high mechanical strength. Keratins are important for the build-up of hairs and 
nails and collagen fibers are the main component in animal connective tissues. Muscle tissue 
contains fibers of actin and myosin, the interaction between these fibers allows for muscle 
contraction. Actin and myosin fibrils are also an important component of the cytoskeleton, the 
cellular scaffold that not only provides cells strength and shape, but is also responsible for 
motility. This network of fibrils in the cell is essential for efficient transport processes and 
organization in the cell.   
In some cases undesired protein structures are formed as a protective measure in the 
removal of misfolded proteins from the cell. In case of a misfolding event otherwise soluble 
proteins can aggregate into fibrillar materials.1,2 Deposits of such material are believed to be 
involved in a number of disorders such as Alzheimer’s disease, Creutzfeldt-Jakob and type II 
diabetes.3 
The diversity and specificity found in protein based materials are possible due to the 
well-defined interactions between the protein building blocks of which these materials are 
constructed.4 Of course similar non-covalent interactions, such as hydrogen bonding, 
hydrophobic and electrostatic interactions, are responsible for the folding of proteins in the 
first place. In case of assembly of protein building blocks specifically the interacting interface 
is of major importance; the actual contact area can be quite small compared to the whole 
surface of either protein. Furthermore, loops and other well-defined secondary structures are 
structural elements often present at these interfaces. Not only the amino acid sequence at the 
interface, but also the exact orientation of the amino-acids – and therefore the three-
dimensional folding is important.5 
In efforts to mimic and influence protein-protein interactions the specific amino acid 
side chain interactions, hydrophobic effects, and the specific spatial distribution have to be 
taken into account. An important field in the examination of protein interactions involves the 
synthesis of model systems. Besides small organic molecules also small peptide fragments 
have been used as model systems. In order to stabilize a specific fold in these peptides6 and 
mimic discontinuous binding sites peptides are often used in combination with a scaffold.7-10   
An important development is the use of peptide amphiphiles as a class of protein 
mimics and model systems. Especially, the assembly behavior of peptide amphiphiles has 
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attracted much attention.11 Not only could the self-assembly behavior provide a starting point 
for peptide based structures, but the peptide amphiphiles could also be co-assembled with 
other components in order to introduce additional functionality and/or biocompatibility, 
leading to a bottom-up fabrication of new nano-materials.12 Properties of assemblies can be 
easily controlled through choice of constituent amino acid residues.13 However, still a lot of 
research will be required to fully grasp the mechanisms involved in e.g. folding and self-
assembly of this type of molecules.  
 
1.2 Classes of peptide amphiphiles 
 Amphiphiles can be dissected into a water-soluble and a hydrophobic part. From a 
structural point of view different types of peptide amphiphiles can be distinguished.14 A first 
category is that of amphiphiles consisting only of amino acids. Inspired by naturally occurring 
small peptidic amphiphiles, many artificial model peptides have been prepared. Especially 
amyloid fibril forming proteins have been the inspiration of many to design low molecular 
weight peptides that can produce amyloid-like assemblies.15,16 These peptides are examined 
either as a model for a fundamental insight into the molecular mechanisms involved in this 
type of assembly or as a mere starting point in the construction of more complex nanoscale 
objects.17-25 These amphiphilic peptides can be further divided into two types. The first class 
is comprised of peptides with a linear stretch of hydrophobic residues coupled to a polar head 
group that mostly is constituted by a number of polar amino acids. The second class consists 
of structures with alternating polar and apolar residues.26 
A second category of peptide amphiphiles comprises so-called lipidated peptides; 
these are amphiphiles obtained through attachment of one or more alkyl chains on the side 
chains or at the C- and/or N-terminus, often inspired by nature’s lipidated proteins. Lipidation 
of proteins plays an essential role in a variety of biological processes such as signal 
transduction, transport, fusion and structure.27-29 The lipidation usually serves to anchor and 
localize proteins in order to create self-assembled structures that can perform their task.30 
Lipidation is a well known strategy to create membrane penetrating peptides as there are e.g. 
pore forming iturins,31 toxins like magainins,32 siderophores such as marinobactins and 
aquachelins,33,34 lipopeptaibols, metabolites of fungal origin35 and surfactins, bacterial cyclic 
lipopeptides well known for their exceptional surfactant power.36 Synthetic peptides with one 
ore more alkyl chains, often at the N- and/or the C-terminus, have been thoroughly 
investigated.37 There is growing interest in their ability to organize and display 
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(bio-)functionality in assemblies38 and on both artificial and natural bilayer membranes.15,39-42 
Furthermore, peptide and protein polymer hybrids show amphiphilic properties.43-45 
The remainder of this introduction will focus on lipopeptide amphiphiles, and more 
specifically on the assembly behavior of these amphiphilic peptides. A main division will 
therefore not be made on the molecular structure of the peptide amphiphiles, but on the type 
of assembly they are associated with: fibrous assemblies, monolayers and vesicular bilayers. 
 
1.3 Peptide amphiphile fibrils 
Peptide amphiphiles based on lipidated peptides and amino acids were pioneered in 
the early eighties by the groups of Kunitake46,47 and Yamada.48,49 It was demonstrated that 
these amphiphiles are able to produce bilayer structures that can assemble into helical and 
tubular superstructures. The head groups of these amphiphiles contained either single amino 
acids or less defined oligomeric peptides obtained through a polymerization reaction. Later, 
Shimizu et al.50 prepared well defined peptide amphiphiles with oligopeptides Sar3 (N-
Methylglycine) and Pro4 as a head group. These compounds were shown to form bilayer 
based aggregates, presumably fibrous or ribbon-like structures that transformed into much 
smaller aggregates above their Tm. Elaborating on these structures Shimizu et al.51 prepared a 
series of peptide amphiphiles each with a head group composed of different type and number 
of amino acids. Unsurprisingly, the phase transition parameters and aggregation morphologies 
were dependent on the nature of the head group, giving rise to not only tubular structures or 
twisted ribbons but also to vesicles and amorphous crystals. 
More recently, the work of the group of Stupp gave a new boost to peptide 
amphiphiles in general and lipidated peptides in specific. Inspired by the way nature employs 
organic material as a scaffold for the control of the formation of inorganic materials,52 
Hartgerink et al.53 demonstrated that a peptide acylated at the N-terminus with a single alkyl 
chain could be used in the construction of nano-scale materials suited as a scaffold for 
biomineralization. They described the reversible self-assembly of discrete micellar nanofibers 
via a pH controlled mechanism (figure 1). The fibers, after stabilization via disulfide cross-
links, were able to direct mineralization of hydroxyapatite. The mineralized nanofibers were 
portrayed as comparable to the lowest level of hierarchical organization of bone and said to be 
easily modified through the selection of different amino acids for other applications in tissue 
engineering and mineralization. The pH controlled formation of peptide fibrils was used to 
assemble fibrils inside liposomal nano-containers.54 After incorporation of the monomers in 
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the liposomes, a photo-induced pH change triggered fibril formation. Further in situ control 
on peptide fibrils was achieved through the introduction of a bulky photo-cleavable 
nitrobenzyl moiety. This group induced the formation of a quadruple helix superstructure that 
dissociated to single fibrils on exposure to light.55 
 
Figure 1. A) General chemical structure of a peptide amphiphile used by Stupp and 
Hartgerink, highlighting five key structural features,. B) Molecular model of the 
peptide amphiphile, showing its conical shape. C) Schematic showing the self-
assembly of the amphiphiles into a cylindrical micelle. Copyright 2001 AAAS. 
 
Indeed, many variations on this type of amphiphile have been reported by the Stupp 
group, all self-assembling into nanofibers. A variety of subjects was covered using a 
combination of peptide amphiphiles,56,57 mineralization of a metal sulphide semiconductor,58 
the encapsulation of carbon nanofibers,59 ‘ink’ for dip-pen patterning60 and catalysis.61,62 They 
were even able to induce very rapid differentiation of cells into neurons, which was explained 
by the amplification of bioactive epitopes presented to the cells on the nanofibers.63 
Moreover, the peptide amphiphile nanofibers were suggested as possible vehicles in e.g. drug 
delivery. Probing the interior of the fibers revealed it was possible to capture small organic 
Chapter 1 
 6 
molecules inside the core, which were still solvated enough to allow them to diffuse out of the 
assemblies again.64 Furthermore, the nanofibers were also decorated with non-peptidic 
functionalities,, such as biotin, allowing the binding to avidin.65 Finally, azacrowns were 
introduced, enabling the binding of Gd(III) ions to be used as MRI contrast agents;66 
fluorescent labels were introduced for transfer studies.67  
The use of self-assembled peptide amphiphile structures as scaffolds for the 
construction of inorganic nanotubes was studied by the group of Shimizu.68  Nanotubular 
peptide self-assemblies were used as a template to construct CdS nanotubes.69 Furthermore, it 
was shown that the binding of di- and tri-valent metal ions to Gly-Gly and Gly-Gly-Gly based 
peptide amphiphiles could be used to easily produce metal-functionalized nanotubes, which 
were converted into completely inorganic nanotubes by calcination.70  
Lee et al.71 studied peptide amphiphiles to explore their use in controlled release drug 
delivery. They prepared tripeptides coupled to glutamic acid dialkyl amide with alkyl chains 
of varying lengths. The helical ribbons and tubular structures they observed were coined high 
axial ratio microstructures (HARM). Incubation with liposomes or fetal calf serum suggested 
that the assemblies would survive long enough to be useful as drug delivery vehicles. A 
similar peptide amphiphile containing a decapeptide, spontaneously assembled into hollow 
tubes and helices.72 Interestingly, the peptide was found to be significantly protected against 
degradation by trypsin, which was thought to be due to the tight molecular packing and 
folding of the peptide in the bilayer aggregates compared to that of dispersed peptide 
amphiphiles. The protection against proteolysis was considered to be a useful feature 
providing the assemblies with a potentially prolonged lifetime in vivo.  
The conjugation of a lipid tail to a peptide not only has an impact on the folding and 
morphology of the formed aggregates, but also on the way in which the peptides prefer to 
assemble.73 The Aβ(16-22) peptide, KLVFFAE, assembles into fibrils and nanotubes.74,75 
However, Gordon et al. demonstrated with the use of solid-state NMR techniques that while 
the unmodified peptide formed anti-parallel β-sheets the same peptide with merely an N-
terminal octanoyl moiety formed parallel sheets.76 The authors suggest that this demonstrates 
that the amphiphilicity is critical in determining the mode of assembly and structural 
organization of the β-sheets that form and may provide a method for controlling the structure 
of amyloid fibrils.  
Over the last decade Tirrell and Fields77-85 have shown how to exploit the dynamic 
structure of bilayers to have peptide amphiphiles self-assemble into biologically active 
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protein-like structures. They showed that already a single N-acylation of a peptide with a 
hydrophobic moiety can be used to induce protein-like structures. E.g. a peptide, derived from 
a model peptide for α-helices, did not form any distinct structure in solution. However, once 
connected to just a C6 alkyl chain an α-helical structure was adopted. Expectedly, the longer 
the alkyl chain of the modified peptide the higher the thermal stability of the assemblies that 
formed compared with the C6 analogue. The increase of the temperature of α-helix to coil 
transition could be correlated to the extent of aggregation. A similar stabilization was also 
shown with a 39-residue peptide, derived from type IV collagen which is prone to form triple-
helix assemblies. Again, N-acylation with hexanoic acid already improved the stability of the 
triple helices. Furthermore, it was found that simple alkylation of peptides like (Gly)n (n=1-5) 
with a C18 alkyl chains resulted in the formation of helical structures, which the peptides 
would not form otherwise. The stabilizing effect on peptide secondary structure by the 
attachment of hydrophobic alkyl chains to peptides seems to be a concept that might be 
utilized for studying the mechanisms of peptide folding and for the formation of more 
complex protein-like structures and peptide-based assemblies. 
Similarly, a secondary structure was induced in an otherwise unordered, biologically 
active sequence derived from a matricellular protein, i.e. SPARC(119-122).86 The activity was 
found to be enhanced while the susceptibility towards proteolysis was reduced. The results 
indicated amphiphilic surfaces can be designed to combine desired activities and select out 
undesired ones. Along this line an application of simply palmitoylated peptides as antifungal 
and antibacterial agents has recently been reported by Avrahami et al.87 
 In recent years van Hest and Löwik have shown that the introduction of an alkyl tail to 
the non-self-assembling Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly peptide causes the resulting 
peptide amphiphile to self-assemble in water; moreover, the morphology of the assemblies 
depends on the length of the hydrophobic tail.88 With tails of C12 and shorter micellar 
assemblies prevail, while longer tails induce the formation of fibrils. These fibrils can be 
disassembled by heating the solution. However, these assemblies can be stabilized by the 
introduction of a di-yne containing alkyl tail and subsequent photopolymerization.89 This 
photo-polymerization of di-yne moieties organized by peptide amphiphile self-assembly was 
subsequently also shown by Stupp et al.90  
 
Chapter 1 
 8 
1.4 Monolayer assemblies 
Biological membranes are important for the organization of functionality.91 
Monolayers at the air-water interface can be regarded as simplified two-dimensional systems 
useful as models for fundamental understanding on e.g. the relation between the morphology 
of monolayers and the chirality of its constituent components92 but also for the construction of 
functional surfaces exploited in a variety of devices. The introduction of a peptide into a 
monolayer can be readily achieved by lipidation.  
The most widely employed means of lipidation is the attachment of one or more alkyl 
chains at either the N- or C-terminus, as  pioneered by Ringsdorf93 and Kunitake.94,95 The first 
group used the N-terminal part of a lipoprotein of E. coli, tripalmitoyl-S-glyceryl-L-Cys-Ser, 
and studied its behavior and that of longer analogous peptides at the air-water interface in 
order to obtain information about e.g. their specific surface area and miscibility. The 
compounds were also proposed to be useful as low-molecular weight carrier-adjuvant systems 
evidenced by their mitogenic response towards B-lymphocytes.  
The ability to recognize water soluble peptides at the air-interface was demonstrated 
by Cha et al.96-98 They claimed that peptide amphiphiles can form ordered arrays of functional 
groups at the interface enabling binding events by the display of self-assembled 
complementary binding sites. Typically, it was found that single alkyl chain oligoglycines 
were not able to bind peptides, which was ascribed to strong inter-peptide hydrogen bonds 
preventing the intercalation of other peptides and thus hampering their binding.99 Such 
intermolecular forces have been quantified on related compounds by Schneider et al.100,101 
The binding strength was increased by mixing in guanidinium based amphiphiles which are 
able to strongly interact with the carboxylate terminus of the ligands and to form antiparallel 
β-sheet like hydrogen bonds.102 
The concept of molecular recognition by self-assembled binding sites at the air-water 
interface was further elaborated and examined in a combinatorial set-up by Huo 
et al.103.Peptide libraries were constructed and spread on the air-water interface and the 
surface behavior was studied varying the solutes contained in the subphase. The authors 
claimed that the peptide lipids self-assembled at the air-water interface to form protein-like 
supramolecular structures capable of selectively recognizing specific ligands. Later, the 
ability of similar peptide lipids to form complexes with metal ions like Cu2+ and Zn2+ was 
investigated.104 The binding performance was affected by the nature of the cations. Hard 
metal ions, like K+ and Mg2+, clearly exhibited different binding activity than borderline and 
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soft ions. Furthermore, based on fluorescent probe studies, Cu2+ and Zn2+ in the subphase 
were found to result in different behavior of the monolayers, supposedly due to a different 
mode of binding of the ions, leading to altered folding and thus assembly of the peptides in 
the monolayer. Both studies might well prove to be a starting point of a novel approach in the 
design of receptor molecules, termed combinatorial surface chemistry, to yield unprecedented 
protein-like supramolecular structures.  
With the aim to construct responsive monolayers Huo et al.105 incorporated a 
diacetylene functionality in the hydrophobic alkyl tail. It was found that the chromatic 
properties of the polymers formed after polymerization of the diacetylene moieties were 
indicative of the packing of the peptide amphiphiles at the interface. The area per molecule 
was nicely correlated with the maximum of the absorption peak in UV-VIS, shifting from 640 
nm for a Gly-Gly head group to 525 nm for a Phe-Gly head group. In this respect the 
incorporation of a tryptophan residue was suggested to be useful as fluorescent reporter 
unit.106 The formation of strong inter-peptide hydrogen bonds between the peptide head 
groups, as found by Cha et al.,99 was further examined in the group of Leblanc using a 
pentapeptide based on a fragment of the β-amyloid peptide.107-111 The aggregation process 
was monitored by surface pressure and surface dipole moment measurements combined with 
epifluorescence. It was shown the peptide was able to aggregate during compression and that 
the obtained topographies of the aggregates were explained by the peptide moieties. 
An approach to design receptors based on protein-like supramolecular structures was 
thoroughly investigated by Tirrell and Fields.77-80,82,84,85,112,113 Tirrell e.g. studied monolayers 
containing a peptide amphiphile based on RGD the so-called universal recognition site 
present in a variety of proteins that interact with cell-surface receptors of the integrin family. 
The amphiphilic peptide was mixed with a PEG-lipid and the structure of the resulting 
monolayers was studied employing neutron reflection. The head group was found to be 
perpendicularly oriented to the air-water interface; incorporation of the amphiphile into a 
PEG-lipid monolayer enhanced the configurational constraints.113  The introduction of a short 
PEG spacer between an RGD tripeptide and the anchoring aliphatic moiety increased the 
proliferation of mouse fibroblasts on a monolayer while an aliphatic C2 spacer did not have 
this effect.114  This shows that the whole amphiphile is important in the recognition process, 
not only the functional peptide. 
In an attempt to gain further control over peptide folding Pakalns et al.115 attached 
doubly alkylated glutamic acid derivatives to both the N- and C-terminus of an RGD 
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tripeptide to afford a compound which can be anchored with both termini, restricting its 
conformational freedom (figure 2). Most approaches to display peptides immobilize the 
peptide by covalently linking it through the N-terminus, leaving the carboxy-terminus free. It 
is a well-known fact, however, that many peptides exist in a conformationally constrained 
loop. It has been demonstrated that cyclic peptides which contain the RGD sequence can 
display higher affinities than their unconstrained linear counterparts. These peptide 
amphiphiles were utilized to prepare self-assembled monolayers which could be deposited as 
Langmuir-Blodgett films on a surface. On these surfaces functionalized with looped RGD 
amphiphiles melanoma cell were able to spread in a concentration dependent manner. Jensen 
et al.116 showed a high biological activity at low incorporation levels using a cyclized RGD 
peptide with only N-terminal alkylation. Based on these results, they stated that engineered 
lipopeptide-based surfaces offer unique presentation opportunities that cannot be achieved by 
any other means of immobilization. Ochsenhirt et al.117 not only showed synergy between 
amphiphiles based on RGD and PHSRN, but also showed a selective binding of linear and 
cyclized RGD sequences to different integrins. 
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Figure 2 . An N- and C-terminally lipidated ‘looped’ RGD peptide. 
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In an interesting approach Kros et al modified the water soluble amphiphatic (Leu-
Glu)x  peptide with a phospholipid moiety. The resulting amphiphilic peptide formed a stable 
monolayer on the air-water interphase for 3 and 4 repeats of the Leu-Glu sequence.118 In this 
monolayer the peptide was organized in an antiparallel β-sheet. Furthermore, it was shown 
that these monolayers could be used as template for the mineralization of calcium 
carbonate.119  
The use of peptide amphiphiles in combination with liquid crystalline materials in 
sensor applications was examined by Park et al.120 Peptide amphiphiles were created by 
coupling a 17 amino acid peptide to amphiphiles that were interacting with a 
4-cyano-4’-pentylbiphenyl (5CB) liquid crystalline (LQ) domain. This immobilization 
resulted in a stabilized loop conformation of the peptide. Furthermore, the introduction of the 
peptide resulted in a change in the LQ domain from planar to homeotropic alignment. The 
change in LQ phase could be reversed by cleaving the loop of the peptide with trypsin. 
 
1.5 Vesicles 
Peptide amphiphiles usually do not self-assemble into vesicular structures, they can 
however be readily integrated into for example liposomes. Integrins seem to be a suitable 
target for peptide functionalised liposomes because they serve as a model in many studies of 
cell-cell and cell-substrate interactions.121 Recently, Waterhouse et al.122 prepared a peptide 
sequence (PLAEIDGIELA) that targets α9β1-integrin. Interestingly, they used cholesterol as 
a hydrophobic moiety, instead of an alkyl chain, and showed its applicability in gene delivery. 
However, most research has focused on introducing the arginine-glycine-aspartic acid (RGD) 
sequence.  
Hojo et al.123 reported the synthesis of a glycerol derivative containing the cell-
adhesion sequence RGDSG, as an archaebacterial lipid model. They showed the conjugate 
was able to form stable liposomes. Yagi et al.124,125 prepared liposomes whose surface was 
modified with peptides containing a five-time repeat of the GRGDS sequence, as found in the 
cell adhesion sequence of fibronectin. The peptide was lipidated by incorporation at the N-
terminus of an aspartic acid residue modified with two C16 alkyl chains. The availability of 
the peptides on the surface was confirmed using immuno-electron microscopy, employing a 
specific antibody to the peptide that could be visualized with gold colloids. The liposomes 
were shown to bind mouse fibroblast cells. The association takes place through interaction of 
the exposed peptide and the corresponding cell surface receptor. 
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Many different sequences have been anchored to liposomes to promote targeting to 
specific cells. In many cases a PEG chain is inserted between the peptide and the hydrophobic 
anchor, but at times more simple peptide amphiphiles are used.126,127 For example, collagen 
based peptide amphiphiles have been introduced to induce a selectivity towards melanoma.128 
In addition to these specific targeting sequences, aspecific cell penetrating peptides have been 
used to stimulate uptake of liposomes into the cell.129,130 
The group of Waldmann has extensively examined the role of hydrophobic alkyl 
chains attached to proteins.27,131 Moreover, they have developed practical routes to synthesize 
peptides lipidated via thioesters, derived from a number of lipoproteins such as eNOS (NO-
synthase),132 Ras (guanine nucleotide binding protein) or hemagglutinin (glycoprotein from 
influenza virus A).133,134 In the latter case, e.g., they prepared peptides with S-palmitoylated 
cysteines. They showed that one single alkyl chain cannot prevent a peptide from hopping 
from one membrane to another, where two will. A recent alternative approach to prepare S-
palmitoylated peptides, without the use of enzymes, has been described by Rijkers et al.135  
To increase the activity of a peptide ligand often the structure is constrained fixing it 
in an active conformation. This strategy was employed by Marchi-Artzner et al.136 who 
attached a cyclized RGD containing pentapeptide to lipid alkyl chains connected through a 
short ethylene glycol spacer (figure 12). Giant vesicles functionalized with these cyclic RGD 
peptides adhered to endothelial cells of the human umbilical cord, a process that could be 
inhibited by adding the corresponding soluble peptide. This suggests a specific interaction 
between the bilayer anchored peptide and the integrin receptors of the cells.  
The RGD sequence has also been employed to construct vesicles that can be used to 
detect and report the interaction with an integrin. This can be accomplished by making use of 
the chromism of polydiacetylenes, which can be incorporated in vesicular bilayers.137 
Biesalski et al.138 adopted this method, developed by Charych et al.,139 for vesicles assembled 
from an RGD containing peptide amphiphile with a diacetylene lipid tail. It was shown that 
activated α5β1 integrins in solution produced a chromatic shift in the polymerized vesicles, 
visible as a color change of the solution (figure  3).  
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Figure 3. Structure of an RGD-diacetylenic peptide amphiphile and a schematic 
description of the molecular recognition of the peptide ligands located on the surface 
of the polymerized vesicles by the β5α1 integrin in solution. Copyright 2005 
American Chemical Society.138 
 
Another constrained peptide that was used as a head group in a peptide amphiphile is a 
cyclic NPNA derivative, a tetrapeptide that is found in a repeat region of the 
Circumsporozoite (CS) protein of the Malaria parasite Plasmodium falciparum in which it 
adopts a β-turn. Robinson and Pluschke140,141 displayed this epitope on the surface of so-
called immunopotentiating reconstituted influenza virosomes (IRIV) as an approach towards 
new designed synthetic vaccines. The conformational constraint was imposed upon the 
peptide by the incorporation of an L-Pro-D-Pro or an analogous peptidomimetic template that 
induced a hairpin. The approach was even extended to the preparation of a 35-membered 
library of cyclic peptide amphiphiles displaying a part of the AMA-I (apical membrane 
antigen-I) found on the surface of Plasmodium falciparum merozoites.142 
Löwik et al.143 demonstrated that the dynamic bilayer of a liposome can also be 
exploited to limit the conformational freedom of a peptide in non-covalent manner. They 
showed that the attachment of C18-alkyl chains to both the N- and C-terminus of a peptide 
allowed anchoring of both termini of the peptide into a liposome and thus forcing the peptide 
to adopt a β-hairpin fold (figure 4), similar to the work reported by Pakalns et al.115 on 
monolayers of RGD containing looped amphiphiles described above. The peptide was easily 
prepared via an entirely solid phase route, starting with a commercially available aldehyde 
resin that was reductively aminated with the appropriate alkylamine. Similar to the work of 
Robinson and Pluschke141 described above, a peptide was used containing a similar  NPNA 
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sequence. It was shown that both the unmodified peptide in solution and the peptide 
containing only one alkyl chain, inserted into liposomes, showed random coil behavior, 
different from the doubly functionalized peptide that displayed β-hairpin characteristics once 
anchored in a lipid membrane. It was proposed that this simple approach can be conveniently 
employed for stabilizing a variety of peptides into a β-hairpin fold and might be used in the 
presentation of multiple properly folded epitopes.  
Liposome Liposome
H
NGly AlaAsn ProAsnAla Ala Gly
O
Gly AlaAsnPro AsnAla AlaGlyAc OH
OHGly AlaAsn ProAsnAlaAla Gly
O
1
2
3
1 2 3
 
Figure 4. Stabilization of a β-hairpin fold through the attachment of an N- and C-
terminal anchor. Copyright 2003 RSC.143 
 
The necessity of stabilization of peptide structures, and the possibility of achieving 
this through non-covalent interactions was nicely shown by Muhs et al.144 They investigated 
two liposome based vaccines against the Aβ amyloid sequence. Hydrophobic tails were 
introduced at both N- and C-terminus of the Aβ 1-15 fragment and the fragment was 
incorporated in a liposome. Liposomes were also functionalized with the  Aβ 1-16 fragment 
through PEG anchors at both termini. The directly palmitoylated peptide was effective, in 
contrast to the PEG-anchored variety. The authors attributed this difference to a difference in 
the conformation of the peptide depending on the anchor used. The directly anchored 
molecule was present in a β-sheet conformation, while the PEG-functionalized peptide was 
present in a random coil conformation. 
Introduction 
 
 15 
1.6 Thesis 
The goal envisaged at the start of the research described in this thesis was the 
synthesis of protein mimics by spontaneous non-covalent assembly of peptides. The assembly 
process should not only be able to bring the building blocks together, but also stabilize the 
peptides in a biologically relevant conformation. As shown in this introduction one process 
capable of answering these demands is the (self-) assembly of peptide amphiphiles. Tuning of 
this self-assembly process should be possible by tuning the hydrophobicity of peptide 
amphiphiles. This thesis describes the influence of added hydrophobicity, achieved by the 
introduction of alkyl tails of varying lengths, on peptide (self-) assembly and folding.  
In chapter 2, the influence of additional hydrophobic interactions on a peptide that 
forms amyloid like fibrils, with the sequence Lys-Thr-Val-Ile-Ile-Glu, is described. 
Specifically the effect of the introduction of an alkyl tail at the N-terminus or C-terminus on 
the stability of fibrils formed by the peptide is investigated.  
In chapter 3 it is examined whether it is also possible to not only stabilize, but also 
disassemble fiber assemblies by manipulating the hydrophobic – hydrophilic balance. 
Furthermore, the possibility of in situ disassembly of peptide fibrils through the introduction 
of a cleavable hydrophobic moiety is studied. 
In chapter 4 the influence of introduced hydrophobic interactions on the folding and 
assembly of a non-self assembling peptide, with the sequence 
Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly (GANPNAAG), is described. This non-assembling 
peptide has the propensity to fold in a β-turn. 
 In chapter 5 a series of alkyl modified GANPNAAG peptides is synthesized and 
anchored into liposomes. The effect on folding and anchoring is examined, by varying the 
length of the alkyl tails on the peptide and liposome composition..  
Finally, in chapter 6, the possibilities are investigated to use alkyl modified 
GANPNAAG peptides, either anchored in liposomes or attached to a carrier protein, for the 
production of vaccines. 
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Stabilization of peptide fibrils by  
hydrophobic interaction‡ 
 
 
Hydrophobic interactions play an important role in assembly processes in aqueous 
environments. In the case of peptide amphiphiles hydrophobicity is combined with hydrogen 
bonding to yield well-defined peptide-based aggregates. In this chapter we report a 
systematic study after the role of hydrophobic interactions on both stabilization and 
morphology of a peptide fibrillar assembly. For this purpose alkyl tails were connected to a 
known β-sheet forming peptide with the sequence Lys-Thr-Val-Ile-Ile-Glu (KTVIIE). The 
introduction of n-alkyl groups lowered the critical assembly concentration and induced 
thermal stability to the assemblies, without affecting the morphology of the peptide 
aggregates. 
                                                 
‡
 Part of this chapter has previously been published: J.T. Meijer, M. Roeters, V. Viola, 
D.W.P.M. Löwik, G. Vriend, J.C.M. van Hest, Langmuir 2007, 23, 2058. 
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2.1 Introduction 
The assembly behavior of peptides can be strongly influenced by the presence of 
amphiphilicity.1 In principle there are two methods for the introduction of amphiphilic 
character into peptides. Firstly a peptide can be built up out of a combination of hydrophobic 
and hydrophilic amino acids, either in alternating or block sequence.2 A second well-studied 
method is based on the attachment of alkyl-tails,3-5 which allows even peptides that normally 
do not self-assemble to yield stable aggregates.6,7 A single glutamic acid can e.g. form fibrils 
when coupled to stearic acid.8 Not only self-assembly can be induced via the attachment of 
alkyl-tails,9-11 but it can also change (the orientation of) the secondary structure12,13 stabilizing 
a peptide in its bioactive conformation.  
Peptide amphiphile based fibrils that are formed via this spontaneous assembly 
process have proven to be very useful, for example as scaffolds for cell growth or as template 
for the build-up of materials.5,6,14 Self assembly of amphiphilic peptides and proteins is also 
important in biological processes; exposure of hydrophobic patches in proteins has been 
linked to amyloid formation.15 The increase in solvent-exposed hydrophobic regions precedes 
insolubilization and aggregation of the protein. This spontaneous transition of soluble proteins 
into amyloid fibrils is a major cause of several disorders such as Alzheimer’s disease16,17 and 
diabetes type II.18 Investigating and influencing this aggregation process, which is based on a 
combination of hydrophobic interactions and β-sheet forming peptide sequences, can 
contribute to the understanding of fibril formation and can possibly be useful for drug 
development.19 Because of this biological relevance, much research has been devoted in 
recent years to study model peptides that self assemble into β-sheet like structures.20-22  
The ability  to induce stability to soluble peptide aggregates via the introduction of 
alkyl chains has remarkably so far only been applied to coiled-coil peptides13,23 and non-
aggregating peptides.24,25 In the research presented in this chapter our main focus is on the 
effect of alkyl modification on peptide assembly of a known β-sheet forming peptide. We 
would like to know whether hydrophobic interactions could influence the stability of the 
peptide aggregate without affecting the existing peptide conformation. As a model peptide, 
the hexapeptide KTVIIE (K = Lysine, T = threonine, V = valine, I = isoleucine, E = glutamic 
acid), as designed by Serrano et al21 was chosen, which is known to mimic amyloid fibril 
forming proteins. This model peptide is one of the smallest peptide sequences to form stable 
β-amyloid fibers at a wide pH range.26  The peptide is small and can be easily and quickly 
synthesized. Furthermore, as previously published, the peptide sequence and charges in the 
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side chains are important for the self-assembly into fibrils.21 The N-terminus of the model 
peptide is acetylated and the C-terminus amidated to limit the amount of charged states. 
Therefore, other functionalities can be introduced without disturbing either the peptide 
sequence or the charge that is responsible for the assembly process. This renders this model 
peptide an ideal candidate to systematically vary both the length and the position of alkyl 
chains, and study in detail the effect on assembly with respect to concentration and 
temperature dependence. 
 
2.2 Synthesis 
 
2.2.1 Synthesis of peptide amphiphiles 
Peptide amphiphiles were constructed with an aliphatic alkyl chain at either the N- or 
C- terminus of hexapeptide KTVIIE. For the N-terminal modified peptides the synthesis 
commenced on a solid support using a Breipohl amide resin (Figure 1).27,28  Fmoc protected 
amino acids were coupled using the carbodiimide DIPCDI coupling agent with HOBt in 
DMF. Subsequently the Fmoc group was repeatedly removed using a 20% solution of 
piperidine in DMF. After the final amino acid was coupled, the alkyl chain could be 
introduced efficiently by a classical carbodiimide mediated coupling with the corresponding 
aliphatic carboxylic acid. This final coupling was performed in a dichloromethane/DMF 
mixture; the aliphatic tail was dissolved in dichloromethane, and neat DIPCDI and HOBt 
dissolved in DMF were added. Especially the longer aliphatic tails are more soluble in 
dichloromethane, and coupling efficiencies were found to be higher when this cosolvent was 
applied. Still, yields of the peptides with longer tails were lower, probably due to losses as a 
result of the higher hydrophobicity and thus solubility during the work up procedure 
involving precipitation in diethyl ether. (Table I, 1, 2, 5-9).  
Alternatively, an aliphatic moiety was introduced on the C-terminus of the peptide 
(Figure 2). For this purpose an aldehyde functional resin was used and a coupling procedure 
was followed,29 which was adapted from a method developed by Barany et al.30,31 A primary 
aliphatic amine was coupled to the aldehyde resin by means of a reductive amination and the 
resulting secondary amine was subsequently the starting point for peptide synthesis. This 
versatile method can be used to introduce a wide variety of functional groups at the C-
terminus of a peptide, such as fluorescent groups, aliphatic tails, crown ethers and even 
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polymers.5,29,32 Introduction of the first amino acid to this secondary amine was slow. To 
ensure complete coupling an extended coupling procedure was used. The first amide coupling 
was performed using DIPCDI and HOBt in DMF. After an hour the solution was removed, 
and replaced with a fresh batch of reagents, after which the reaction was continued for another 
15 hours. A chloranil test33 was performed to ascertain the completion of the reaction. Any 
possibly remaining free secondary amines were capped by treatment of the resin with acetic 
anhydride. The loading yield of the resin was determined using an Fmoc-cleavage UV-assay, 
and was typically found to be higher than 90%. Subsequent amide couplings were performed 
in an identical way as in the first route. (Table I, 3, 4). 
In either synthetic pathway the last three amino acid couplings (Val, Thr and Lys) 
were troublesome if one of the preceding amino acids had been coupled overnight. Coupling 
times dramatically increased and refreshing of the amino acid and coupling reagents was 
found to be necessary. Furthermore, deletions occurred even if the Kaiser test34,35 indicated 
complete coupling of the amino acids. A possible cause could be incomplete Fmoc-removal, 
but increased treatment with piperidine in DMF did not completely prevent the problems. 
Probably, there is some interaction or folding of the peptide on the resin hampering peptide 
chain extension. A trivial solution was found in synthesizing the peptide without any 
interruptions, as diligence has more often proven to enhance the quality of the product of a 
solid phase peptide synthesis.36 The combination of the two routes gave full access to 
independent functionalization of the C- and N-terminus, while keeping the advantages of solid 
phase peptide synthesis.  
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Figure 1. Solid phase synthesis of N-terminally functionalized peptides 1 (n=1), 2 
(n=15) and 5-9 (n=5, 7, 9, 11, 13 respectively). Reaction conditions: i) piperidine 
(20% in DMF) ii) Fmoc-Xxx, DIPCDI, HOBt in DMF, iii) CnH2n+1COOH, DIPCDI, 
HOBt in dichloromethane; or acetic anhydride, pyridine in DMF , iv) TFA/H2O (95/5) 
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Figure 2. Solid phase synthesis of C-terminally functionalized peptides 3 (n=1) and 4 
(n=15). Reaction conditions: i) C16H33NH2, acetic acid, NaCNBH3 in DMF/MeOH 
(1/1), 80 °C ii) Fmoc-Glu(tBu), DIPCDI, HOBt in DMF 1 hour, followed by Fmoc-
Glu(tBu), DIPCDI, HOBt in DMF 18 hours, iii) piperidine (20% in DMF), iv) Fmoc-
Xxx, DIPCDI, HOBt in DMF, v) CnH2n+1COOH, DIPCDI, HOBt in dichloromethane; 
or acetic anhydride, pyridine in DMF, vi) TFA/H2O (95/5) 
 
 
Table I: Overview of the peptides synthesized  
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Peptide R1 R2 Yield (%) 
1 CH3 H 65 
2 C15H31 H 55 
3 CH3 C16H33 50 
4 C15H31 C16H33 55 
5 C5H11 H 75 
6 C7H15 H 75 
7 C9H19 H 65 
8 C11H23 H 70 
9 C13H27 H 60 
Chapter 2 
 
 26 
 
2.2.2 Peptide fibril formation 
The synthesized KTVIIE-derived peptides were allowed to form fibrils according to a 
procedure adapted from Serrano et al.21 Each peptide was dissolved in a 20 mM glycine-HCl 
buffer (pH 2.5) to a concentration of 1 mg mL-1. The samples were sonicated at 50 °C for 30 
minutes. Some of the amphiphilic peptides did not completely dissolve and were therefore 
filtered. Subsequently, the samples were left to stand for five days at room temperature. 
Because the solutions were filtered an assay was necessary to determine the concentration of 
the peptide. In contrast to the amphiphilic peptides the basic Ac-KTVIIE-NH2 yielded a clear 
solution after sonication. Therefore, from this peptide a dilution series was prepared and the 
absorption of the samples at 220 nm was used to construct a calibration curve, which allowed 
the determination of the concentrations of the peptide solutions. The peptide fibril solutions 
could be further diluted to prepare solutions of lower concentrations. 
Solutions were prepared in standard Eppendorf tubes, but the determined 
concentrations of the peptide in the solutions were regularly much lower than expected, even 
taking into account some losses from the filtration step. Furthermore, the concentration 
decreased over time even though no precipitation was observed.  Probably adherence of the 
peptides or the fibrils to the standard Eppendorf tube surface was the cause of the losses.37,38 
Therefore, samples were prepared in low adhesion Eppendorf tubes39 or sealable glass vials, 
which resulted in peptide concentrations which remained unaltered. 
 
2.3 Fibril characteristics 
 
2.3.1 Influence of a hydrophobic domain on structure 
The first molecular assembly parameter that was investigated was the effect of the 
position of the hydrophobic tail on stabilization of the fibrils. Alkyl tails were therefore 
introduced in three different ways: at the N-terminus, the C terminus, or both termini were 
functionalized simultaneously (peptides 2, 3 and 4 respectively). Alkyl chains containing 16 
carbons were chosen as a representative hydrophobic group. Thus, hexadecanoic acid was 
introduced at the N-terminus or hexadecylamine at the C-terminus, or both were coupled to 
the same peptide. The aggregation properties of the model peptide KTVIIE 121 were 
subsequently compared to the properties of these three amphiphilic peptides. In the assembly 
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process as described by Serrano et al.21 the charged lysine and glutamic acid residues in the 
peptide direct the aggregation process. The aggregation of the peptide proceeds in two stages, 
and these stages can be followed using CD spectroscopy. Freshly dissolved, the peptide has a 
random coil conformation characterized by a minimum near 200 nm. During the assembly 
process first the dissolved peptide organizes in a β-sheet polymer and a typical β-sheet 
spectrum develops with a minimum at 220 nm and a maximum at 200 nm. Secondly these 
polymers aggregate in regular fibril structures. 
After filtration, peptide 1 and the singly functionalized peptides 2 and 3 were found to 
be present in solution at a concentration of 0.6 mM. In contrast, peptide 4 with two introduced 
hydrophobic tails proved to be highly insoluble. No UV-Vis or Circular Dichroism (CD) 
spectra could be recorded and no fibrils could be found using Transmission Electron 
Microscopy (TEM). Apparently, the two hydrophobic tails decreased the solubility of peptide 
4 too much and structured aggregates were not formed anymore, therefore this peptide was 
not examined any further. 
The CD spectrum of model peptide 1 showed a negative signal at 220 nm and a 
positive peak at 200 nm (Figure 3). This spectrum is typical for a β-sheet type assembly and is 
in accordance with previous reports.21  Similarly, the CD spectra of solutions of both singly 
modified peptides 2 and 3 showed a minimum near 220 nm and a maximum at 200 nm. 
The high molar ellipticity of peptide 1 was attributed to a contribution of linear 
dichroism.40,41 The position of the minimum near 220 nm of the N- and C- terminally 
modified peptides differed slightly between the two peptides. This shift probably originates 
from small deviations of the actual peptide folding from a perfect β-sheet. A typical CD signal 
for a β-sheet has been determined using large proteins; in the small peptide contributions from 
end groups that fold slightly differently will contribute significantly to the final CD spectrum.  
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Figure 3. CD spectra of 0.6 mM solutions of amyloid fibril forming peptides 1-3. The 
curves are typical for a β-sheet conformation of the peptides. 
 
 
Furthermore, TEM pictures showed in all cases the presence of fibrils (Figure 4); 
fibrils obtained from the alkylated peptides possessed a similar morphology as the fibrils 
formed by the non-functionalized peptide. Both twisted and straight fibrils could be observed 
in TEM pictures of all samples, and fibrils had assembled into larger aggregates. Typically, 
fibrils were several micrometers long. Upon increasing the exposure time of a carbon coated 
TEM grid to a fibril solution the fibril density increased, until the fibril density became too 
high to discern individual structures, which is indicative of their inclination to stick to 
hydrophobic surfaces.  
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Figure 4. TEM pictures of Ac-KTVIIE 1 (a), C16-KTVIIE 2 (b), Ac-KTVIIE-C16 3 
(c) and of C16-KTVIIE 2 with high concentration of fibrils on grid (d); bars represents 
200 nm 
 
To further probe the internal structure of the fibers infrared spectra were recorded of 
lyophilized fibrils42 from aqueous solutions of peptides 1, 2 and 3. The amide I and II bands 
are indicative of the folding of peptides in aggregates.43,44 All samples showed a strong amide 
I band at 1625 cm-1 and the amide II band at 1535 cm-1 consistent with a β-sheet conformation 
of the peptides (figure 5, table II). The presence of alkyl tails was evident from the 
corresponding absorption band of the C-H vibration at 2925 and 2850 cm-1. 
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Figure 5. Amide vibrations of peptides 1, 2. 
 
 
Table II: Observed frequencies (cm-1) of polypeptides in various conformations44 
compared to the frequencies observed for lyophilized samples of fibrils. 
 Amide I  Amide II  
Random coil 1656 (s)  1535 (s)  
Alpha helix 1650 (s) 1652 (m) 1516 (w) 1546 (s) 
Parallel beta 1645 (w) 1630 (s) 1530 (s) 1550 (w) 
Anti Parallel beta 1685 (w) 1632 (s) 1530 (s)  
Ac-KTVIIE 1 1675 (w) 1625 (s) 1545 (s)  
C16-KTVIIE
 
2 1675 (w) 1625 (s) 1545 (s)  
Ac-KTVIIE-C16 3 1675 (w) 1625 (s) 1545 (s)  
 
These IR data indicate that the peptide conformation and the fibril structure are 
independent on the presence of the alkyl tails. The lyophilization procedure could possibly 
have changed the conformation of the peptide, but the fibrils are already present in solution, 
and correctly folded enzymes can be lyophilized without losing activity. Furthermore, β-
amyloid aggregates are structurally much more stable than proteins; therefore, the fibrils and 
the peptide conformation are expected to remain intact during lyophilization. 
It can therefore be concluded that peptide assembly and conformation is not affected 
by the introduction of the hydrophobic tails, which furthermore did not seem to promote non-
specific aggregation of the amphiphilic peptides.  
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2.3.2 Temperature and concentration dependence 
As described above, introduction of a hydrophobic tail to either terminus of 
hexapeptide KTVIIE did not affect the tendency of the peptide to form fibrils in solution, nor 
its conformation and fiber morphology. Temperature-dependent CD measurements were 
deployed to investigate whether the stability of the fibril structures was affected by the 
presence of the alkyl chains.45 On increasing the temperature to 80 °C the spectrum of the 
model peptide 1 changed to a minimum at 200 nm and a maximum at 220 nm (Figure 6). 
Such a spectrum is typical for a random coil-conformation of this peptide. This change was 
not readily reversible upon cooling, indicating that fibril structures were completely disrupted. 
The β-sheet spectrum returned only slowly after maintaining the peptide solution for several 
days at room temperature.  
In contrast, the CD spectra of both the C- and N-terminally modified peptides 2 and 3 
did not change on increasing the temperature up to 90 °C (Figure 6), neither did subsequent 
cooling of the samples lead to any change in structure. TEM showed that fibrils were still 
present in the solutions of the amphiphilic peptides after heating the sample, in accordance 
with the observed CD-signal. The temperature experiments show that the properties of the 
peptide fibrils are not only determined by the amino acids, but also by the hydrophobic tail. 
The hydrophobic tails introduce stability to the peptide fibrils, to the extent that the peptide 
structure stays unchanged over a temperature range from 4 °C up to 90 °C. 
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Figure 6. CD spectra of peptides in the range of 20-80 °C; A) Ac-KTVIIE 1, arrow 
indicates the change on temperature increase from a spectrum indicating a β-sheet to a 
random conformation; B) C16-KTVIIE 2, showing a spectrum typical for a β-sheet at 
all temperatures. 
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As a second tool to probe the stability of the fibrils, the effect of peptide concentration 
on assembly behavior was investigated for the series of peptide 1 and 2. A solution of an 
amphiphile will contain assemblies if the concentration is higher than the critical aggregation 
concentration, below which the amphiphile will be molecularly dissolved. The higher 
hydrophobicity of the amphiphilic peptides should lower this critical concentration compared 
to that of Ac-KTVIIE-NH2. Fibrils formed by peptide 2 were therefore expected to be stable 
at a lower concentration. 
A dilution series was made with glycine buffer, starting from a peptide concentration 
of approximately 0.6 mM which showed a minimum at 220 nm and a maximum at 200 nm in 
the CD spectrum. The diluted samples were equilibrated overnight at room temperature. The 
CD spectra were recorded in a 1 mm quartz cell, since the absorption of the used glycine 
buffer below 200 nm prohibited the use of a 1 cm cell. 
Diluting the solution of peptide 1 caused a change of the CD-spectrum. At 
concentrations below 60 µM the minimum at 220 nm in the CD spectrum disappeared and a 
minimum at 195 nm appeared. This indicates that also upon dilution the fibrils disassemble. 
In contrast, the CD spectrum of the amphiphilic peptide 2 did not change upon dilution; the 
minimum at 220 nm was present down to the lowest concentrations in which the CD signal 
could be measured accurately (Figure 7). Therefore, introduction of the hydrophobic tail to 
the peptide sequence stabilizes the fibrils formed by the peptide down to a concentration of at 
least 10 µM. 
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Figure 7. CD spectra of fibril forming peptide at a concentration range. A) Ac-
KTVIIE 1 showing a transition below 7 µM; B) C16-KTVIIE 2 showing a constant 
signal at all concentrations; C) Ratio of the peaks at 200 nm to 220 nm of peptides 1 
and 2 at the concentrations. Lines are presented to guide the eye. 
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CD spectroscopy, TEM and IR spectroscopy indicated that the introduction of an alkyl 
tail did not influence fibril structure and the folding of the peptide in the fibril. In order to 
determine whether the peptides 1 and 2 would co-assemble the mixing behavior of the 
hexapeptides was examined in some preliminary experiments. Clear aqueous solutions of 
fibrils of Ac-KTVIIE-NH2 and C16-KTVIIE-NH2 were mixed in a 1:1 molar ratio. The 
mixture was sonicated for 60 minutes at 50 ºC and left overnight at room temperature. 
Temperature scan measurements in the CD spectrometer showed characteristics of both stable 
C16-KTVIIE-NH2 assemblies and the dissolution of Ac-KTVIIE-NH2 assemblies. CD spectra 
recorded after cooling down the samples also indicated that separate assemblies of both 
peptides were present. Therefore, with this experimental setup peptides 1 and 2 do not co-
assemble into fibrils.  
In conclusion, introduction of a hydrophobic alkyl tail to the KTVIIE peptide 
sequence increases the stability of the fibrils formed by the peptide. At the same time the 
structure of the fibrils is not influenced by the introduction of the alkyl tail.  
 
2.4 Varying the hydrophobic domain 
 
2.4.1 Influence of chain length on peptide assembly 
To further examine the scope of the stabilization a series of peptides was synthesized 
with decreasing hydrophobic character. In phospholipids the length of the hydrophobic tails 
influences the assembly properties of the molecules. The longer the hydrophobic groups the 
lower the critical assembly concentration. Furthermore, the length of the alkyl group 
influences other properties such as melting temperature of the assemblies. Therefore, variation 
of the alkyl tail length in the lipopeptides could be used to fine-tune the assembly properties. 
Since C-terminally and N-terminally functionalized peptides showed identical 
stabilization, only the N-functionalized series was prepared, because the latter are 
synthetically more readily available. The aggregation properties of peptides 5-9 at room 
temperature and at a concentration of 0.5 mg mL-1 were first examined. The CD spectra of 
these peptides showed a negative peak at 220 nm and a positive peak at 200 nm indicating the 
presence of peptide aggregates of a structure similar to peptides 1 and 2, TEM pictures again 
showed the presence of fibrils with a morphology comparable to that of the model peptide 
(figure 8). 
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Figure 8. TEM pictures of C8-KTVIIE 6 (a), C10-KTVIIE  7 (b), C12-KTVIIE 8 (c) 
and of C14-KTVIIE 9 (d); (bars represents 200 nm) 
 
 
IR spectra of the peptides showed a strong amide I band at 1625 cm-1 and the amide II 
band at 1535 cm-1 consistent with a β-sheet conformation (figure 9, table III). The increasing 
length of the alkyl tails was reflected in a corresponding increase in the absorption band of the 
C-H vibration at 2925 and 2850 cm-1. Again this was in accordance with the structures of both 
peptide 1 and 2 as described above. Varying the hydrophobic domain from the acetyl to the 
C16 tail does not influence the assembly behavior and conformation of the peptide, as far as 
can be observed by IR spectroscopy.  
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Figure 9. IR spectra of hydrophobically modified KTVIIE peptides in the amide 
vibration region. 
 
 
Table III: Observed frequencies (cm-1) of polypeptides in various conformations44 
compared to the frequencies observed for lyophilized samples of fibrils. 
 Amide I  Amide II  
Random coil 1656 (s)  1535 (s)  
Alpha helix 1650 (s) 1652 (m) 1516 (w) 1546 (s) 
Parallel beta 1645 (w) 1630 (s) 1530 (s) 1550 (w) 
Anti Parallel beta 1685 (w) 1632 (s) 1530 (s)  
C8-KTVIIE 6 1675 (w) 1625 (s) 1545 (s)  
C10-KTVIIE 7 1675 (w) 1625 (s) 1545 (s)  
C14-KTVIIE 9 1675 (w) 1625 (s) 1545 (s)  
 
2.4.2 Temperature and concentration dependence 
The influence of length of the hydrophobic group on temperature stability of the 
peptide fibrils was examined.46 On increasing the temperature of a 0.6 mM solution of the C6 
functionalized peptide 5 the CD spectrum showed a marked decrease of the intensity of the 
peak at 220 nm. Keeping the sample at 80 °C the peak at 220 nm disappeared whereas a peak 
at 190 nm became more intense, indicating a decrease in structure and hence the disassembly 
of the fibrils. Upon cooling, the peak at 220 nm did not return. Compared to model peptide 1 
the disappearance of the fibrils is however a slower process. The transition temperature of 
peptide 5 was 70 ºC, whereas in case of the non-modified peptide 1 already at 40 ºC the 
process of disassembly could be observed. 
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The CD spectra of the C8 and C10 functionalized peptides 6 and 7 also changed upon heating. 
The intensity of the minimum at 220 nm and the maximum at 200 nm decreased (figure 10). 
However, the CD-spectra did not change into spectra which were reminiscent of random coil 
structures. Furthermore, the change was fully reversible; upon cooling the original CD-spectra 
were obtained. The solution of C12 functionalized peptide 8 showed a stable CD spectrum in 
the whole examined temperature range. Expectedly peptide 9 with the C14 tail also had a 
stable CD spectrum already observed for the C16 functionalized peptides 2 and 3 (figure 10). 
TEM pictures of the solutions of the peptides with alkyl tails of C8 (6) and longer showed 
fibrils, irrespective of thermal history (Figure 11).  
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Figure 10. CD spectra at different temperatures in the range from 20-80 °C of 
C8-KTVIIE 6 (left) and C12-KTVIIE 8 (right). Arrow indicates the change on 
temperature increase 
 
The temperature measurements show that a small increase in hydrophobic interactions 
can already have a profound effect on the stability of peptide aggregates and peptide folding 
in the aggregate. Upon the introduction of the C6 alkyl tail the disassembly temperature 
increases by 30 ºC compared to the fibers obtained from the non-alkylated peptide 1. 
However, the general temperature behavior of the molecule is still the same and the fibrils 
completely dissociate while the formation of the fibrils is seemingly not affected. Increasing 
the alkyl length to C8 or C10 moves the disassembly temperature so high it is not attainable 
anymore in water.  
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Figure 11. TEM pictures of fibrils formed by C8-KTVIIE 6 before (A) and after (B) 
heating to 80 °C (bars represents 200 nm). 
 
For peptides 6 and 7 with a C8 and C12 tail respectively the CD signal changed 
somewhat on increasing the temperature. This change was readily reversible suggesting the 
assemblies were at least partly intact, though the peptide conformation changed slightly. The 
change in the CD spectrum suggests that while the fibrils are stable at increased temperatures 
the peptide structure is flexible (Figure 12).  Finally, extending the alkyl tail length to 12 and 
higher to 14 and 16 carbon atoms, the conformation of the peptide is fixed and the assembly is 
stable. 
 
Figure 12. Effect of hydrophobic tail on peptide fibril stability at 80 °C. A) Soluble 
peptides when the tail is C6 or shorter, B) Some freedom for conformational change of 
the peptide in the fibril for C8 and C10, C) Stable fibrils at 80 °C for C12 and longer 
hydrophobic tails. 
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Because a marked difference was found for peptides 1 and 2 in their behavior upon 
dilution also the concentration dependence of aggregates of acylated peptides 5-9 was 
determined using CD spectroscopy. On dilution the CD spectrum of the C6 functionalized 
peptide 5 changed at concentrations below 40 µM. Compared to model peptide 1 the 
transition took place over a broader concentration range, and at a lower concentration. 
Similarly to the effect on the aggregate stability at increased temperatures the hexyl tail was 
capable to a certain level of stabilization.  
In contrast to peptide 5 with the C6 tail the aggregates of peptides with longer tails did 
not disassemble upon dilution. The CD spectrum showed a distinct minimum at 220 nm down 
to the lowest concentration that could be measured, indicating that the peptide fibrils are 
stable at low micromolar concentrations. No difference was observed between the CD spectra 
of C8 compound 6 and C12 compound 8 in these dilution series. This is in contrast to the 
difference observed in the CD spectra of these compounds at increased temperatures 
described above. This suggests that the behavior at increased temperature is related to the 
melting temperature of the n-alkyl chains. 
In conclusion introduction of an alkyl tail to the KTVIIE peptide stabilizes the 
assemblies formed. Tails shorter than C6 induce some stabilization but the fibrils disassemble 
at 80 ºC and below 40 µM. Introduction of C8 and C10 chains results in stable fibrils, 
although there is some flexibility in the assemblies at 80 ºC and the folding of the peptide can 
change somewhat. For C12 and longer hydrophobic tails the conformation of the peptide in 
the fibril is stabilized to 90 ºC. 
 
2.5 Fluorous stabilization 
Not only normal alkyl groups can be used to introduce hydrophobicity, also 
fluorinated alkyl chains can be used for this purpose. Fluorinated alkyl tails not only behave 
hydrophobically in aqueous environment, but can also form assemblies in organic solvents in 
which alkanes dissolve.47 Furthermore, fluorinated amino acids have been introduced in 
sequences to enhance selectivity of peptide interactions and folding.48-50  
Fluorous tails were introduced at the N-terminus of the Lys-Thr-Val-Ile-Ile-Glu 
hexapeptide. As described above the hexapeptide was synthesized on the solid phase. Two 
different fluorinated tails were introduced using C6F13C2H2COOH and C7F15COCl. The 
former was synthesized following a literature procedure.51 A standard peptide coupling using 
DIPCDI as a coupling agent in the presence of HOBt in DMF was used to couple 
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C6F13C2H2COOH to the peptide N terminus. The acid chloride C7F15COCl was added to the 
peptide in the presence of DIPEA. This approach resulted in complete acylation of the N-
terminus of the peptide. The fluorinated peptides were cleaved off the resin using TFA/H2O 
(95/5).  
The peptides resulted in clear solutions in MilliQ water at a concentration of 1 mg/mL, 
after sonication at 50 ºC. The CD spectra of these solutions showed a β-sheet like spectrum 
with a minimum at 220 and a maximum at 200 nm. Upon heating the sample from 20 ºC to 90 
ºC and cooling back again there was a reversible increase of the intensity maximum at 200 
nm. This change in the CD spectrum is opposite to the change observed for the alkylated 
peptides (6 and 7, with C8 and C10 tails respectively), where the peak at 200 decreased in 
intensity upon an increase in temperature. The difference might be a result of a different 
aggregation behavior of the fluorinated alkyl tails compared to the standard tails. Still, the 
stabilizing effect of the fluorous tail is apparent. 
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Figure 13. CD spectra of C7F15CO-KTVIIE-NH2 at 20 and 90 ºC 
 
C7F15CO-KTVIIE-NH2 was mixed with Ac-KTVIIE-NH2 in a 1:1 ratio. The peptides 
were separately dissolved in trifuorethanol, the solutions were mixed and after evaporation to 
dryness redissolved in MilliQ to a final concentration of 1 mg mL-1. Solutions of the pure 
compounds were prepared following the identical procedure. The CD spectra of pure 
compounds were identical to the spectra of the same peptides directly dissolved from solid. 
The spectrum of the mixture was consistent with a linear combination of the spectra of both 
compounds in the mixture.  
Chapter 2 
 
 42 
Introduction of a fluorinated tail to the KTVIIE peptide stabilized the assemblies of 
the peptide. The stabilization was similar to the effect of an alkyl tail of the same length, 
showing stabilization of the fibrils at increased temperatures with a small and reversible 
change in conformation of the peptide.  
 
2.7 Conclusion 
Based on the results described in this chapter it can be concluded that introduction of 
hydrophobic tails to peptide 1 is an efficient method to stabilize aggregates formed by this 
peptide in glycine buffer. Remarkably TEM, IR and CD spectroscopy show that the 
morphology of the aggregates and the conformation of the peptide are not influenced by the 
introduction of the additional hydrophobic interactions. This strong morphological stability is 
independent of functionalization at either N- or C-terminus of the peptide. The peptide 
therefore controls the morphology of the aggregates, while introduction of alkyl tails only 
results in a higher stability of the fibrils to an increased temperature and lower concentrations. 
Although the introduction of linear hydrocarbons with up to 10 carbon atoms already leads to 
remarkable added thermal stability, this induced stability seems to be maximal when the alkyl 
tail is C12 or longer. In contrast to previous examples where the systematic increase of 
hydrophobic interactions showed a steady increase in melting temperature52 or a slow change 
in aggregate morphologies,7 in our β-sheet forming peptide added hydrophobic interactions 
seem to work as a switch without affecting the peptide conformation.  
 
2.8 Experimental 
Methods and materials 
1H-NMR spectra were measured on a Varian Inova 400 MHz NMR spectrometer. MALDI-TOF spectra 
were measured on a Bruker Biflex II mass spectrometer, 2,5-dihydroxybenzoic acid (DHB) was used as matrix. 
UV-Vis measurements were performed on a Varian Cary 50 UV-Vis spectrophotometer and CD measurements 
were performed on a Jasco J-810 spectropolarimeter with Peltier temperature control. IR spectra were recorded 
on a Thermo Wattson IR300 spectrometer, fitted with a Harrick ATR unit. Transmission Electron Microscopy 
was performed on a JEOL 1010 transmission microscope. Peptides were synthesized on a Labortec SP4000 or a 
Labortec SP640 semi-automatic peptide synthesizer. Peptide couplings were followed to completion using the 
Kaiser test.34 Low adhesion eppendorf tubes were obtained from BIOplastics (B74030). All reagents were 
obtained from common commercial sources and used as received. 
 
Synthesis of peptide R1-Lys-Thr-Val-Ile-Ile-Glu-NH2 (1,2,5-9) 
 The peptide was synthesized using standard Fmoc peptide synthesis on a Breipohl resin.27,28 Peptide 
coupling was achieved using 3 equivalents of Fmoc amino acid and diisopropylcarbodiimide (DIPCDI, 3.3 eq.) 
with N-hydroxy benzotriazole (HOBt, 3.6 eq.) in DMF. The resin was swollen in DMF for 20 minutes prior to 
use. The Fmoc-group was removed using piperidine in DMF (20% v/v, 3 times 6 minutes). After coupling of the 
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final amino acid the Fmoc-protected peptide on the resin was washed thoroughly with DMF, dichloromethane, 
methanol and diethyl ether. The resin was dried in vacuum and divided in batches. 
The dry resin was swollen for 30 minutes in DMF. Subsequently the Fmoc protecting group was removed 
using piperidine in DMF (20% v/v). The resin was washed well with DMF and dichloromethane. Three 
equivalents of the aliphatic carboxylic acid were dissolved in dichloromethane and 3.6 equivalents of HOBt (1M 
in DMF) were added. After mixing 3.3 equivalents of neat DIPCDI were added. The solution was added to the 
resin and the resin was agitated for 18 hours. Peptide 1 was synthesized by treating the detrotected peptide on the 
resin with acetic anhydride. To DMF 10 equivalents of acetic anhydride and 20 equivalents of pyridine was 
added. This mixture was added to the resin and the mixture was agitated for 30 minutes. After washing the resin 
with DMF, dichloromethane, methanol and diethyl ether the resin was dried in vacuo. The peptides were cleaved 
from the resin by treatment with trifluoroacetic acid/water (95/5, v/v) for 4 hours. After precipitation in diethyl 
ether the peptides were lyophilized from acetic acid. The peptides were characterized using 1H-NMR 
spectroscopy and MALDI-TOF mass spectrometry of which the details are summarized in the table below. 
 
Synthesis of peptide R1-Lys-Thr-Val-Ile-Ile-Glu-NHC16H33 (3,4) 
The C-terminal n-hexadecylamine tail for peptides 3 and 4 was introduced through reductive amination of 4-
(4-formyl-3-methoxyphenoxy)butyryl aminomethyl resin.53 In 15 mL of a mixture of DMF and methanol (1/1, 
v/v) 10 mmol of n-hexadecylamine was dissolved. To this solution 10 mmol of acetic acid, 10 mmol of 
NaCNBH3 and 1.0 g of resin (1.0 mmol) were added. The mixture was stirred slowly and heated to 80 °C for two 
hours. Subsequently the resin was washed thoroughly with methanol and dichloromethane. To the secondary 
amine formed on the resin Fmoc protected glutamic acid was coupled using standard Fmoc solid phase 
methodology using 3 equivalents of the protected amino acid dissolved in DMF,  HOBt (1M in DMF, 3.6 eq) 
and DIPCDI (1M in DMF, 3.3 eq.). After 1 hour this reaction mixture was refreshed and subsequently the 
reaction mixture was left for 18 hours. The resin was washed with DMF and treated with 10 equivalents of acetic 
anhydride in the presence of pyridine to cap any possibly remaining secondary amines. The resin was washed 
using DMF, methanol, dichloromethane and diethyl ether and was dried thoroughly. The loading of the dry resin 
was determined using an Fmoc-cleavage UV-assay and was found to be 0.37 mmol g-1 (75 % of theoretical 
yield). 
With the resulting resin the other amino acids were again coupled using the standard Fmoc solid phase 
synthesis protocol. After coupling of the final amino acid, the Fmoc-protected peptide on the resin was washed 
thoroughly with DMF, dichloromethane, methanol and diethyl ether. The resin was dried in vacuum and divided 
in batches.The dry resin was swollen for 30 minutes in DMF. Subsequently the Fmoc protecting group was 
removed using piperidine in DMF (20% v/v). The resin was washed well with DMF and dichloromethane. 
Acylation of the N-terminus was achieved by either a standard peptide coupling of n-hexanoic acid or treatment 
with acetic anhydride in the presence of pyridine. In the first case (4) 3 equivalents of n-hexanoic acid was 
dissolved in dichloromethane and 3.6 equivalents of HOBt (1M in DMF) were added. Finally 3.3 equivalents of 
neat DIPCDI was added to this solution. The resin was washed using DMF, dichloromethane, methanol and 
diethyl ether. After drying the products were cleaved from the resin by treatment with trifluoroacetic acid (95%, 
water 5%) during three hours. After cleavage the peptides were purified by precipitation in diethyl ether. The 
peptides were characterized using 1H-NMR spectroscopy and MALDI-TOF mass spectrometry  
 
 MALDI-TOF mass spectra peptides 1-9 
Compound Structural 
formula 
(M+H)+ 
calc 
(M+Na)+ 
calc 
(M+H)+ (M+Na)+ 
1 C34H62N8O10 743.46 765.45 743.08 765.07 
2 C48H90N8O10 939.68 961.67 939.25 961.24 
3 C50H94N8O10 967.71 989.70 967.33 989.31 
4 C64H122N8O10 1163.93 1185.92 1163.67 1185.66 
5 C38H70N8O10 799.52 821.51 799.36 821.38 
6 C40H74N8O10 827.55 849.54 827.41 849.39 
7 C42H78N8O10 855.58 877.57 855.48 877.43 
8 C44H82N8O10 883.62 905.61 883.47 905.50 
9 C46H86N8O10 912.65 934.64 912.33 934.31 
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II 1H-NMR spectra peptides 1-9 
 
CH3CO-Lys-Thr-Val-Ile-Ile-Glu-NH2 1 
12.0 (br s, 1H), 8.0 (d, 1H) 7.9 (m, 1H) 7.8 (m, 2H) 7.5 (m,1H), 7.1 (s 1H), 7.0 (s, 1H), 4.9 (s, 1H), 4.3 (q, 1H), 
4.2 (q, 2H), 4.1 (t, 3H), 3.9 (q, 1H), 2.7 (t, 1H), 2.2 (t, 2H), 1.9, (s, 1H), 1.8 (s, 3H), 1.7 (m, 4H), 1.5 (q, 2H), 1.4 
(m, 2H), 1.3 (m, 3H), 1.0 (m, 4H) 0.8 (m, 24H) 
 
C15H31CO-Lys-Thr-Val-Ile-Ile-Glu-NH2  2 
12.0 (br s, 1H), 8.0 (d, 1H), 7.9 (d, 1H) 7.85 (t, 2H), 7.7 (d, 1H), 7.5 (m, 3H) 7.0 (s 1H), 7.9 (s, 1H), 4.9 (s, 1H), 
4.2 (q, 2H), 4.1 (t, 3H), 3.9 (q, 1H), 2.7 (t, 2H), 2.2 (t, 2H), 2.1 (t, 2H), 1.9, (m, 2H), 1.7 (m, 4H), 1.5 (m, 4H), 
1.4 (m, 2H), 1.2 (s, 28H), 1.05 (q, 2H), 0.95 (d, 2H), 0.8 (t, 2H), 0.75 (m, 20H) 
 
CH3CO -Lys-Thr-Val-Ile-Ile-Glu-NHC16H33 3  
12.0 (br s, 1H), 8.0 (d, 1H), 7.9 (d, 1H) 7.85 (t, 2H), 7.75 (d, 1H), 7.7 (t, 1H), 7.6 (m, 3H), 4.8 (d, 1H), 4.3 (q, 
1H), 4.2-4.1 (m, 5H), 3.9 (q, 1H), 2.7 (q, 2H), 2.2 (q, 2H), 1.9, (s, 1H), 1.8 (s, 3H), 1.65 (m 4H), 1.45 (q, 3H), 1.4 
(m, 6H), 1.2 (s, 33 H), 1.0 (m, 4H), 0.8 (m, 24H) 
 
C15H31CO-Lys-Thr-Val-Ile-Ile-Glu-NHC16H33 4 
12.0 (br s, 1H), 8.0 (d, 1H), 7.9 (d, 1H) 7.85 (t, 2H), 7.7 (d, 1H), 7.5 (m, 3H) 7.0 (s 1H), 7.9 (s, 1H), 4.9 (s, 1H), 
4.2 (q, 2H), 4.1 (t, 3H), 3.9 (q, 1H), 2.7 (t, 2H), 2.2 (t, 2H), 2.1 (t, 2H), 1.9, (m, 2H), 1.7 (m, 4H), 1.5 (m, 4H), 
1.4 (m, 2H), 1.2 (s, 60H), 1.05 (q, 2H), 0.95 (d, 2H), 0.8 (m, 26H) 
 
C5H9CO-Lys-Thr-Val-Ile-Ile-Glu-NH2  5 
12.0 (br s, 1H), 8.0 (d, 1H), 7.9 (d, 1H) 7.8 (m, 3H), 7.5 (m, 3H) 7.0 (s 1H), 7.9 (s, 1H), 4.9 (s, 1H), 4.2 (q, 2H), 
4.1 (t, 3H), 3.9 (q, 1H), 2.7 (t, 2H), 2.2 (t, 2H), 2.1 (t, 2H), 1.9, (m, 2H), 1.7 (m, 4H), 1.5 (m, 4H), 1.4 (m, 2H), 
1.2 (s, 4H), 1.05 (q, 2H), 0.95 (d, 2H), 0.8 (t, 2H), 0.75 (m, 20H) 
 
C7H15CO-Lys-Thr-Val-Ile-Ile-Glu-NH2 6 
12.0 (br s, 1H), 8.0 (d, 1H), 7.9 (d, 1H) 7.85 (t, 2H), 7.7 (d, 1H), 7.5 (m, 3H) 7.0 (s 1H), 7.9 (s, 1H), 4.9 (s, 1H), 
4.2 (q, 2H), 4.1 (t, 3H), 3.9 (q, 1H), 2.7 (t, 2H), 2.2 (t, 2H), 2.1 (t, 2H), 1.9, (m, 2H), 1.7 (m, 4H), 1.5 (m, 4H), 
1.4 (m, 2H), 1.2 (s, 10H), 1.05 (q, 2H), 0.95 (d, 2H), 0.8 (t, 2H), 0.75 (m, 20H) 
 
C9H19CO -Lys-Thr-Val-Ile-Ile-Glu-NH2 7 
12.0 (br s, 1H), 8.0 (d, 1H), 7.9 (d, 1H) 7.85 (t, 2H), 7.7 (d, 1H), 7.5 (m, 3H) 7.0 (s 1H), 7.9 (s, 1H), 4.9 (s, 1H), 
4.2 (q, 2H), 4.1 (t, 3H), 3.9 (q, 1H), 2.7 (t, 2H), 2.2 (t, 2H), 2.1 (t, 2H), 1.9, (m, 2H), 1.7 (m, 4H), 1.5 (m, 4H), 
1.4 (m, 2H), 1.2 (s, 14H), 1.05 (q, 2H), 0.95 (d, 2H), 0.8 (t, 2H), 0.75 (m, 20H) 
 
C11H23CO -Lys-Thr-Val-Ile-Ile-Glu-NH2  8 
12.0 (br s, 1H), 8.0 (d, 1H), 7.9 (d, 1H) 7.85 (t, 2H), 7.7 (d, 1H), 7.5 (m, 3H) 7.0 (s 1H), 7.9 (s, 1H), 4.9 (s, 1H), 
4.2 (q, 2H), 4.1 (t, 3H), 3.9 (q, 1H), 2.7 (t, 2H), 2.2 (t, 2H), 2.1 (t, 2H), 1.9, (m, 2H), 1.7 (m, 4H), 1.5 (m, 4H), 
1.4 (m, 2H), 1.2 (s, 20H), 1.05 (q, 2H), 0.95 (d, 2H), 0.8 (t, 2H), 0.75 (m, 20H) 
 
C13H27CO -Lys-Thr-Val-Ile-Ile-Glu-NH2  9 
12.0 (br s, 1H), 8.0 (d, 1H), 7.9 (d, 1H) 7.85 (t, 2H), 7.7 (d, 1H), 7.5 (m, 3H) 7.0 (s 1H), 7.9 (s, 1H), 4.9 (s, 1H), 
4.2 (q, 2H), 4.1 (t, 3H), 3.9 (q, 1H), 2.7 (t, 2H), 2.2 (t, 2H), 2.1 (t, 2H), 1.9, (m, 2H), 1.7 (m, 4H), 1.5 (m, 4H), 
1.4 (m, 2H), 1.2 (s, 24H), 1.05 (q, 2H), 0.95 (d, 2H), 0.8 (t, 2H), 0.75 (m, 20H) 
 
Synthesis of C6F13C2H2COOH (12) 51 
In a flask equipped with a cooler and a dropping funnel containing 10 g (21 mmole) 
1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-8-iodooctane dissolved in 15 mL dry diethyl ether, 0.52 g (21 mmole) of 
magnesium turnings and 35 mL dry diethyl ether were placed. While stirring 1 ml of the iodooctane solution was 
added at room temperature. After the start of the reaction the remainder of the iodooctane solution was slowly 
added during an hour. After the addition was completed the solution was stirred for 2 hours, during this time the 
solution became turbid. The solution was cooled with a waterbath to 5 °C and solid carbondioxide was added, 
The reaction was stirred for 20 minutes resulting in a precipitate. Subsequently 25 mL of a 25% solution of 
H2SO4 was added and the reaction mixture was allowed to warm to room temperature. The aqueous phase was 
separated and the diethyl ether was extracted 3 times using a 10 M NaOH solution. The NaOH layers were 
combined and heated to 100 °C for 15 minutes. Subsequently the aqueous layers were cooled to 0 °C and 50% 
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H2SO4 was carefully added to yield a white precipitate. After filtration the solid was washed with cold water, and 
subsequently dried in vacuum. Finally recrystallization from toluene yielded pure white crystals of 
4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononanoic acid (3.3 g, 8.4 mmol, 40%). The product was characterized and 
found to be identical to literature values. 
 
Synthesis of C6F13C2H2CO- Lys-Thr-Val-Ile-Ile-Glu-NH2 (10) 
The peptide was prepared by standard solid phase peptide protocol. Fluorinated tail 12 (3.0 equivalents) was 
dissolved in DMF and mixed with 3.6 equivalents of HOBt (1M solution in DMF). To this mixture 3.3 
equivalents of DIPCDI (1M in DMF) were added and after mixing the solution was immediately added to the 
resin. After 18 hours the resin was washed with DMF, dichloromethane, methanol and diethyl ether and finally 
dried in vacuo. The peptides were cleaved from the resin by treatment with trifluoroacetic acid/water (95/5, v/v) 
for 4 hours. After precipitation in diethyl ether the peptide was lyophilized from acetic acid. Maldi-TOF Mass 
(C41H63F13N8O10) calc.: 1074.45, obs.: 1097.17 ([M+Na])+, 1119.15 ([M+2Na-H])+ 
 
 
Synthesis of C7F15CO- Lys-Thr-Val-Ile-Ile-Glu-NH2 (11) 
The peptide was prepared described by standard solid phase peptide protocol. Perdecafluorooctanoylchloride 
(3.0 equivalents) was dissolved in DMF and DIPEA (6.0 equivalents) was added. This solution was added to the 
resin and the reaction mixture was agitated for 18 hours. After washing the resin with DMF, dichloromethane, 
methanol and diethyl ether the resin was dried in vacuo. The peptides were cleaved from the resin by treatment 
with trifluoroacetic acid/water (95/5, v/v) for 4 hours. After precipitation in diethyl ether the peptide was 
lyophilized from acetic acid. Maldi-TOF Mass (C40H59F15N8O10) calc.: 1096.41, obs.: 1119.11 ([M+Na])+, 
1131.10 ([M+2Na-H])+ 
 
Fibril formation 
Solutions of peptides with a concentration of approximately 1 mg mL-1 were prepared in a pH 2.5, 20 mM 
glycine-HCl buffer, in low adhesion Eppendorf tubes. The buffer was filtered through a 0.2 µm filter prior to 
use. The samples were sonicated at 50 °C for 30 minutes. Not all peptides completely dissolved upon this 
treatment and therefore all solutions were again filtered through a 0.2 µm GHP membrane filter, after which the 
concentration was determined as described below. The peptide solutions were incubated for 5 days to allow for 
fibers to form. 
Dilution series were prepared from the filtrated 1 mg mL-1 solutions of peptide. After dilution the samples were 
incubated overnight at room temperature.  
 
Mixed peptide solutions 
Clear solutions of fibrils of 1 mg mL-1 of Ac-KTVIIE-NH2 and C16-KTVIIE-NH2 in buffer were mixed in 
low adhesion eppendorf tubes. The mixture was sonicated at 50 °C for 1 hour, subsequently the sample was 
slowly cooled to room temperature and stored at room temperature. 
Solutions of C7F15CO-KTVIIE-NH2 and Ac-KTVIIE-NH2 were prepared in trifluoroethanol. Solutions were 
transferred to low adhesion eppendorf tubes to obtain tubes with 1 mg C7F15CO-KTVIIE-NH2 , 1mg Ac-
KTVIIE-NH2 and 1 mg of a 1:1 mixture of both. The trifluoroethanol was removed using a nitrogen-flow and 
subsequent vacuum. The dry peptide was redissolved in 1 mL MilliQ water by sonication at 50 °C for 30 
minutes, yielding clear solutions. The solutions were left for 5 days to allow for fibrils to form. 
 
Determination of resin loading by Fmoc cleavage assay54 
To determine the loading of Fmoc-protected amino acids on a resin an Fmoc cleavage assay was used. In 
triplicate 1-2 mg of dry resin (an estimated 1 µmole Fmoc) was weighed. To each sample 3 mL of a piperidine 
solution (20 % in DMF) was added, the mixture was agitated and left for 20 minutes. Before taking the sample 
the dispersion was quickly homogenized and the resin was left to settle. UV spectra were recorded of the 
samples and of the piperidine solution and the absorbance at 290 nm was recorded (Abs). The loading was 
determined by the following calculation: Fmoc loading (mmole/g) = (Abssample-Absref)/(1.65 ·  mg resin).  
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Determination of concentration 
Acetylated peptide 1 was dissolved in 20 mM glycine-HCl buffer of pH 2.5 to a concentration of 1 mg mL-1 
(0.74 mM) by sonication. From the clear solution a dilution series was prepared. The UV absorption spectrum of 
the solutions was determined in a 1 mm quartz cell at 220 nm (ε/dm3 mol-1 cm-1 4430). The concentration of 
peptide amphiphile solutions was determined using this known absorption coefficient. 
 
CD spectroscopy 
Samples were measured at 25 °C in a 1 mm quartz cell. Temperature dependent CD measurements were 
performed in a temperature range from 20 to 90 °C. The temperature was decreased or increased at a speed of 3 
°C per minute. The ellipticity was followed at 222 nm at 0.5 nm intervals, while a full spectrum was measured 
every 10 °C. 
 
IR spectroscopy 
Solutions of fibrils in water were lyophilized and the dry samples were compressed on the ATR crystal with 
a pressure of 0.5 Kg. Infrared spectra were recorded for 128 scans at 2cm-1 resolution. 
 
TEM 
A carbon-coated grid was placed on a drop of peptide solution for 5 minutes. The grid was blotted, dried in 
vacuo and shadowed with platinum under an angle of 45˚. 
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 Disassembling peptide-based fibers by switching the 
hydrophobic-hydrophilic balance‡ 
 
 
In this chapter a convenient methodology is described to disassemble peptide fiber 
assemblies by manipulating the hydrophobic – hydrophilic balance. For this purpose peptides 
were modified with both a hydrophilic and a cleavable hydrophobic moiety, of which the 
overall balance of non-covalent interactions was still in favor of peptide assembly. After 
cleaving off the hydrophobic tail, the peptide fibers spontaneously disassembled. 
                                                 
‡
 Part of this chapter has been published: J.T. Meijer, M.J.A.G. Henckens, I.J.  Minten, 
D.W.P.M. Löwik, J.C M.  van Hest; Soft Matter 2007, 3, 1135-1137 
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3.1 Introduction 
Alkylated peptides represent a versatile class of self-assembling building blocks, due 
to the subtle interplay between directional hydrogen-bonds and hydrophobic interactions.1-3 
This versatility has recently been explored in a variety of applications. For example Stupp et 
al. have demonstrated the usefulness of peptide amphiphile assemblies for the construction of 
bioactive materials.4-7 Furthermore, well defined peptide aggregates have also been used to 
direct and organize assemblies of synthetic polymers to enhance material properties.8-10 One 
of the interesting aspects of peptide assembly is that it can be affected by changing the 
balance between the non-covalent forces that govern the supramolecular architecture. 
Induction of peptide assembly has in this respect already been shown using light,11-13 
chemical switches14,15 and enzymes.16-18 In all of these cases, changes in hydrophobicity lead 
to an increased inclination towards aggregation. In the previous chapter it has been shown that 
introduction of a hydrophobic tail to amyloid-like fibril forming hexapeptide Ac-Lys-Thr-
Val-Ile-Ile-Glu-NH2 (KTVIIE) also increased the stability of the fibrils and rendered the 
assemblies amenable to manipulation.19 Upon attachment of the hydrophobic moiety complete 
absence of fiber disassembly was observed, even at elevated temperatures (up to 90 ºC), 
whereas the unmodified peptide could be disassembled upon heating.19,20 
Contrary to triggered peptide assembly, the reverse process, i.e. controlled peptide 
fiber disassembly by changing non-covalent interactions in situ has not been studied 
extensively.21,22 Such a strategy is worth while pursuing since it could lead to new release 
mechanisms of bioactive peptide fragments and controlled degradation processes for e.g. 
biomedical applications.7 In this chapter we describe a convenient methodology to 
disassemble peptide fiber assemblies by manipulating the hydrophobic – hydrophilic balance. 
The strategy to achieve this goal is depicted in figure 1. The fibril forming peptide 
KTVIIE is first modified with a hydrophilic PEG moiety (i), to prevent assembly of the 
peptide. Next an additional hydrophobic moiety is introduced (ii), which causes the overall 
balance of non-covalent interactions to be in favor of peptide assembly. Removing this 
stabilizing group in situ (iii) should now allow us to trigger the disassembly of the fibrils. In 
order to investigate this possibility peptides are synthesized, which contain both a hydrophilic 
PEG moiety and an alkyl chain. In this case the alkyl chain is connected to the peptide via the 
UV cleavable nitrobenzyl moiety.23-25 Finally, as an alternative approach to disrupt peptide 
fibrils the in situ coupling of a solubilizing PEG tail to a fibril in solution is explored (iv), 
using the 2+3 cycloaddition reaction between azides and alkynes.26 
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Figure 1. Control of peptide fibril stability using hydrophobic and hydrophilic groups; 
KTVIIE forms amyloid-like fibrils in solution; i) introduction of a PEG tail should 
prevent assembly ii) introduction of an additional hydrophobic tail should stabilize 
fibrils; iii) in situ removal of the stabilizing tail destroys fibrils; iv) in situ introduction 
of a PEG moiety to KTVIIE destroys fibrils. 
 
 
 
 
 
 
3.2 Synthesis 
3.2.1 Synthesis of peptides 
In the previous chapter the stabilization of assemblies of the amyloid forming 
hexapeptide Ac-Lys-Thr-Val-Ile-Ile-Glu-NH2 was discussed (peptide 1, Figure 2). It was 
shown that the introduction of a hydrophobic moiety led to a complete absence of fiber 
disassembly, even at elevated temperatures (up to 90 ºC), whereas the unmodified peptide 
could be disassembled upon heating.19,20 Now, we wanted to investigate whether the opposite 
effect could be achieved by introduction of a hydrophilic group. Therefore, the peptide was 
synthesized on a resin containing an immobilized PEG moiety of 3 kg mol-1 by solid phase 
peptide synthesis following a standard Fmoc-protection group protocol, yielding after 
cleavage C-terminally modified KVTIIE (figure 2, peptide 2). 
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Figure 2. Peptides synthesized; Ac-KTVIIE-NH2 1; pegylated hexapeptide Ac-
KTVIIE-PEG 2; amphiphilic peptides: C2n+4-KTVIIE-PEG 3a-f (a: n=1; b: n=2; c: 
n=3; d: n=4; e: n=5; f: n=6); peptides containing a UV cleavable nitrobenzyl moiety 
C12-hν-KTVIIE-PEG 4a (n=5) and C18-hν-KTVIIE-PEG 4b (n=8); Alkyne-
functionalized KTVIIE 5 for in solution functionalization with PEG 
 
 
In order to establish whether the solubilizing effect of the PEG chain could be 
counterbalanced hydrophobic tails were introduced N-terminally. The pegylated peptides 
were synthesized on a resin as described above. After the final amino acid was coupled, an 
alkyl chain could be introduced efficiently by a classical carbodiimide mediated coupling with 
the corresponding aliphatic carboxylic acid (peptides 3a-f, Figure 2). This final coupling was 
best performed in dichloromethane rather than DMF, due to solubility issues as discussed in 
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chapter 2. Peptides were cleaved from the resin by treatment with TFA/H2O (95/5) for 4 
hours. Shorter cleavage times lowered the yield, but more peptide could be removed from the 
resin repeating the cleavage procedure. The peptides could be precipitated in diethyl ether and 
lyophilized from acetic acid.  
Furthermore, two peptides modified with either a C12 or C18 tail were synthesized 
containing a UV cleavable linker between the hydrophobic group and the N-terminus (figure 
2, structures 4a-b).23-25 The UV cleavable hydrophobic tail was synthesized as a single 
building block in order to facilitate solid phase synthesis (scheme 1). The UV cleavable 
nitrobenzyl moiety was synthesized following a modified literature procedure.27 The p-
nitrophenol carbonate building blocks were synthesized from commercially available 3-nitro-
4-bromomethylbenzoic acid, as shown in scheme 1. Also the commercially available 2-
nitroterephthalic acid-1-methyl ester was considered as a starting material for the preparation 
of benzylalcohol 7. However, procedures to selectively reduce the methyl ester only resulted 
in products that were difficult to purify and therefore this route was not further explored. 
Alternatively, benzylbromide 6 was easily transformed into the corresponding alcohol 7 in a 
95% yield.28 Either dodecylamine or octadecylamine were coupled to 4-(hydroxymethyl)-3-
nitrobenzoic acid using BOP (benzotriazole-1-yl-oxy-tris-(dimethylamino)-
phosphoniumhexafluorophosphate) as a coupling agent yielding 8a and 8b. The use of BOP 
prevented any polymerization of 7 as might be expected when employing stronger acylating 
agents such as N,N'-dicyclohexyl-carbodiimide (DCC). The two different chain lengths were 
chosen because in advance it was uncertain whether the nitrobenzyl moiety would affect fibril 
formation. The combination of a C12 chain with the benzyl linker was estimated to be 
comparable in length with a C16 alkyl chain. The C18 analogue was expected to give more 
stable assemblies, due to its greater hydrophobicity. C12 and C18 compounds 8a and 8b were 
obtained in yields of at least 86% from carboxylic acid 7. Finally, para-nitrophenol 
chloroformate was reacted with the alcohol, resulting in the final building blocks 9a and 9b 
after column chromatography in an 80% and 79% yield respectively. The para-nitrophenol 
leaving group allows the tail to react with the free N-terminus of a peptide on the solid phase 
during synthesis. After the final Fmoc protecting group was removed, 9a or 9b was added in 
dry dichloromethane in the presence of DIPEA. The peptides were cleaved from the resin 
using TFA/H2O, precipitated in diethyl ether, and finally lyophilized from acetic acid. 
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Scheme 1. Synthesis of the UV cleavable hydrophobic tail. 
 
The UV cleavable group was chosen because it met several requirements. First a 
cleavable site has to be minimally intrusive; it should not inhibit the formation of the fibrils. 
Furthermore, incorporation between the hydrophobic tail and peptide along the backbone 
should be chemically compatible with solid phase peptide synthesis and cleavage protocols. 
Finally, inducing the switch should not affect the rest of the molecule or the assemblies apart 
from the effect of the removal of the stabilizing moiety.  
In a parallel synthesis of the peptides described in Chapter 2 and the pegylated 
peptides described above the synthesis of the latter proceeded more smoothly; none of the 
amide couplings and deprotections was troublesome. It is conceivable that the PEG chain 
might destabilize aggregation of the peptide on the resin, or even prevent interactions between 
the peptide and the polystyrene based resin. 
Finally, in order to be able to couple PEG in situ to peptide fibrils via the 2+3 
cycloaddition reaction between azides and alkynes (click chemistry)29,30 pentynoic acid 
functionalized KTVIIE 5 (figure 5) was synthesized from a Breipohl amide resin, in the same 
way as the N-alkylated peptides in Chapter 2.31,32  Pentynoic acid was coupled to the free 
amine of the peptide on the resin through a classical carbodiimide mediated coupling. 
Pentynoic acid was used in the functionalization of the peptide because propionic acid was 
shown to lead to a lot of side reactions in our hands. Furthermore, the slightly longer 
pentynoyl tail was expected to yield some additional stability to the fibril, as observed earlier 
for C6-KTVIIE-NH2 (Chapter 2). 
 
3.2.2 Preparation of peptide solutions 
Solutions of the pegylated peptides were prepared according to the following general 
procedure. Each peptide was dissolved in a 20 mM glycine-HCl buffer (pH 2.5) or MilliQ 
water to a concentration of 0.6 mM. The samples were sonicated at 50 °C for 30 minutes, 
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resulting in clear solutions. The peptide solutions were filtered and subsequently incubated for 
5 days to allow for fibers to form. CD spectra were identical for solutions prepared in buffer 
and in water. Because pure water has a larger transmission window in CD this resulted in 
more informative CD spectra. Furthermore, the absence of salt in the MilliQ solution also 
improved TEM-sample preparation.  
 
3.3 Peptide assembly 
3.3.1 Influence of PEG 
The presence of fibrillar assemblies in a solution of Ac-KTVIIE-PEG3000 2 in water 
was examined using CD spectroscopy and TEM.33 The peptide showed a CD spectrum with a 
minimum at 200 nm (Figure 3). The CD spectrum did not change over the course of several 
weeks. Furthermore, varying the temperature of the peptide solution between 4 °C and 90 °C 
did not have any effect on the CD spectrum. Increasing the concentration of the peptide from 
2 mg mL-1 to 6 mg-1 also resulted in similar CD spectra. Furthermore, no fibrils were 
observed using TEM microscopy. 
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Figure 3. CD spectrum of pegylated peptide 2 showing a random coil type CD 
spectrum, with spectra of model peptide 1 free in solution and assembled as 
comparison. 
  
The spectrum of the pegylated KTVIIE peptide was identical to the spectrum of Ac-
KTVIIE-NH2 when it was not assembled in fibrils (chapter 2). This indicated that the peptide 
was in a random coil fold and therefore in a non-aggregated state. Whereas for peptide 1 a 
slow self-assembly process was observed,20 the presence of the PEG chain increased the 
solubility of the peptide and prevented the assembly into fibrils. The random coil type 
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spectrum of peptide 2 did not change during several weeks. Ac-KTVIIE-NH2 showed a 
minimal assembly concentration of about 0.06 mM, while pegylated peptide 2 did not yet 
form fibrils at 1.6 mM, which is evidence for a strong inhibitory effect on the self-assembling 
process.  
 
3.3.2 Hydrophobic stabilization 
Introduction of PEG to the beta-amyloid fibril forming hexapeptide either increased 
aggregation concentration dramatically or prevented peptide assembly altogether. On the 
other hand, addition of a C16 tail to KTVIIE
 
lowered the critical assembly concentration from 
60 µM to below 3 µM, Therefore, the introduction of a C16 tail to a KTVIIE-PEG peptide 
could possibly bring back the ability of the peptide to self-assemble. 
The CD spectrum of C16-KTVIIE-PEG (3f) showed a CD spectrum with signals at 
220 nm and at 200 nm (Figure 4). This CD spectrum is similar to the spectra obtained for the 
previously examined self-assembling amphiphilic peptides such as peptide 1 above the critical 
aggregation concentration after they formed fibrils. On heating the solution of 3f to 90 °C the 
CD spectrum did not change indicating a stable aggregate of the peptide. TEM confirmed that 
fibrils were present in the sample (Figure 5). 
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Figure 4. CD spectrum of C16-KTVIIE-PEG (3f), showing a beta sheet type CD 
spectrum typical of fibril assemblies, with spectra of peptide 2 and model peptide 1 
free in solution and assembled as comparison. 
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Figure 5. TEM picture of fibrils formed by C16-KTVIIE-PEG, bar represents 2 µm. 
 
 
3.3.3 Varying the hydrophobic domain 
 As described above Ac-KTVIIE-PEG 2 does not form assemblies in solution while 
C16-KTVIIE-PEG 3f does. In order to establish what hydrophobic domain is required to 
stabilize fibrils of pegylated KTVIIE, the peptide series 3a-e was investigated. Introduction of 
a C6 tail (3a) resulted in a CD spectrum with a minimum at 200 nm (Figure 6A), identical to 
the spectrum of peptide 2. The same CD spectrum was observed for peptides with a C8 and 
C10 tail (3b and 3c respectively). Changing the concentration of the solutions or the 
temperature did not result in changes in the CD spectra. Furthermore no structures were found 
using TEM microscopy. 
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Figure 6. A) CD spectra of pegylated KTVIIE peptides. Acylated 2 and C10 
functionalized 3c show a spectrum typical for the dissolved species; C12 
functionalized 3d and C16-KTVIIE-PEG 3f  show a beta sheet type CD spectrum 
typical of fibril assemblies. B) TEM picture of fibrils formed by C12-KTVIIE-PEG 
(3d) bar represents 500 nm. 
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Upon increasing the length of the hydrophobic tail further to C12 (3d) the CD 
spectrum of the peptide had a minimum at 220 nm and a maximum at 200 nm (Figure 6A). 
This CD spectrum did not change on increasing the temperature to 90 °C. The same was 
observed for the peptide with a C14 tail (3e). In both cases fibrils were present in TEM 
pictures (Figure 6B). Therefore, the CD spectra showed that the small change in the length of 
the hydrophobic tail between C10 and C12 resulted in a large change in the assembly 
properties of the peptides. This suggests that once a critical hydrophobicity is acquired a 
strong stabilization of the assemblies is established (Figure 7). 
 
 
Figure 7. Influence of a hydrophobic alkyl tail on the N-terminus on the formation of 
peptide fibrils. Peptides 2 and 3a-c with tails of C10 and shorter do not form fibrils, 
while peptides 3d-f with stabilizing tails longer than C12 do. 
 
To gain more information on the effect of the hydrophobic stabilization on peptide 
folding infrared spectra were recorded of lyophilized aqueous solutions of peptides 2, 3c, 3e 
and 3f (Figure 8). The first two peptides do not form fibrils in solution while the latter two do. 
Spectra showed bands at 1630 cm-1 and 1550 cm-1, with a broad signal at 1675 cm-1. These 
bands are indicative of a beta-sheet conformation of the peptide (Table I).34,35 IR spectroscopy 
on the fibrils in aqueous solution was attempted, but no vibrational bands could be observed. 
In contrast to the CD data, the interpretation of the IR spectra was therefore 
inconclusive, since beta-type amide absorption bands were observed not only in the samples 
in which fibril-assemblies are present according to CD and TEM, but also in the samples 
where molecularly dissolved species were expected. Nevertheless, since the KTVIIE 
sequence has a high tendency to aggregate it is not inconceivable that the peptides will form 
fibrils at very high concentrations and in the solid state. Therefore, the observed IR spectra on 
the lyophilized samples do not provide additional information on the assembly behavior in 
solution that is summarized above in figure 7. 
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Figure 8. Amide region of the IR spectra of Ac (2), C10 (3c), C12 (3d) and C16 (3f) 
KTVIIE-PEG peptides, the first two dissolve while the latter two form fibers in 
solution according to CD spectroscopy and TEM.  
 
Table I:  Amide vibrations of peptides 2 and 3c, d, f (cm -1) with theoretically derived 
vibration bands for several secondary protein structures.35 
 Amide I  Amide II  
Random coil 1656 (s)  1535 (s)  
Alpha helix 1650 (s) 1652 (m) 1516 (w) 1546 (s) 
Parallel beta 1645 (w) 1630 (s) 1530 (s) 1550 (w) 
Anti Parallel beta 1685 (w) 1632 (s) 1530 (s)  
Ac-KTVIIE-PEG 2 1675 (w) 1630 (s) 1550 (s)  
C10-KTVIIE-PEG 3c 1675 (w) 1630 (s) 1550 (s)  
C12-KTVIIE-PEG 3d 1675 (w) 1630 (s) 1550 (s)  
C16-KTVIIE-PEG 3f 1675 (vw) 1630 (s) 1550 (s)  
 
To try and determine the difference in peptide interactions between the fibrils and the 
dissolved peptides 1H NMR spectra were recorded of Ac-KTVIIE-PEG and C16-KTVIIE-
PEG in D2O. In both species the signals of the amino acids were well defined in the spectrum, 
and the signal of the alkyl tail of C16-KTVIIE-PEG was highly attenuated. This indicates a 
conformational freedom of the peptide segment of the construct. In contrast, the presence of a 
strongly packing hydrophobic domain seems to be paramount in the assembly of the 
amphiphilic species. This is in accordance with the observed minimal C12 length of the 
hydrophobic domain required to induce fibril formation. 
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3.3.4 Influence of the UV cleavable linker 
We postulated the introduction of a UV cleavable group able to remove the fibril 
stabilizing hydrophobic tail would allow us to disassemble the fibrils. For this purpose a 
nitrobenzyl based UV sensitive linker was introduced between the hydrophobic tail and the 
peptide (figure 2). To determine the influence of the introduction of this nitrobenzyl moiety 
on the formation of fibrils two analogues were prepared, one with a C12 tail (4a) and one with 
a C18 tail (4b). The C12 tail should reflect any negative effect of the introduction of the UV 
cleavable linker as the shortest stabilizing group for the pegylated peptide contained 12 
carbon atoms, whereas the C18 tail was expected to introduce a large stabilizing effect on 
fibrils.  
After incubating a solution of peptide 4a containing the UV-cleavable linker with the 
C12 tail no beta-sheet type CD signal could be observed; the CD spectrum was similar to the 
non-fibril forming pegylated peptides (Figure 9). Furthermore, no fibrils could be found using 
TEM. Increasing the temperature of the solution to 90 ºC did not result in a change in the CD 
spectrum. The influence of the included linker on the assembly probably caused this domain 
to be too short to stabilize fibrils. 
In contrast peptide 4b with the C18 tail formed the same fibril structures as the 
amphiphilic peptide 3f, corroborated by CD spectroscopy and TEM. Apparently, the C18 
moiety compensated for any destabilizing effect of the nitrobenzyl linker, as the CD spectrum 
did not change up to 90 ºC. The CD spectrum of cleavable peptide 4b only differed at 200 nm 
compared to C16 functionalized peptide 3f (Figure 9). This is attributed to the presence of the 
UV cleavable linker, which also absorbs in this region.  
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Figure 9. A) CD spectra of peptides 2, 3f, 4a and 4b; B) TEM picture of fibrils 
formed by C18-hν-KTVIIE-PEG (4b) bar represents 2 µm. 
 
 
3.4 Fiber disassembly by UV exposure 
As described above we are able to manipulate the assembly of a fibril forming peptide. 
Pegylation of hexapeptide KTVIIE prevented aggregation, while subsequent introduction of a 
hydrophobic n-alkyl group longer than C12 overcame this solubilizing effect. In order to 
determine the effect and dynamics of the removal of the hydrophobic tail solutions of 4a and 
4b were exposed to UV radiation and CD spectra were recorded. Typically a peptide solution 
was placed in a 1 mm quartz cell, 5 cm below the terminus of a quartz lightguide. The shutter 
was opened for a minute and after exposure the sample was moved to the CD spectrometer to 
record the CD spectrum. Exposure and CD spectroscopy were repeated for at least an hour or 
until no further change in the CD spectrum was observed. Exposure times were lengthened up 
to 15 minutes when the CD spectrum showed no change during the shorter exposures. 
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Figure 10. Disassembly of Cn-hν-KTVIIE-PEG peptide fibrils by UV initiated 
removal of a stabilizing hydrophobic tail. 
 
Irradiation of a solution of C12 peptide 4a with a strong UV-source did not result in 
any changes to the CD spectrum, even after one hour of irradiation (Figure 11). In contrast, 
irradiation of assemblies of C18 peptide 4b resulted in clear changes to the CD spectrum after 
3 minutes of exposure (Figure 12a). The ratio of the peaks at 200 and 220 nm increased, 
characteristic for a change from β-sheet to random coil (Figure 12a). Prolonged exposure 
changed the CD spectrum completely to a spectrum typical for the dissolved state, showing 
the destruction of the fibrils which was substantiated by TEM confirming the absence of 
fibrillar structures. The presence of an isosbestic point in figure 12A indicates a two state 
mechanism in the change from fibrils to dissolved peptides. During extended waits between 
cycles of exposure the CD spectrum did not change, showing the dependence of the 
disassembly process on UV light. Furthermore, sonication of an intermediately disassembled 
sample did not change the CD spectrum either. The effect of the UV exposure on the 
cleavable peptide was also monitored via a TLC experiment. The solutions of peptides 4a and 
b were spotted on the plate before and after exposure to UV. The spots of the complete 
peptide disappeared during the exposure. 
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Figure 11. CD spectra of C12-hν-KTVIIE-PEG 4a exposure to UV radiation, the 
random coil type signal does not change upon exposure up to an hour.   
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Figure 12. A) C18-hν-KTVIIE 4b upon exposure to UV, showing a transition from a 
β-sheet like spectrum to a random coil spectrum. B) Peptide C18-hν-KTVIIE-PEG 4b, 
ratio of the CD signals at 200 nm and 220 nm upon exposure to UV radiation. 
 
Using the intense UV source complete disassembly of the fibrils took almost an hour 
of exposure, implying a low reactivity of the linker. In order to ascertain that the observed 
effect solely depended on this exposure, solutions of peptide 4b were exposed to different UV 
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sources.  A solution in a 1 mm cell placed for an hour under the UV source used to examine 
TLC plates (366 nm) did not show a change in the CD spectrum. Furthermore, the CD 
spectrum of a sample of 4b that was exposed for 10 hours to 350 nm radiation in a Jasco 810 
CD spectrophotometer had not changed.  
In a control experiment fibers of peptide 3f without the labile linker were exposed to 
the same powerful UV-source for 1 hour. The minimum at 220 nm did not change, but the 
maximum of the peak at 200 nm increased. This change does not indicate a change in the 
beta-sheet fold of the peptide in solution, because the signal still represents the beta-sheet fold 
best. The change in signal could be a result of an increase in temperature of the sample during 
the exposure to the UV source. The UV exposure therefore did not disrupt the assembly of the 
fibrils.  
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Figure 13. Exposure of C16-KTVIIE-PEG 3f to a UV source, showing the persistence 
of the β-sheet like spectrum. 
 
 
3.5 Fiber disassembly by conjugation 
As shown above pegylated KTVIIE amphiphiles do not assemble if the hydrophobic 
tail is shorter than C12. Furthermore, hydrophobically stabilized fibrils can be disassembled 
by removing the hydrophobic tail. An alternative approach to disrupt peptide fibrils in situ 
would be the coupling of a solubilizing PEG tail to a peptide fibril in solution. The 
conjugation reaction should be selective and the reaction conditions should be mild enough 
not to disrupt the fibrils. Moreover, the reaction has to be compatible with the aqueous 
environment of the fibrils. A reaction that fulfills these requirements is the copper (I) 
catalyzed alkyne-azide cycloaddition.36 
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The copper catalyzed alkyne-azide cycloaddition resulting in triazoles is a variant of 
the Huisgen 1,3-dipolar cycloaddition.29,30 The selective Cu(I)-catalyzed reaction takes place 
under mild biocompatible conditions and in a regioselective manner, which makes this a 
robust bioconjugation reaction in aqueous systems, often referred to as a ‘click’ reaction.36 
The reaction has been used for a wide variety of reactions such as functionalization of 
polymers and proteins and cyclization of peptides. 26,37-40  
 
3.5.1 Assembly of fibrils 
As described above in chapter 3.2.1 alkyne functionalized peptide 5 could be readily 
synthesized. To ascertain that peptide 5 still formed fibrils in aqueous solution CD spectra 
were recorded of the solution at room temperature. The CD spectrum showed a negative peak 
at 220 nm and a positive peak at 200 nm indicating the presence of peptide aggregates of a 
structure similar to Ac-KTVIIE-NH2 1. Furthermore, TEM pictures showed the presence of 
fibrils with morphology comparable to that of Ac-KTVIIE-NH2 1. In order to determine 
whether the presence of the alkyne tail influences the stability of the peptide fibrils CD 
spectra were recorded at various temperatures. Upon increasing the temperature of the 
solution of peptide 5 from 20 to 90 °C the intensity of the peaks decreased above 50 °C, but 
the spectrum remained characteristic for a beta-fold of the peptide (figure 14a) . Upon cooling 
the change in the spectrum was fully reversible. This stabilization of the fibrils by the alkyne 
tail is similar to the behavior of C8-KTVIIE as described in chapter 2. Since a C12 tail was 
necessary to form fibrils of pegylated KTVIIE as described in 3.4 above, we still expected the 
fibrils of peptide 5 to disassemble upon conjugation with PEG. 
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Figure 14. A) Alkyne functionalized KTVIIE 5, CD spectra at various temperatures, 
the minimum at 215 nm and the maximum at 195 nm indicate the presence of fibrils at 
all temperatures; B) TEM picture of fibers formed by peptide 5, bar represents 
500 nm. 
 
3.5.2 Clicking: conjugation of PEG 
To a solution of fibrils of peptide 5 in water one equivalent of PEG-azide 
(2.0 kg mol-1) was added. To this mixture one equivalent of copper(II)sulfate and 1.5 
equivalents of sodium ascorbate were added and the mixture was diluted with water to a final 
peptide concentration of 0.3 mM. As a control a sample was prepared lacking the copper 
sulfate. The reaction mixtures were left to stand at room temperature. CD spectra of the 
reaction mixture containing the copper catalyst were recorded at regular intervals during 18 
hours, the CD spectrum of the fibers in the reaction mixture containing copper initially 
changed. Specifically, immediately after addition of all reagents the CD spectrum resembled 
that of the peptide 5 at 90 °C. During the 18 hours however, no more changes were observed. 
The minimum at 220 nm and the maximum at 200 nm remained and no change in the ratio 
was observed. Upon heating the sample to 90 °C this spectrum did not change either (Figure 
15). Even after a week at room temperature the spectrum did not completely convert to a 
random coil conformation. The reaction mixture without copper showed a similar behavior, 
therefore the change in the CD spectrum upon addition of the reagents might be the result of 
the  presence of ascorbate. 
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Figure 15. CD spectra of  alkyne functionalized KTVIIE 5 after addition of CuSO4, 
Ascorbic acid and PEG-N3. The spectra were recorded at various temperatures. 
 
To establish whether cycloaddition had occurred mass spectra were recorded from the 
solutions after 24 hours of reaction. Clearly, an additional mass distribution was observed in 
the reaction mixture containing the copper catalyst, at a mass that was expected for the 
reaction product (Figure 16). However, not all of the alkyne and azide groups were converted 
as both unreacted peptide and PEG-azide could still be observed. This could explain why the 
CD spectrum of the reaction mixture even after 18 hours of reaction time did not change to a 
random coil conformation. In contrast in the reaction mixture without Cu no peptide-PEG 
conjugate was observed. 
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Figure 16. Mass spectroscopy images of A) Peptide 5 mixed with PEG-N3, B) Crude 
reaction mixture of peptide 5 with PEG-N3, CuSO4 and sodiumascorbate, showing the 
distribution corresponding to the product. 
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Using the click approach through the copper (I) catalyzed alkyne-azide cycloaddition 
it was possible to introduce a PEG tail to preformed fibrils of the KTVIIE peptide. But the 
introduction did not disrupt the fibrils present in solution, as indicated by CD spectroscopy. In 
contrast, peptides C6-KTVIIE-PEG 3a and even C10-KTVIIE-PEG 3c with similar 
hydrophobic and hydrophilic groups as the reaction product of the click reaction did not form 
fibrils in solution. Mass spectroscopy of the reaction mixture containing copper indicated that 
not all PEG-N3 and peptide did react. However, it was expected that even a mixture of 
dissolved peptides and fibrils should result in a different CD spectrum then observed for the 
reaction mixture as was shown in chapter 2.3.2. Possibly the stability of the fibrils formed by 
peptide 5 is too great to be disrupted by the introduction of the PEG chain and brush-like 
structures are formed. In that case steric effects could be partially responsible for the 
incomplete reaction. The presence of fibrils after the click reaction could however not be 
corroborated by electron microscopy. 
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3.6 Conclusion 
The introduction of the hydrophilic group to amyloid-fiber forming peptide KTVIIE 
inhibited the formation of structured assemblies of this peptide. Upon increasing the 
hydrophobic character of the peptide by introducing an additional N-terminal alkyl chain the 
well-structured aggregates return. Interestingly the transition from soluble to fibril forming 
peptide takes place on a small increase of the hydrophobic character; i.e. on an increase of the 
length of the introduced n-alkyl group from 10 to 12 carbon atoms.  
This led to the possibility of controlling the presence of peptide fibrils in situ. In a first 
approach a UV cleavable nitrobenzyl moiety was introduced between the pegylated peptide 
and the hydrophobic tail. The introduction of this group lessened the stabilizing effect of the 
hydrophobic group, but this negative effect could be overcome by a lengthening of the tail 
from C12 to C18. Exposure of the fibrils of the peptide containing the cleavable linker to UV 
led to the disruption of the assemblies, resulting in dissolved peptide. In a second approach a 
handle was introduced to the peptide to enable the selective introduction of PEG to pre-
formed fibrils. Although this approach resulted in the formation of pegylated peptide the 
fibrils were not disrupted.  
 
3.7 Experimental 
Methods and materials 
1H-NMR spectra were measured on a Varian Inova 400 MHz NMR spectrometer. MALDI-TOF spectra 
were measured on a Bruker Biflex II mass spectrometer, 2,5-dihydroxybenzoic acid (DHB) was used as matrix. 
Electrospray mass spectra were recorded on a Thermo LCQ or JEOL Accu-TOF. UV-Vis measurements were 
performed on a Varian Cary 50 UV-Vis spectrophotometer.  Peptides were synthesized on a Labortec SP4000 or 
a Labortec SP640 semi-automatic peptide synthesizer. All reagents were obtained from common commercial 
sources and used as received. Transmission Electron Microscopy was performed on a JEOL 1010 transmission 
microscope. A carbon-coated grid was floated on a drop of fibril solution for 5 minutes. The grid was blotted and 
dried in vacuo. 
 
4-(hydroxymethyl)-3-nitrobenzoic acid 7 
This compound was prepared according to a modified literature procedure41. 0.26 g (1.0 mmol) 3-nitro-4-
bromomethylbenzoic acid 6 and 0.53 g (5.0 mmol) Na2CO3 were dissolved in 4 mL H2O and 4 mL acetone. The 
mixture was heated to reflux for 5 hours. Subsequently, the acetone was removed by evaporation. The residual 
solution was washed with diethyl ether and concentrated HCl was added until a precipitate was formed at pH 2. 
The resulting suspension was extracted with ethyl acetate while the pH was kept at 2. The combined organic 
layers were washed with water, dried over MgSO4, filtered and concentrated to a brown solid. The product was 
purified by column chromatography on silica yielding an orange solid (eluent: dichloromethane, methanol, acetic 
acid (89/10/1, v/v/v)) (yield: 70%). Rf 0.26.  
Analytical data were in accordance with that reported.41 1H-NMR (DMSO-d6): δ ), 13.55 (s, 1H, COOH) 
8.45 (d, 1H, Ar-H), 8.25 (dd, 1H, Ar-H), 7.95 (d, 1H, Ar-H), 5.67(s, 1H, CH2OH), 4.86 (s, 2H, CH2-OH). 
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4-(hydroxymethyl)-3-nitro-N-dodecylbenzamide 8a 
0.20 g (1.0 mmol) 4-(hydroxymethyl)-3-nitrobenzoic acid 7 and 0.19 g (1.00 mmol) C12H25NH2 were 
dissolved in dichloromethane (~2.5 mL), 0.44 g (1.00 mmol) benzotriazole-1-yl-oxy-tris-(dimethylamino)-
phosphoniumhexafluorophosphate BOP and 270 µl (2.00 mmol) N,N-diisopropylethylamine were added. The 
reaction mixture was stirred overnight; pH was kept at 8 The reaction mixture was evaporated in vacuo and the 
product was dissolved in ethylacetate. The mixture was washed three times with 1M HCl and with water, 1M 
NaHCO3, water and finally brine. The ethyl acetate was dried over MgSO4 filtered and the solvent was 
evaporated in vacuo. The product was purified by column chromatography (eluent: dichloromethane, methanol, 
acetic acid (84/5/1, v/v/v)) to afford a 90% yield. Rf 0.37  1H-NMR (CDCl3): δ 0.88 (t, 3H), 1.26 (m, 18H), 1.64 
(qu, 2H), 3.48 (q, 2H), 5.05 (s, 2H), 6.26 (t, 1H), 7.88 (d, 1H), 8.06 (d, 1H), 8.44 (s, 1H). 
 
4-(hydroxymethyl)-3-nitro-N-octadecylbenzamide 8b 
0.20 g (1.0 mmol) 4-(hydroxymethyl)-3-nitrobenzoic acid 7 and 0.27 g (1.0 mmol) C18H37NH2 were 
dissolved in dichloromethane (2.5 mL), 0.44 g (1.0 mmol) benzotriazole-1-yl-oxy-tris-(dimethylamino)-
phosphoniumhexafluorophosphate (BOP) and 345 µl (2.0 mmol) N,N-diisopropylethylamine were added and the 
mixture was stirred overnight while the pH was kept at 8. The reaction mixture was evaporated in vacuo and the 
product was dissolved in ethylacetate. The mixture was washed three times with 1M HCl and with water, 1M 
NaHCO3, water and finally brine. The ethyl acetate was dried over MgSO4 filtered and the solvent was 
evaporated in vacuo. The product was purified by column chromatography (eluent: dichloromethane, methanol, 
acetic acid (84/5/1, v/v/v)) to afford a 90% yield. Rf 0.29. 1H-NMR (DMSO-d6) δ 8.70 1H (t), 8.58 1H (d), 8.25 
1H (dd), 7.85 1H (d), 5.60 1H (s), 4.80 2H (s), 3.25 2H (q), 1.5 2H (quint), 1.26 4H (m), 1.20 26H (s), 0.80 3H 
(t). ESI-Ion trap: Calcd. mw. for C26H45N2O4 = [M+H]+: 449.34 , found: 449.36. 
 
4-(dodecylcarbamoyl)-2-nitrobenzyl 4-nitrophenyl carbonate 9a 
0.37 g (1.00 mmol) 4-(hydroxymethyl)-3-nitro-N-dodecylbenzamide 8a, 125 µl (1.50 mmol) pyridine and 
0.10 g (1.05 mmol) 4-nitrophenyl chloroformate were dissolved in distilled THF and stirred at 0 °C for 2 hours 
under argon atmosphere. The solvent was evaporated in vacuo and the product was redissolved in 
dichloromethane. The mixture was washed with brine and 1M HCl, dried over Na2SO4 and the volatiles were 
evaporated in vacuo. Column chromatography, in dichloromethane/methanol (97.5/2.5 v/v), afforded the product 
as a white solid in a 79% yield. Rf 0.54. 1H-NMR (CDCl3): δ 8.53 (d, 1H), 8.29 (dt, 2H), 8.16 (dd, 1H), 7.81 (d, 
1H), 7.42 (dt, 2H), 6.53 (t, 1H), 5.76 (s, 2H), 3.49 (q, 2H), 1.65 (qu, 2H), 1.33 (m, 18H), 0.88 (t, 3H).  13C-NMR 
(CDCl3) δ 164.7, 155.4, 152.2, 147.2, 145.8, 136.4, 133.8, 132.8, 129.4, 125.6, 123.8, 121.9, 67.2, 40.8, 32.1, 
29.8, 29.7, 29.5, 27.2, 22.9, 14.3. ESI-TOF: Calcd. for [C27H35N3O8 + Na]+ 552.23210, found 552.23218. 
 
4-(octadecylcarbamoyl)-2-nitrobenzyl 4-nitrophenyl carbonate 9b 
0.48 g (1.00 mmol) 4-(hydroxymethyl)-3-nitro-N-octadecylbenzamide 8b, 125 µl (1.50 mmol) pyridine and 
0.10 g (1.05 mmol) 4-nitrophenyl chloroformate were dissolved in distilled THF and stirred at 0 °C for 2 hours 
under argon atmosphere. The solvent was evaporated in vacuo and the product was redissolved in 
dichloromethane. The mixture was washed with brine and 1M HCl, dried over Na2SO4 and the volatiles were 
evaporated in vacuo. Column chromatography (eluent: dichloromethane/methanol (97.5/2.5 v/v), afforded the 
product as a white solid in a 79% yield. Rf 0.54. 1H-NMR (DMSO-d6) δ 8.80 1H (t), 8.58 1H (d), 8.30 2H (d), 
8.25 1H (dd), 7.85 1H (d), 7.58 2H (d), 5.69 2H (s), 3.25 2H (q), 1.5 2H (quint), 1.26 4H (m), 1.20 26H (s), 0.80 
3H (t).  13C-NMR (CDCl3) δ 164.7, 155.4, 152.2, 147.2, 145.8, 136.4, 132.8, 129.4, 125.6, 123.8, 121.9, 67.2, 
40.8, 32.1, 29.9(broad), 28.81, 29.76, 29.6, 29.5, 27.2, 22.9, 14.3. ESI-TOF: Calcd. for [C33H47N3O8 + Na]+ 
636.326, found 636.322. 
 
Ac-Lys-Thr-Val-Ile-Ile-Glu-NH2 1 
The synthesis of this compound is described in Chapter 2. 
 
H2n+1CnCO-Lys-Thr-Val-Ile-Ile-Glu-NH-PEG-OH 2, 3 
The peptides were synthesized from a tentagel PAP resin (Rapp Polymere). The resin was swollen in N,N-
dimethylformamide (DMF) for 30 minutes before use. The coupling reactions were carried out in DMF with 
three equivalents of Fmoc protected amino acid in the presence of N-hydroxybenzotriazole (HOBt; 3.6 
equivalents) and diisopropylcarbodiimide (DIPCDI; 3.3 equivalents). The amide coupling was monitored for 
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completion with a Kaiser Test.42,43 The Fmoc protecting group was removed by treatment of the resin with a 
20% solution of piperidine in DMF (v/v) (3 times 6 minutes). Between each step the resin was washed 
thoroughly with DMF. The completed peptide was washed with DMF, dichloromethane, isopropanol, 
dichloromethane and finally diethyl ether and subsequently dried in vacuo. The resin was divided in batches that 
were further functionalized. 
Dry Fmoc-Lys-Thr-Val-Ile-Ile-Glu-NH-PEG-resin was swollen in DMF for 1 hour and subsequently treated 
with piperidine (20% in DMF v/v, three times 6 minutes). The resin was washed with DMF and 
dichloromethane. Three equivalents of the appropriate n-alkyl carboxylic acid were dissolved in 
dichloromethane; HOBt (3.6 equivalents, 1M in DMF) and neat DIPCDI (3.3 equivalents) were added and the 
resulting mixture was added to the resin. (For the acetyl group 10 equivalents of acetic anhydride and 10 
equivalents of pyridine were employed instead) The suspension was agitated overnight. The resin was washed 
thoroughly with dichloromethane and methanol, finishing with dichloromethane. The final product was cleaved 
from the resin in 4 hours by treatment with TFA/water (95/5 v/v). The resin was removed by filtration and the 
peptide was isolated by precipitation in diethyl ether. 
A typical 1H-NMR (DMSO-d6) is given for H31C15CO- Lys-Thr-Val-Ile-Ile-Glu-NH-PEG-OH 2f : δ 12.1 
1H (br s), 8.15 1H (d), 8.0 3H (m), 7.80 1H (t), 7.65 4H (m), 4.7 1H (s), 4.2 4H (m), 3.9 1H (q), 3.7 2H (t) 3.6 
110H (s), 2.8 2H (t), 2.2 2H (q), 2.0 2H (m), 1.9 2H (d), 1.7 4H (m), 1.5 2H (m), 1.4 2H (m), 1.2 28H(s), 1.0 (q, 
2H), 1.1 2H (d), 0.75 25H (m). 
 
H2n+1CnCO-linker-Lys-Thr-Val-Ile-Ile-Glu-NH-PEG-OH 4. 
Fmoc-Lys-Thr-Val-Ile-Ile-Glu-NH-PEG-resin was swollen in DMF for 1 hour and subsequently treated with 
piperidine (20% in DMF v/v, three times 6 minutes). The resin was washed with DMF and dichloromethane. 
Two equivalents of nitrophenyl carbonate 9 were dissolved in dry dichloromethane and three equivalents of 
N,N-diisopropylethylamine were added. The mixture was added to the resin and the reaction mixture was 
agitated overnight. The resin was washed using dichloromethane, DMF, dichloromethane, methanol and diethyl 
ether and dried in vacuo. The peptide was cleaved from the resin using a mixture of TFA, water, ethanedithiol 
and triisopropylsilane (92.5/2.5/2.5/2.5 by volume). The peptide was isolated by precipitation in diethylether. 
NMR H35C17CO-linker-Lys-Thr-Val-Ile-Ile-Glu-NH-PEG-OH 1H-NMR (DMSO-d6) (δ ppm): 12.1 1H (br s), 
8.75 1H (t), 8.50 1H (d) 8.15 1H (d), 8.0 3H (m), 7.80 1H (t), 7.65 4H (m), 7.6 1H (d), 5.4  2H (s), 4.7 1H (s), 
4.2 4H (m), 3.9 1H (q), 3.7 2H (t) 3.6 110H (s), 2.8 2H (t), 2.2 2H (q), 2.0 2H (m), 1.9 2H (d), 1.7 4H (m), 1.5 
2H (m), 1.4 2H (m), 1.2  30H (s), 1.0 (q, 2H), 1.1 2H (d), 0.75 25H (m) 
 
 
Alkyne Lys-Thr-Val-Ile-Ile-Glu-NH2 5 
The peptide was synthesized using standard Fmoc peptide synthesis on a Breipohl resin.31,32 Peptide 
coupling was achieved using 3 equivalents of Fmoc amino acid and diisopropylcarbodiimide (DIPCDI, 3.3 eq.) 
with N-hydroxy benzotriazole (HOBt, 3.6 eq.) in DMF. The resin was swollen in DMF for 20 minutes prior to 
use. The Fmoc-group was removed using piperidine in DMF (20% v/v, 3 times 6 minutes). The resin was 
washed well with DMF and dichloromethane. Three equivalents of the pentynoic acid were dissolved in 
dichloromethane and 3.6 equivalents of HOBt (1M in DMF) were added. After mixing 3.3 equivalents of neat 
DIPCDI were added. The solution was added to the resin and the resin was agitated for 18 hours. After washing 
the resin with DMF, dichloromethane, methanol and diethyl ether the resin was dried in vacuo. The peptide was 
cleaved from the resin by treatment with trifluoroacetic acid/water (95/5, v/v) for 4 hours. After precipitation in 
diethyl ether the peptide was lyophilized from acetic acid. The peptides were characterized using 1H-NMR 
spectroscopy and Maldi-TOF mass spectrometry. Maldi-TOF Mass (C37H64N8O10) calc.: 780.47, obs.: 781.73 
([M+H]+) 803.72 ([M+Na]+), 819.71 ([M+K]+), 825.72 ([M+2Na-H]+) 
 
Click to fibrils 
A 1.2 mM solution of peptide 5 was prepared in water and the clear solution was left for 5 days to allow for 
fibrils to form. Aqueous solutions of N3-PEG-OMe (1.8 mM, 2.0 kg mol-1), copper(II)sulfate (50 mM) and 
sodium-ascorbate (130 mM) were freshly prepared. To the solution of peptide 4 N3-PEG-OMe (1 eq.), Cu(II) (1 
eq.) and ascorbate (1.5 eq) were added and the mixture was diluted with water to obtain a final peptide 
concentration of 0.30 mM. The solution was mixed well and left at room temperature. Furthermore, a reference 
solution was prepared without addition of the copper(II)sulfate. 
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Fibril formation  
Solutions of peptides with a concentration of 1 mg mL-1 were prepared in Mili-Q water, in low adhesion 
Eppendorf tubes. The samples were sonicated at 50 °C for 30 minutes and subsequently filtered through a 0.2 
µm filter. The peptide solutions were incubated for 5 days to allow for fibers to form. 
 
CD spectroscopy 
CD spectra were recorded performed on a Jasco J-810 spectropolarimeter with Peltier temperature control. 
Samples were measured at 25 °C in a 1 mm quartz cell. CD measurements were performed in a temperature 
range from 10 to 90 °C. The temperature was decreased or increased at a speed of 3 °C per minute. The 
ellipticity was followed at 222 nm at 0.5 nm intervals, while a full spectrum was measured every 10 °C. 
 
UV exposure 
A solution of peptide in a 1 mm quartz cell was placed 5 cm below the UV source, a Bluepoint 2 with a 
quartz UV guide (dr Hönle, 290-450 nm, 3 mW/cm2). The solution was exposed to the source between 1 and 15 
minutes, determined by the timer-controlled shutter of the source. The sample was shaken and the CD spectrum 
was recorded. The procedure was repeated until the total exposure time was 1 hour. Subsequently a sample was 
taken and transferred to a TLC plate (chloroform, methanol, water 65/25/4, v/v/v), spots were visualized using 
TDM.44 
 
IR spectroscopy.   
IR spectra were recorded on a Thermo Wattson IR300 spectrometer, fitted with a Harrick ATR unit. 
Solutions of fibrils in water were lyophilized and the dry samples were compressed on the ATR crystal with a 
pressure of 0.5 Kg. Infrared spectra were recorded for 128 scans at 2cm-1 resolution. 
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 Manipulation of a non self-assembling peptide‡ 
 
 
The intricately interconnected folding and assembly behavior of an N-terminally 
acylated peptide, with the sequence Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly, has been tuned by 
varying its hydrophobic tail and thermal history. The change in interplay between 
hydrophobic forces and peptide folding allowed the occurrence of different types of 
aggregation, from soluble peptides with a random coil conformation to aggregated peptides 
arranged in a β-sheet assembly, which form helically twisted bilayer ribbons. The 
introduction of a UV-labile linker between the peptide and the hydrophobic tail allowed for 
controlled disassembly of fibrils. 
                                                 
‡
 Parts of this chapter have been published: D.W.P.M. Löwik, J. Garcia-Hartjes, 
J.T. Meijer, J.C.M van Hest; Langmuir 2005, 21, 524-526 & D.W.P.M. Löwik, J.T. Meijer, 
I.J. Minten, H. van Kalkeren, L. Heckenmüller, I. Schulten, K. Sliepen, P. Smittenaar, 
J.C.M. van Hest; J. Pept. Sci. 2008, 14, 127-133 
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4.1 Introduction 
Self-assembly is one of nature’s mechanisms by which higher order structures are 
obtained. Two of the main driving forces for self-assembly, hydrophobic interactions and 
hydrogen bonding, are both present within amphiphilic peptides. The change in interplay 
between hydrophobic forces and peptide folding allows the occurrence of different modes of 
assembly. The previous chapters described the introduction of a hydrophobic tail to further 
stabilize assemblies formed by a self-assembling peptide.1-3 In contrast, in this chapter the 
influence of additional hydrophobic interactions on the folding and assembly behaviour of a 
non-aggregating peptide is examined.  
The water-soluble peptide Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly was selected as non-
self-assembling peptide. This GANPNAAG sequence is derived from the circumsporozoite 
(CS) surface protein of the malaria parasite Plasmodium falciparum. Specifically, the Asn-
Ala-Asn-Pro sequence is repeated 43 times in this protein, and has the propensity to fold in a 
β-hairpin conformation.4,5 In the CS-protein this fold is stabilized through the scaffolding 
provided by the rest of the protein. The free peptide however, is not stabilized in this way and 
is present in a random coil conformation in solution.6  
It was shown by Löwik et al. that the β-hairpin conformation of the NPNA sequence 
could be stabilized in a β-hairpin by modifying both N- and C-terminus with alkyl chains and 
anchoring this amphiphilic peptide in a liposomal scaffold.6 This stabilizing effect of the 
double alkylation on the secondary structure of the GANPNAAG peptide indicated it was 
interesting to examine whether stabilization of the preferred β-turn could also be obtained by 
introduction of a single alkyl tail. In peptide assemblies, such as peptide amphiphile fibrils, 
the interactions between the building blocks confer a stable conformation to a peptide. 
Furthermore, Stupp and co-workers have shown that the recognition of the tightly packed 
peptide amphiphiles in a peptide fibril is still possible.7-9  
A series of peptide amphiphiles based on the GANPNAAG peptide was synthesized, 
the peptides were N-terminally functionalized with a hydrophobic tail. The length of the tail 
was varied to examine its effect on aggregation behavior and stability of aggregates.10,11 
Furthermore, a UV cleavable linker was introduced in between the hydrophobic tail and the 
peptide to enable the in situ disassembly of peptide amphiphile fibrils.  
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4.2 Synthesis  
 
4.2.1 Peptides 
The GANPNAAG peptide was conveniently prepared on a Wang resin using a 
standard Fmoc-based protocol.12,13 Fmoc protected amino acids were coupled using the 
carbodiimide DIPCDI coupling agent with HOBt in DMF. The Fmoc group was repeatedly 
removed using a 20% solution of piperidine in DMF.14 After the final amino acid was 
coupled, the alkyl chain could be introduced efficiently by a classical carbodiimide mediated 
coupling with the corresponding aliphatic carboxylic acid. It was found that the longer 
alkanoic acids (C16 and C18) employed in the final N-acylation step coupled easier in 
dichloromethane than in the more polar dimethylformamide, probably because of the higher 
solubility of the acids and their corresponding activated intermediates. Typically, the Rf 
values on silica thin layer chromatography plates of the lipidated peptides 2-7 (C6-C18) 
differed only slightly, whereas reverse phase silica exhibited behavior as expected, with more 
pronounced differences.  
 
 
Figure 1. Overview of the peptides synthesized, Ac-GANPNAAG 1; amphiphilic 
peptides alkyl-GANPNAAG 2-7 (2: n=2; 3: n=4; 4: n=5; 5: n=6; 6: n=7; 7: n=8); and 
peptides containing a UV cleavable nitrobenzyl moiety C12-hν-GANPNAAG 8 (n=5) 
and C18-hν-GANPNAAG 9 (n=8) 
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Further, a photo-cleavable linker was introduced through treatment of the 
GANPNAAG peptide with p-nitrophenol carbonates 10 and 11 (figure 2) in the final solid 
phase step in the preparation of peptide 8 with a C12 tail and 9 with a C18 tail respectively 
(Figure 1).15 The two different chain lengths were chosen because in advance it was uncertain 
whether the nitrobenzyl moiety would affect the fibril formation. The combination of a C12 
chain with the benzyl linker (8) was estimated to be comparable in length and hydrophobicity 
with a C16 alkyl chain. The C18 analogue (9) was expected to give more stable assemblies, 
due to its greater hydrophobicity. 
These two different chain lengths had previously been used in combination with the β-
amyloid fibril forming pegylated KTVIIE hexapeptide as described in chapter 3. For that 
sequence the introduction of the linker hindered the formation of fibrils for the dodecyl 
functionalized compound. However, since the GANPNAAG peptide described in this chapter 
has a different assembly behavior both hydrophobic groups were evaluated again. All peptides 
were synthesized and fully characterized using NMR and mass spectroscopy.  
 
N
H
O O
NO2
O
O
NO2
10, 11
n
 
Figure 2. Para-nitrophenol carbonates of the UV cleavable hydrophobic tails, with 
C12 (n = 1, 10) and C18 (n=4, 11) alkyl tails. 
 
 
4.2.2 Preparation of peptide solutions 
Assemblies of the peptide amphiphiles were obtained by hydration of the samples in 
MilliQ at 50 °C and subsequent sonication for half an hour at that temperature. This resulted 
in visually clear solutions for all samples which were stable for several weeks at room 
temperature, as was evidenced by the reproducibility of their CD spectra. Solutions of C16-
GANPNAAG (6) formed gels at concentrations higher than 1 mg mL-1. 
 
4.3 Peptide folding and assembly 
4.3.1 Influence of an alkyl tail 
Acetylated peptide 1 showed a CD spectrum with a minimum at 200 nm, typical for a 
random coil conformation. Also, the CD spectra of C6, C10, and C12 peptides (2-4) were 
indicative of the absence of a structural folding.16 This could be expected for such short 
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peptides lacking conformational stabilization via hydrophobic interactions (figure 3). 
However, increasing the alkyl chain length further it was found by CD spectroscopy that the 
conformational behavior was affected. At room temperature, the C14 derivative 5 exhibited a 
β-sheet-type fold, with a minimum at 220 nm and a maximum at 196 nm. Also for the 
peptides with a length of the hydrophobic tail of 16 or 18 carbon atoms (6, 7) the CD spectra 
were indicative of a β-sheet fold of the peptide. The high intensity of the signal at 200 nm for 
peptides 6 and 7 is most probably caused by a linear dichroism component caused by partial 
alignment of the fibrils due to the container effect of the thin cell used in the CD 
experiments.17,18 
 
 
Figure 3. CD spectra of the GANPNAAG peptide amphiphiles, showing a spectrum 
typical for a random folding for peptides 1-4 with tails up to C12; a spectrum 
indicating a β-sheet conformation for C14 peptides 5; and spectra with β-sheet 
characteristics for the C16 and C18 functionalized peptides 6 and 7.  
 
Electron microscopy was utilized to investigate the presence and nature of assemblies 
formed by the peptides. For the peptides with C12 or shorter alkyl chains, no aggregates could 
be observed. For C14 fibrous aggregates were found with a 20 nm diameter and micrometers 
in length but with no other distinctive features. The peptides with C16 and C18 chains formed 
similar structures, but also twisted ribbons could be observed (figure 4). 
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Figure 4. TEM pictures of fibrils of a) C14-GANPNAAG 5; b) C16-GANPNAAG 6; 
bars represent 500 nm 
 
The peptide amphiphiles based on the amyloid model peptide KTVIIE discussed in 
chapter 2 formed fibrils at room temperature independent of the presence of a hydrophobic 
tail. The morphology of the fibrils formed by KTVIIE did not change on introduction of an 
alkyl tail at the N-terminus. In contrast, the GANPNAAG peptide did not form assemblies in 
solution and the introduction of the hydrophobic tail was necessary to induce fibril formation. 
The fibrillar morphology of the assemblies of 5-7 with tails of C14 and longer was 
determined by the combination of the hydrophilic peptide and hydrophobic tail. The 
hydrophobic tails provide the driving force for assembly, while the peptides induce the 
structure of the fibers. 
 
4.3.2 Influence of temperature  
CD measurements at a range of temperatures were deployed to investigate how the 
stability of the peptide structures was dependent on the nature of the alkyl chains. Upon 
increasing the temperature from 20 to 90 °C of the solution of peptides with Ac, C6, C10 and 
C12 tails (1-4) the CD spectrum did not change; the peptides remained in a random coil 
fold.16 Heating a sample of C14 peptide 5 however, induced a change in the CD spectrum. 
Between 40 and 70 °C the spectrum changed from a β-sheet to random coil. This change was 
reversible, upon cooling back to 20 °C the β-sheet spectrum returned (Figure 5). 
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Figure 5. Effect of temperature on the CD spectrum of C14-GANPNAAG (5), 
showing the reversible transition of a signal typical for a β-sheet to random coil. A) 
CD signal typical for a β-sheet at 4°C, random coil at 90 °C. B) change in the signal at 
200 nm upon first heating the sample and subsequent cooling. 
 
For the C16 peptide 6 the CD spectrum did not change until heated above 80 °C. 
Strikingly, at 90 °C still some form of organization was maintained for the C16 peptide as 
was evidenced by the CD signal that had not reverted to that of a random coil but was closer 
to that of a beta sheet. The state of aggregation at 90 °C was found to have changed, because 
after cooling the sample exhibited a very strong increase in the CD signal observed around 
196 nm, while the optical density of the solution did not change significantly (figure 6).  
Increasing the alkyl chain further to 18 carbon atoms (peptide 7) at first afforded 
structures in which the peptides displayed a CD spectrum similar to that of the C16 
compound. However, when these samples were heated above 70 °C, the assemblies already 
converted into the same structures as those found for the C16 amphiphiles that after heating 
had been cooled below at least 50 °C. Remarkably, once these samples had undergone a full 
heating and cooling cycle, further heating almost did not affect the CD spectrum anymore. 
Only a small decrease in the strong positive effect at 198 nm was observed, reflecting a 
drastic stabilization of the assemblies that were formed 19 
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Figure 6. CD spectrum of  C16-GANPNAAG 6, showing an decrease in the intensity 
of the peak at 200 nm upon heating from room temperature to 90 °C, upon cooling the 
intensity of the signal increases to a value significantly higher than the starting signal. 
 
A comparison of the CD signals of peptides 6 and 7 with those of helical, sheet, or 
random coil folded peptides indicated that the Cotton effect could not merely be due to 
folding of the peptide backbone. The strong increase of the observed signal could be due to, 
for example, circular intensity differential scattering20,21 and/or linear dichroism22,23. The 
decrease in intensity of the strong CD signal of peptide 6 with the C16 tail upon heating could 
be caused by (partial) disassembly or reorganization of the peptide structures. 
As described above, upon dissolving the peptides with C16 and C18 chains initially 
featureless assemblies were formed. However, once the samples of these peptides 6 and 7 had 
been heated to 90 °C and were cooled again, the assemblies converted into a twisted ribbon 
configuration, as shown in figure 7, possessing a width of approximately 20 nm. Particularly 
for the C18 compound 7 the helical fibers were found to be very long (5-10 µm) and straight, 
indicative of a high rigidity. 
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Figure 7. TEM picture of C18-GANPNAAG fibrils (7) after a heating cycle (bar 
represents 200 nm)  
 
Similar twisted fibrils have been reported earlier and are assumed to be formed from 
bilayer sheets that coil into a helical structure,24,25 however surprising it may be that this type 
of aggregation seems to be the most thermodynamically stable in an aqueous environment.26-
28
 Such assemblies comprise hydrophobic edges exposed to water, which is in agreement with 
their strong inclination to adhere to carbon-coated grids. The presence of these hydrophobic 
patches also seems to be reflected in the tendency of further aggregation into bundles of 
helical fibers, which ultimately form dense networks at higher concentrations. 10,29 
 
4.3.3 Influence of concentration 
In order to determine the critical aggregation concentration of the amphiphilic peptides 
fluorescence spectroscopy was used following an established procedure. The fluorescence of 
the probe molecule 1,6-diphenyl-1,3,5-hexatriene (DPH) is low in water and highly enhanced 
in a hydrophobic environment, for example upon incorporation in a micelle.19,30  The critical 
association concentration of C16 peptide 6 was determined using this methodology. A 10 mM 
stock solution of DPH was prepared in THF, and 1 µL of this solution was added to various 
amounts of peptide 6 in water. The increase in fluorescence above a concentration of 1.5·10-5 
M indicated the presence of aggregates (figure 8). This result was corroborated by CD 
spectroscopy using a dilution experiment. Below 3·10-5 M the CD spectrum of C16 peptide 6 
resembled that of the water-soluble peptide 1 indicating molecularly dissolved peptides. C18 
functionalized peptide 7 did not show a change in CD spectrum at a concentration of 1.0·10-
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5M, below which the CD could not be reliably recorded. The CD signal at 196 nm of the β-
sheet type signal was characteristic for the presence of fibrils (figure 8). 
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Figure 8. Determination of critical assembly concentration of C16-GANPNAAG 6 
using the fluorescent DPH probe and CD spectroscopy at 196 nm, typical for the β-
sheet signal and the presence of fibrils. 
 
4.3.4 The influence of a cleavable linker 
As described above a nitrobenzyl moiety was introduced between the GANPNAAG 
peptide and the hydrophobic tail to allow for controlled disassembly, resulting in peptides 8 
and 9 (figure 1). CD spectroscopy was used in order to determine whether peptides 8-9 
containing the UV linker formed fibrillar structures comparable to those formed by peptides 6 
and 7. The compounds displayed a very strong positive signal around 196 nm in their CD 
spectra (figure 9a), which can be related to fibril formation as was shown above. This was 
confirmed with TEM measurements which revealed the presence of fibrillar structures, as is 
shown in figure 9b for compound 8. From these results it can be concluded that the 
incorporation of the linker had no adverse effect upon fibril formation. 
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Figure 9. A) CD spectra of 1 mM solutions of peptides with C12 (8) and C18 (9) tails 
containing the UV cleavable linker B) TEM picture of a fibril of C12-hν-
GANPNAAG 8 (bar represents 200 nm) 
 
Typically, the photo-cleavable nitrobenzyl based linker added to the stability of the 
peptide fibers that were formed, because the same GANPNAAG peptide with only an N-
terminal C12 dodecanoyl chain did not form fibrillar structures. Temperature-dependent CD 
measurements were deployed to investigate whether the stability of the peptide structures was 
affected by the presence of the UV cleavable linker. On increasing the temperature of a 
solution of C12 peptide 8 from 20 to 90 °C the intensity of the strong signal at 195 nm 
decreased (Figure 10), comparable to the behavior of C16 peptide 6 described earlier.  Above 
70 °C the resulting CD spectrum was typical of a peptide in a β-sheet fold. Therefore above 
70 °C the CD spectrum of 8 was comparable to the CD spectra obtained for peptide 5 with 14 
carbon atoms in the tail and for peptide 6 at 90 °C (figure 6). This confirmed the previous 
observation that the nitrobenzyl moiety added to the stabilizing effect of the alkyl tail. 
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Similarly the effect of temperature on the CD signal of C18 peptide 9 was comparable to C18 
peptide 7 described above. The strong CD signal of the fibrils at 196 nm was stable up to 
90°C and remained unchanged upon cooling. 
 
190 200 210 220 230 240 250 260
-30
0
30
60
90
120
150
180
CD
 
(m
de
g)
Wavelength (nm)
 10 °C
 30 °C
 50 °C
 70 °C
 90 °C
 
Figure 10. CD spectra of C12-hν-GANPNAAG (8), upon increasing the temperature 
from 10 to 90 °C the change in the curve indicates a transition from a β-sheet to a 
random conformation of the peptide. 
 
Introduction of the nitrobenzyl linker in peptide 8 induced a stabilizing effect to the 
structures formed by the peptide amphiphile, this is in contrast to the introduction of the same 
moiety to the pegylated KTVIIE peptide described in chapter 3. The KTVIIE peptide 
assembled into β-amyloid like structures and the peptide dictated the organization of the 
fibrils, while the structure of the GANPNAAG amphiphiles is dependent on the interaction 
between the hydrophobic tail and the soluble peptide. Hence, where for the KTVIIE sequence 
all amino acids (and interactions) are necessary to form peptide fibrils this is probably not a 
prerequisite for the GANPNAAG peptide amphiphiles. 
 
4.4 Fiber disassembly by UV exposure 
The response towards UV-light of fibrils composed of photo-labile peptide 
amphiphiles 8 and 9 was examined. The fibril solutions were transferred to 1 mm quartz cells 
and irradiated with a strong UV source for a certain time period, after which a CD spectrum 
was recorded. In figure 11a it can clearly be seen that for C12 compound 8 the strong CD 
signal around 195 nm rapidly decreased upon irradiation. After 4 minutes the signal had 
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completely transformed into that of a peptide with a random coil conformation, which is 
expected for the free GANPNAAG peptide in solution.31 Therefore, it was concluded the 
fibril structures had been completely disassembled, which was corroborated by the fact that 
with TEM no structures could be found (fig. 12).  
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Figure 11. CD spectra of C12-hν-GANPAAG (8) and C18-hν-GANPAAG (9) fiber 
solutions treated with UV irradiation for different time periods (in seconds, irradiation 
time increases in the direction of the arrow). Inset: Ellipticity at 192 nm versus 
irradiation time. 
The decomposition of the peptide amphiphile was further evidenced by performing 
thin-layer chromatography (TLC) of the solutions after different periods of UV irradiation. 
After 10 minutes all of the starting material had disappeared. The fact that all fibers had 
disassembled already after 4 minutes, as determined with CD, can be explained by assuming 
that at that time the peptide amphiphile concentration was reduced below its critical 
aggregation concentration of 20 µM (vide infra), approximately one tenth of the starting 
concentration.32 Additionally, the conversion of compound 8 into ‘free’ GANPNAAG 11 was 
verified by mass spectrometry (figure 13). C18 peptide amphiphile 9 gave results comparable 
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to peptide 8 upon irradiation with UV. There was no marked difference in the exposure time 
needed to disassemble the fibrils (figure 11b). 
 
Figure 12. TEM images obtained from a C12hν-GP (8) fiber solution before (A) and 
after (B) UV irradiation. Bars correspond to 1 and 2 µm respectively. 
 
 
Figure 13. ESI-ion trap mass spectra of a solution of C12-hν-GANPAAAG (8) before 
(A) and after (B) UV irradiation 
 
Finally, it was established that peptide 6, lacking the photo-labile linker, was stable 
under the irradiation conditions described above; no changes were observed in the CD spectra 
or in the TEM pictures that were taken from the irradiated fiber solutions of 6. These results 
indicate that the process of controlled disassembly of peptide amphiphile fibers can be 
successfully established using a photochemical method, mediated by the photo-labile linker in 
molecules 8 and 9. 
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4.5 Conclusion 
The introduction of an N-terminal alkyl chain to the soluble GANPNAAG peptide 
induced the resulting amphiphilic peptide to assemble into fibers with a β-sheet like structure. 
The stability of these fibrils was altered by modifying the length of the hydrophobic chain, 
leading to highly stable assemblies for peptides with a C16 and C18 alkyl chain respectively. 
The introduction of a nitrobenzyl derivative as a labile linker between the peptide part and the 
hydrophobic alkyl chain of a peptide amphiphile did not affect the formation of structured 
assemblies. In fact the photo-labile moiety added to the hydrophobic character of the peptide, 
reducing the length of the N-terminal alkyl chain required for fiber formation from C14 to 
C12. The removal of the hydrophobic moieties upon exposure of the peptides containing the 
labile linker resulted in disassembly of the fibrils, opening up the possibility of controlled 
disassembly of fiber aggregates.  
 
4.6 Experimental 
General  
All starting materials were obtained from commercial suppliers and used as received. Thin layer 
chromatography was performed on Kieselgel F-254 pre-coated silica plates or RP-8 F-254s. Visualization was 
accomplished with TDM33. Column chromatography was carried out on Merck silica gel 60 (230-400 mesh 
ASTM). 1H-NMR spectra were recorded on a Varian Mercury, 400 MHz. Proton chemical shifts are reported in 
ppm downfield from tetramethylsilane (TMS). Matrix assisted laser desorption/ionization mass spectra were 
obtained using DHB (dihydroxybenzoic acid) as the matrix on a Bruker BIFLEX spectrometer. Mass spectra 
were recorded on a Thermo-Finnigan LCQ Advantage Max (ESI-Ion trap) or a JEOL AccuTOF JMS-T100CS 
(ESI-TOF). UV/Vis spectra were recorded on a VARIAN Cary 50 Conc spectrometer. CD spectra were recorded 
on a Jasco J-810 spectropolarimeter equipped with a Jasco PTC-423S/L Peltier type temperature control system. 
TEM images were obtained with a JEOL- JEM-1010 equipped with a CCD camera. SEM images were created 
with a Jeol JSM-6330F microscope. Peptides were synthesized on a Labortec SP4000 or a Labortec SP640 semi-
automatic peptide synthesizer. 
 
CnH2n+1C(O)-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-OH 1-7 
The GANPNAAG peptide was prepared by standard solid-phase Fmoc protocols. After removal of the final 
Fmoc protecting group the peptides were capped with either Ac2O/DiPEA or the appropriate alkanoic acid 
dissolved in dichloromethane with diisopropylcarbodiimide as a coupling agent. The product was cleaved from 
the resin by treatment with TFA/H2O (95:5) for two hours followed by precipitation in ether or removal of the 
volatiles. Column chromatography (eluent: CHCl3/MeOH/H2O 65:25:4) and subsequent lyophilization afforded 
pure compounds according to 1H-NMR, Maldi-TOF and TLC. 
Data for C16H31C(O)-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-OH typical for all compounds prepared: Yield: 
76%, based on Fmoc-Gly loading (0.7 mmol/g) of initial resin. TLC: Rf 0.33 (eluent: MeOH/ CHCl3/ AcOH 
25:65:10). 1H-NMR [DMSO-d6]: ), 12.45 (broad s, 1H), 8.27 (d, 1H), 7.96 (broad s, 2H), 7.88 (d, 2H), ), 7.72 (d, 
1H), 7.64 (s, 1H) 7.52 (d, 1H), 7.20 (s, 1H), 7.10 (s,  1H), ), 6.92 (s, 1H), 4.73 (q,  1H ), 4.40 (m, 1H), 4.20 (m 
4H), 3.75 (m, 3H),  3.65 (m 3H), 2.65 (dd, 1H), 2.55 (dd, 1H),  2.40 (m, 2H), 2.18 (m, 3H), 1.85 (m, 3H), 1.48 
(m, 2H), 1.20 (m, 30H), 1.12 (d, 3H), δ 0.85 (t, 3H). Maldi-TOF: Calc. for [C42H72N10O12 + Na]+ 931.5, found 
931.2. 
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MALDI-TOF mass spectra peptides 1-9 
Compound Structural 
formula 
(M+H)+ 
calc 
(M+Na)+ 
Obs 
1 C28H44N10O12 713.31 735.53 
2 C32H52N10O12 769.38 791.61 
3 C36H60N10O12 825.44 847.67 
4 C38H64N10O12 853.47 875.66 
5 C40H68N10O12 881.50 903.62 
6 C42H74N10O12 909.58 931.49 
7 C44H76N10O12 937.56 959.36 
 
 
 
C12H25C(O)-hν linker-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-OH 8 
Peptide 8 containing the UV cleavable linker was synthesized following the procedure for peptides 1-7. 
After removal of the final Fmoc protecting group the resin was washed with dichloromethane, followed by the 
addition of two equivalents of 4-(dodecylcarbamoyl)-2-nitrobenzyl 4-nitrophenyl carbonate (9a Chapter 3) 
dissolved in dry dichloromethane and three equivalents of N,N-diisopropylethylamine. The mixture was agitated 
overnight before the resin was washed subsequently with dichloromethane, DMF, dichloromethane, MeOH and 
diethyl ether and dried in vacuo. The peptide was cleaved from the resin using a mixture of TFA, water, 
ethanedithiol and triisopropylsilane (92.5/2.5/2.5/2.5 by volume). The peptide was isolated by precipitation in 
diethylether and purified by column chromatography (eluent: CHCl3/MeOH/H2O 65:25:4 v/v). 
Rf 0.18 (eluent: CHCl3/MeOH/H2O 65:25:4 v/v). 1H-NMR (DMSO-d6) δ 8.81 (t, 1H). 8.72 (d, 1H), 8.54 
(dd, 1H), 8.21 (dd, 1H), 7.94 (d, 1H), 7.76 (d, 1H), 7.65 (m, 2H), 7.37 (d, 1H), 7.26 (s, 1H), 7.07 (s, 1H), 6.90 (s, 
1H), 5.42 (dd, 2H),  4.81 (q, 1H), 4.49 (m, 1H), 4.20 (m, 4H), 3.65 (m, 3H), 3.29 (m, 3H), 2.60 (m, 2H), 2.38 (m, 
2H), 2.03 (m, 1H), 1.85 (m, 3H), 1.50 (m, 2H), 1.20 (m, 24H), 1.12 (d, 3H), 0.82  (t, 3H).ESI-TOF: Calcd. for 
[C47H72N12O16 + Na]+ 1083.509, found 1083.506. 
 
C18H37C(O)-hν linker-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-OH 9 
This compound was prepared as described for peptide 8 (using 9b, from Chapter 3). 
Rf 0.22 (eluent: CHCl3/MeOH/H2O 65:25:4 v/v). 1H-NMR (DMSO-d6) δ 8.90 (d, 1H) 8.81 (t, 1H).  8.54 
(dd, 1H), 8.21 (dd, 1H), 8.18 (d, 1H), 7.95 (d, 1H), 7.76 (d, 1H), 7.63 (t, 1H), 7.60 (d, 1H), 7.29 (d, 1H), 7.25 (s, 
1H), 7.05 (s, 1H), 6.89 (s, 1H), 5.42 (dd, 2H),  4.81 (q, 1H), 4.53 (m, 1H), 4.20 (m, 4H), 3.65 (m, 3H), 3.30 (m, 
3H), 2.60 (m, 2H), 2.34 (m, 2H), 2.01 (m, 1H), 1.79 (m, 3H), 1.50 (m, 2H), 1.20 (m, 36H), 1.17 (d, 3H), 0.82  (t, 
3H). ESI-TOF: Calcd. for [C53H84N12O16 + Na]+ 1167.6026, found 1167.6028. 
 
H-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-OH 10 
The unmodified peptide 5 was obtained by direct cleavage (TFA/H2O, 95:5 v/v, 2 hours) from the resin after 
removal of the N-terminal Fmoc group. The crude material was used as a reference in mass spectrometry 
experiments. ESI-ion trap: Calcd. for [C26H42N10O11 - H]- 669.3, found 669.4. 
 
Sample preparation  
Aggregates were obtained by the addition of water to the appropriate peptide amphiphile to obtain a 
concentration of 1.0 mg/mL. These solutions were left hydrating at 50 °C for 45 minutes followed by 15 minutes 
of sonication at that temperature. After cooling to room temperature the samples were diluted to their final 
concentration of 0.20 mg/mL. These samples were found to be stable for at least four weeks as evidenced by the 
reproducibility of their CD spectra.  
In the dilution study the aggregates were sonicated after dilution to their final concentration and their CD 
spectra measured immediately.  
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CD spectrometry 
All samples were measured at a concentration of 0.20 mg/mL in a cell with a 1 mm light path. Spectra were 
recorded with the following settings: speed: 50 nm/min, response time: 2 sec, bandwidth: 1nm, data pitch: 0.5 
nm, sensitivity: 1000 mdegrees. Temperature curves were measured at 196 nm at a speed of 1 or 3 °C /min. 
 
Electron microscopy  
Samples for transmission EM were prepared by floating a carbon-coated copper grid on a drop of sample for 
5 minutes followed by blotting off the remaining solvent with filter paper and drying in vacuo. The dried grids 
were platinum shadowed at an angle of approximately 45 degrees. The microscope was set on an accelerating 
voltage of 60 kV.  
 
UV irradiation 
A solution of peptide fibers in a 1 mm quartz cell was placed 10 cm below the output of a quartz light guide 
connected to a Bluepoint 2 UV source (Sadechaf UV). The exposure time was determined by the timer-
controlled shutter of the source. For the TLC experiment at appropriate intervals a sample was taken and 
transferred to a TLC plate (eluent: CHCl3/MeOH/H2O 65:25:4 by volume). 
 
4.8 References 
[1]   M. L. de la Paz, K. Goldie, J. Zurdo, E. Lacroix, C. M. Dobson, A. Hoenger, L. Serrano, Proc. Natl. Acad. 
Sci. U. S. A. 2002, 99, 16052. 
[2]   J. T. Meijer, M. Roeters, V. Viola, D. W. P. M. Löwik, G. Vriend, J. C. M. van Hest, Langmuir 2007, 23, 
2058. 
[3]   J. T. Meijer, M. J. A. G. Henckens, I. J. Minten, D. W. P. M. Löwik, J. C. M. van Hest, Soft Matter 2007, 3, 
1135. 
[4]   C. Bisang, C. Weber, J. Inglis, C. A. Schiffer, W. F. Vangunsteren, I. Jelesarov, H. R. Bosshard, J. A. 
Robinson, J. Am. Chem. Soc. 1995, 117, 7904. 
[5]   M. V. Katti, R. Sami-Subbu, P. K. Ranjekar, V. S. Gupta, Protein Science 2000, 9, 1203. 
[6]   D. W. P. M. Löwik, J. G. Linhardt, P. J. H. M. Adams, J. C. M. van Hest, Org. Biomol. Chem. 2003, 1, 
1827. 
[7]   M. O. Guler, J. K. Pokorski, D. H. Appella, S. I. Stupp, Bioconjugate Chem. 2005, 16, 501. 
[8]   M. O. Guler, L. Hsu, S. Soukasene, D. A. Harrington, J. F. Hulvat, S. I. Stupp, Biomacromolecules 2006, 7, 
1855. 
[9]   J. D. Hartgerink, E. Beniash, S. I. Stupp, Science 2001, 294, 1684. 
[10]   S. G. Zhang, D. M. Marini, W. Hwang, S. Santoso, Curr. Opin. Chem. Biol. 2002, 6, 865. 
[11]   A. Singh, E. M. Wong, J. M. Schnur, Langmuir 2003, 19, 1888. 
[12]   E. Atherton, R. C. Sheppard, Solid phase peptide synthesis. IRL Press: Oxford, England, 1989. 
[13]   G. B. Fields, R. L. Noble, Int. J. Pept. Protein Res. 1990, 35, 161. 
[14]   For some time HOBt was added to the piperidine solution to a concentration of 0.1 M. This was done to 
prevent a side reaction leading to a piperidine adduct to the asperagines. Later, the adduct was not found 
anymore. 
[15]   Chapter 3 
[16]   W. C. Johnson, Proteins-Structure Function and Genetics 1990, 7, 205. 
[17]   D. W. P. M. Löwik, I. O. Shklyarevskiy, L. Ruizendaal, P. C. M. Christianen, J. C. Maan, J. C. M. van 
Hest, Adv. Mater. 2007, 19, 1191. 
[18]   S. J. George, Z. Tomovic, M. M. J. Smulders, T. F. A. de Greef, P. Leclere, E. W. Meijer, A. Schenning, 
Angew. Chem. Int. Ed. 2007, 46, 8206. 
[19]   A. Riepe, H. Beier, H. J. Gross, FEBS Lett. 1999, 457, 193. 
[20]   I. Tinoco, W. Mickols, M. F. Maestre, C. Bustamante, Annual Review of Biophysics and Biophysical 
Chemistry 1987, 16, 319. 
[21]   C. Bustamante, I. Tinoco, M. F. Maestre, Proc. Natl. Acad. Sci. U. S. A. 1983, 80, 3568. 
[22]   A. Rodger, B. Nordén, Circular dichroism and linear dichroism. Oxford University Press: Oxford ; New 
York, 1997; p x. 
Chapter 4 
 92 
[23]   B. M. Bulheller, A. Rodger, J. D. Hirst, Physical Chemistry Chemical Physics 2007, 9, 2020. 
[24]   H. Ihara, T. Fukumoto, C. Hirayama, K. Yamada, Polymer Communications 1986, 27, 282. 
[25]   N. Nakashima, S. Asakuma, T. Kunitake, J. Am. Chem. Soc. 1985, 107, 509. 
[26]   J. V. Selinger, E. C. MacKintosh, J. M. Schnur, Physical Review E 1996, 53, 3804. 
[27]   D. S. Chung, G. B. Benedek, F. M. Konikoff, J. M. Donovan, Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 
11341. 
[28]   O. Y. Zhongcan, J. X. Liu, Physical Review A 1991, 43, 6826. 
[29]   A. Aggeli, I. A. Nyrkova, M. Bell, R. Harding, L. Carrick, T. C. B. McLeish, A. N. Semenov, N. Boden, 
Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 11857. 
[30]   A. Chattopadhyay, E. London, Anal. Biochem. 1984, 139, 408. 
[31]   D. W. P. M. Löwik, J. G. Linhardt, P. J. H. M. Adams, J. C. M. van Hest, Org. Biomol. Chem. 2003, 1, 
1827. 
[32]   D. W. P. M. Löwik, J. Garcia-Hartjes, J. T. Meijer, J. C. M. van Hest, Langmuir 2005, 21, 524. 
[33]   E. V. Arx, M. Faupel, M. Brugger, Journal of Chromatography 1976, 120, 224. 
 
 
 Non-covalent stabilization of a β-hairpin 
peptide into liposomes 
 
Alkyl functionalized peptides were bound in the lipid bilayer of a liposome, in order to 
present stabilized secondary peptide structures, which mimic protein epitopes. As a model 
system a peptide with the sequence Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly (GANPNAAG) was 
used, based on a β-turn structure found in the CS protein of the malaria parasite. The peptide 
was synthesized with alkyl chains attached to both termini, while the length of these tails was 
varied. The hydrophobic tails stabilized the β-turn of the peptide amphiphiles at the air-water 
interface of a Langmuir trough. Furthermore, functionalization of the peptide at both termini 
was shown to not only allow incorporation of the peptide into liposomes, but also to stabilize 
the β-turn secondary structure in the liposome. 
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5.1 Introduction 
In the previous chapters the influence of hydrophobic tails on self-assembly was 
discussed, and it was shown that the introduction of additional hydrophobic interactions could 
stabilize and even induce the formation of peptide assemblies. Besides affecting the 
aggregation properties of peptides by rendering them amphiphilic, another interesting line of 
research is to investigate whether also the folding and, hence, secondary structure of peptides 
can be influenced by the modification with hydrophobic tails. 
In many biologically relevant interaction processes concerning proteins small parts of 
the protein, so-called epitopes, are primarily responsible for the recognition event.1-3 Although 
the primary sequence is of great importance for the specificity of the recognition, in most 
cases also the folding of the epitope is crucial for an adequate response.4-6 When a 
biologically active peptide is designed to mimic this interaction process, it therefore doesn’t 
suffice to merely use the primary sequence, but also the folding of the peptide has to be 
obtained.7,8 In nature the folding is stabilized by the protein itself, which can be considered as 
a scaffold that keeps the epitope in its right conformation. In biomimetic systems artificial 
scaffolds have to be designed which allow the introduction of the peptide of interest into its 
active conformation.  
Over the years many different approaches have been developed. Mimics of natural 
protein binding sites have been prepared by immobilizing linear peptides or stabilized peptide 
loops on a covalent scaffold.9-14 The scaffold stabilizes secondary structures and determines 
the spatial distribution of the peptides.15 However, these synthetic molecules have been 
difficult to synthesize.5,10,11,16 Peptide amphiphiles, comparable in design to the systems 
described in the previous chapters, have been self-assembled while retaining functionality.17-21 
Furthermore, peptide amphiphiles have been incorporated in liposomes.22,23 In the bilayer the 
molecules retain mobility24 enabling multivalent recognition processes.25-27 The use of 
polymerizable lipids allows for the stabilization of self-assembled structures while retaining 
the functionality of incorporated peptide amphiphiles. 28-30 
In our group Löwik et al. have shown that an epitope can be stabilized in its active 
conformation by immobilizing an amphiphilic peptide in a dynamic liposomal scaffold, 
simultaneously presenting the epitope and stabilizing its structure.31 This was achieved by 
synthesis of peptides with C18 tails on either the N-terminus or on both the N- and C-termini. 
Both doubly alkylated and singly alkylated peptides were mixed into DSPC (distearoyl 
phosphatidylcholine) and this way both peptides were successfully incorporated in liposomes 
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(figure 1). Using CD spectroscopy it was demonstrated that while the singly alkylated peptide 
remained in a random coil conformation (figure 1a), the conformation of the doubly alkylated 
peptide was stabilized into a β-turn (figure 1b).   
The epitope that was stabilized was the water-soluble Gly-Ala-Asn-Pro-Asn-Ala-Ala-
Gly (GANPNAAG) sequence. As described before in chapter 4 this sequence originates from 
the circumsporozoite (CS) surface protein of the malaria parasite Plasmodium falciparum.32,33 
Furthermore, Robinson and coworkers showed that a covalently stabilized loop of this peptide 
mimics the biologically relevant structure.34 35 
 
 
Figure 1. Effect of the incorporation of amphiphilic peptides in DSPC liposomes. 
a) Incorporated C18-GANPNAAG remains in a random conformation. 
b) Incorporation of C18-GANPNAAG-C18 results in the stabilization of the peptide in 
a β-hairpin conformation.31 
 
In this chapter the scope of this methodology to stabilize a peptide in a β-turn is 
examined. Since the stabilization was achieved by the interaction between the peptide alkyl 
tails and the phospholipid bilayer it was examined how the folding of the GANPNAAG 
peptide is influenced by the nature of the hydrophobic anchors.36 For this purpose alkyl tails 
of different lengths were introduced onto the GANPNAAG peptide. Two approaches were 
followed for the variation of the hydrophobic moieties. In the first approach the length of the 
tails at both N- and C-terminus was identical. In the second approach the C-terminus was 
functionalized with a C18 n-alkyl chain, while the N-terminal alkyl tail was varied in length. 
Langmuir experiments were performed to determine the influence of the tails on the folding 
of the peptide amphiphile on the air-water interface. The influence of the interaction between 
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the hydrophobic tails of the peptide amphiphiles and the bilayer of the liposomal scaffold was 
examined using phosphatidylcholine lipids with varying  hydrophobic tail lengths.  
 
5.2 Synthesis 
5.2.1 Peptide synthesis 
In order to introduce alkyl tails at both N- and C-termini of the GANPNAAG peptide 
(1-9 table I) a solid phase peptide synthesis protocol was followed. As described in chapter 2, 
the C-terminal alkyl chain was introduced through reductive amination of a commercially 
available aldehyde resin with the appropriate alkyl amine (scheme 1).31,37-39 Subsequently, the 
first amino acid was introduced using an extended coupling procedure. Finally, the remainder 
of the peptide, including the N-terminal alkyl tail, was introduced by standard peptide 
coupling methodologies. The N-terminal alkyl chain was introduced efficiently by a classical 
carbodiimide mediated coupling with the corresponding aliphatic carboxylic acid. This final 
coupling was performed in dichloromethane rather than DMF, due to solubility issues as 
discussed in chapter 2.  
O
O
O
N
O
H
O
NaCNBH3
DMF/MeOH 1/1
80 oC, 2 hours
NH3 +
R
R
 
Scheme 1. Reductive amination reaction that was used to introduce the C-terminal tail 
on the resin prior to the synthesis of the peptide. Reaction conditions: CnH2n+1NH2, 
acetic acid, NaCNBH3 in DMF/ MeOH (1/1), 80 °C for 2 hours. Standard peptide 
couplings, as described in chapter 2, were used to synthesize the remainder of the 
peptide sequence. 
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Table I: Overview of the peptides synthesized  
 
Peptide R1 R2 Yield (%) 
1 C5H11 C5H11 63 
2 C11H23 C11H23 45 
3 C13H27 C13H27 60 
4 C15H31 C15H31 82 
5 C17H35 C17H35 70 
6 C5H11 C17H35 61 
7 C11H23 C17H35 60 
8 C13H27 C17H35 55 
9 C15H31 C17H35 55 
 
 
5.2.2 Preparing liposomes containing peptide amphiphiles 
The conformation of the lipopeptides was studied after incorporation in phospholipid 
vesicles. In order to determine the effect of the interaction between the different alkyl tail 
lengths of the peptide amphiphiles and the phospholipid bilayer, phospholipids with varying 
hydrophobic domains were used.  Phospholipids dimyristoyl phosphatidylcholine (DMPC, 
C14), dipalmytoyl phosphatidylcholine (DPPC, C16) and distearoyl phosphatidylcholine 
(DSPC, C18) were used in combination with the peptides to form mixed liposomes. These 
phospholipids are neutral (zwitterionic) molecules with 2 acyl chains of the same length 
(figure 2). 
O
O
O O
O
P
O
O
O N
n
n
 
Figure 2. General structure of the phosphatidylcholine lipids that formed the 
liposomes which were used to incorporate the amphiphilic peptides; DMPC (n=1), 
DPPC (n=2), DSPC (n=3) 
 
To prepare these functional liposomes both components were dissolved in a mixture of 
chloroform and methanol (9:1), and subsequently mixed. After removal of the organic solvent 
the solids were resuspended in water. It was necessary to dry the sample thoroughly in high 
vacuum in order to remove residual organic solvent before resuspending in water. The 
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presence of organic solvents during resuspension was found to influence the solubility of the 
compounds and hence affect the assembly process in an unpredictable way. Typically, 
solutions were prepared to yield a final concentration of 1 mg mL-1, with 10% peptide and 
90% phospholipid by weight. These liposome dispersions were stable for several weeks.  
Furthermore, the solubility of the peptides in water was examined by determination to 
what extent dissolved molecules could be detected using CD spectroscopy. To 1 mg of 
peptide 1 mL of water was added and these samples were sonicated for an hour at 60 °C. Only 
lipopeptide 1 with two C6 tails afforded a clear solution. The other lipopeptides (2-9) 
remained present as a solid and, after filtration through a 0.2 µm filter, no CD spectrum could 
be observed. 
 
 
5.3 Peptide folding 
5.3.1 Langmuir trough experiments 
In order to obtain information on the molecular packing parameters of the peptide 
amphiphiles Langmuir isotherms were recorded of the lipopeptides on a water-air interface 
(figure 3). The peptides were dissolved in a chloroform/methanol mixture, and spread on a 
water surface in a monolayer through. After stabilization and dispersal of the applied 
molecules the barriers were moved towards each other. The isotherms of stearic acid and 
DSPC were also recorded as typical representatives of neutral molecules with a minimal area 
determined by the presence of one or two alkyl tails, respectively.  
 
Figure 3. Schematic overview of a Langmuir isotherm measurement. A) Typical 
compression curve, with the recorded pressure increasing when the area per molecule 
is lowered due to increased interactions between the amphiphiles. B) The experiment 
is performed by applying the molecule of interest on the water surface in between two 
movable barriers; the pressure is recorded through the Wilhelmy plate. 
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Not unexpectedly, peptide 1 with two C6 tails did not form a stable monolayer due to 
its solubility in water. Peptide 2 with two C12 aliphatic tails did not form a stable monolayer 
either; upon stabilizing the barriers at a selected area the registered pressure decreased. 
Furthermore, the compression isotherm of the C12 compound was not reversible. The other 
symmetric lipopeptides that were studied (3-5), with C14, C16 and C18 alkyl tails 
respectively, formed stable monolayers on the water surface. They could be compressed into 
monolayers at the air-water interface of which the area occupied per lipopeptide molecule was 
determined to be twice the surface of a single n-alkyl carboxylic acid, and comparable to the 
specific surface of the phospholipid distearylphosphatidylcholine (DSPC). The isotherm of 
the C18 peptide 5 was reversible as long as the monolayer was not compressed below an area 
per molecule of 60 Å2. This corresponds to the area expected for two aliphatic chains pressed 
together. Once the area per molecule was lowered below this value the monolayer lost its 
stability and the isotherm became irreversible, which was reflected by a slow decrease of the 
pressure, showing a collapse of the monolayer. This behavior was also observed for peptides 
3 and 4 with C14 and C16 tails respectively. 
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Figure 4. Langmuir isotherms of symmetrical lipopeptides 1-5; isotherms of DSPC 
and stearic acid are included for reference. Peptides 1 and 2 with C6 and C12 tails 
respectively do not form stable monolayers. Peptides 3-5 with the longer tails form 
stable monolayers at an area per molecule comparable to the phospholipid DSPC. 
 
The asymmetric lipopeptides (figure 5a) 8-9 with a C18 tail at the C-terminus and 14 
or 16 carbon atoms at the N-terminus, respectively, also formed stable monolayers. The 
mismatch between the aliphatic chains on the N-and C-terminus did not seem to disturb the 
stability of the packing. The isotherms of peptides 6-7 with a C6 or a C12 tail revealed a 
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different behavior. These peptides showed an increase in pressure and, therefore, an 
interaction at a surface per molecule higher than for 8 and 9, at 100 Å2 for 7 and even 140 Å2 
for 6 in contrast to 70-80 Å2 for 8 and 9. Furthermore, the peptides could be readily 
compressed to an area per molecule smaller than 55 Å2 which is the calculated value for the 
peptide folded in a tight β-hairpin structure. Isotherms showed that monolayers of 6 and 7 
could be reversibly compressed down to an area per molecule approaching the area occupied 
by one aliphatic tail.  
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Figure 5. Langmuir isotherms of asymmetrical lipopeptides 6-9; isotherms of DSPC 
and stearic acid are included for reference. A) Peptides 8 and 9 with C14 and C16 tails 
respectively show a stable monolayer at an area comparable to DSPC and symmetrical 
peptide 5. B) Peptides 6 and 7 with C6 and C12 tails respectively show an interaction 
at a higher area per molecule, furthermore these peptides could be compressed to an 
area that was lower than expected for two alkyl tails. 
 
Monolayers of the amphiphilic peptides were transferred to a quartz plate through a 
Langmuir-Schaefer transfer. CD spectroscopy was employed on these transferred monolayers 
to gain further information on the conformation of the peptide in the compressed monolayers. 
The formation of a closely packed monolayer was indicated by a bend in the isotherm, 
transfers were made at an area per molecule higher and lower than this transition. Recorded 
CD spectra of peptides with C14 tails or longer, both symmetrical and asymmetrical (3, 4, 5, 
8, 9), showed a maximum at 200 nm typical of a β-sheet conformation. These peptides all 
formed a stable monolayer at a surface per molecule of 60 Å2 and the CD spectrum of the 
transferred monolayer was independent on whether the transfer was made before or after this 
transition.  
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Figure 6. Schaefer transfers of the Langmuir monolayers were performed at the 
compression ratios indicated by the arrows. For peptides that formed a stable 
monolayer at an area of 60 Å2 and peptide 2 with two C12 tails monolayers were 
transferred just below and above this critical area (circle). For peptides 6 and 7 
isotherms showed a first transition above 60 Å2 (circle); transfers were made above 
this transition and at an area per molecule of 20 Å2. 
 
The Langmuir isotherm of C12-GANPNAAG-C12 (2) showed a transition at 33 Å2. A 
transfer of the monolayer at 35 Å2 showed a CD signal similar to the amphiphilic peptides 
with the longer tails, with a maximum at 200 nm and a minimum at 217 nm. In contrast, a 
transfer of a monolayer compressed to 20 Å2 per molecule showed a spectrum with a high 
signal at 200 nm, but lacking the minimum at 215 nm that is indicative of a β-sheet spectrum. 
A similar CD spectrum was observed for the monolayers of asymmetrical peptides 6 and 7, 
with C6 and C12 chains on the N-terminus respectively, after a transfer at a compression to 20 
Å2. For neither peptide, transfers at an area per molecule higher than this resulted in a CD 
spectrum.  
In order to get further insight into the contribution of the peptide to the specific area 
per molecule at the compressed monolayer Langmuir monolayer experiments were carried out 
with the mono-alkylated peptides described in chapter 4. However, with none of these peptide 
amphiphiles reproducible isotherms could be obtained, as at any area per molecule ratio the 
pressure readily decreased in time. Therefore, it was concluded that these monoalkylated 
peptide amphiphiles were not able to form stable monolayers. This is probably due to the 
solubility of the monoalkyl peptides with tails of C12 or shorter and the formation of soluble 
aggregates by the C14, C16 and C18 peptides. Nevertheless, as a general trend an increase in 
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the length of the hydrophobic tail corresponded to a higher obtainable pressure. This is 
probably a reflection of the higher energy barrier for these longer alkyl chain peptides to 
become dispersed in the aqueous phase. 
The results from the Langmuir isotherms and CD measurements give a clear picture 
for the conformation of peptides 3-5 and 8 and 9. For these molecules a molecular area was 
extrapolated of just over double the size of a stearic acid molecule. The first rise of the curve 
compared favorably with DSPC, a neutral amphiphile with two stearoyl tails, demonstrating 
that the molecular area occupied by these peptides is mainly determined by the lipophilic 
alkyl chains. Therefore, the peptide part of the amphiphile must be able to adopt such a 
conformation which facilitates a close packing of the alkyl tails in a similar fashion as for the 
model phospholipid DSPC (figures 4 and 5). The β-turn fold of the GANPNAAG sequence 
allows for such a close-packed fold and a molecular model of compound 5, as shown in figure 
7, indicates that such a fold is indeed feasible. This is substantiated by the observed CD 
spectrum of the transferred monolayers showing a β-sheet character of the folded peptide 
amphiphiles. 
 
 
A      B 
Figure 7. A) Spacefilling model of 5 showing the peptide in a β-turn conformation, 
with the aliphatic tails closely packed. B) Model of the peptide part of the compressed 
amphiphile indicating the intramolecular hydrogen bonds stabilizing the β-turn of the 
peptide. 
 
Symmetrically functionalized GANPNAAG peptides with either C12 (2) or C6 (1) 
alkyl tails are water soluble to such an extent that they do not form stable monolayers. 
However, CD spectroscopy on transferred monolayers still shows the presence of a β-turn 
conformation for 2.  
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The Langmuir isotherm and CD measurement results of the asymmetric peptides 6 and 
7, with C6 and C12 N-terminal alkyl chains respectively, indicate a different type of 
conformation. First, in contrast to symmetrical peptides 1 and 2 stable monolayers were 
obtained for these compounds with a higher average area per molecule than the more 
hydrophobic compounds (3-5, 8, 9). This indicates that these amphiphilic peptides are 
anchored at the air-water interface by the hydrophobic C18 tail, but that the size of the area 
per molecule that is taken up by these peptides is increased due to the water solubility of the 
C6 and C12 alkyl tails. Moreover, the CD spectra of monolayers of these compounds at 20 Å2 
showed an intense peak at 200 nm, which was similar to the signal of the C16- and C18-
GANPNAAG-OH fibrils described in chapter 4. All of these results can be explained by an 
unfolding of the peptide structure upon compression, resulting in immersion of the shorter 
alkyl tail in the water subphase, while the C18 tail remains in the air (figure 8).40 The 
compression of the monolayer might have imposed an alignment of the peptides, which 
contributes to the strong CD signal.41  
 
Figure 8. Langmuir monolayer experiments: schematic overview of the effect of 
compression on different amphiphilic peptides. A) Compression of amphiphilic 
peptides with tails of C14 or longer results in a stable monolayer in which the peptide 
is folded in a β-turn and the average area per molecule is determined by the 
hydrophobic tails. B) Compression of a peptide with a strongly hydrophobic alkyl tail 
and a more soluble short tail (6, 7) does not result in a stable β-turn conformation. The 
hydrophobic tail anchors the amphiphile at the interface, while the shorter tail is forced 
into the aqueous phase, resulting in a monolayer where the area per molecule is 
determined by the peptide rather than the hydrophobic moieties. 
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5.3.2 Stabilization in liposomes 
CD spectroscopy was also used to examine the folding of lipopeptides 1-5 mixed in 
liposomes of DSPC (C18). CD spectra of peptide 1 with two C6 tails in the presence of DSPC 
liposomes showed a minimum at 200 nm, indicative of a random coil conformation of the 
peptide. In contrast the CD spectra of peptides 2-5, with tails increasing from C12 to C18 
showed the presence of a β-sheet conformation (figure 9). Remarkably, even peptide 2 with 
two C12 tails, which did not form a stable monolayer, showed sufficient interaction with the 
DSPC vesicle to stabilize its β-turn conformation. Variation in length of the hydrophobic tails 
of these peptides did not result in a reproducible difference on the CD spectra. Therefore, the 
interaction between these tails and the DSPC bilayer, which depends in part on the match in 
length between these hydrophobic domains did not influence the folding characteristics of the 
peptides.  
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Figure 9. CD spectra of GANPNAAG amphiphiles incorporated in DSPC liposomes. 
 
 
In order to determine the influence of the number of carbon atoms in the phospholipid 
tails that form the bilayer on the folding of the lipopeptides, the peptide amphiphiles were also 
mixed with DPPC and DMPC with C16 and C14 hydrophobic tails respectively. These 
liposome preparations showed the same folding as the peptides in the DSPC liposome; 
Non-covalent stabilization of a β-hairpin peptide into liposomes 
 105 
peptide 1 with the C6 tails showed a random coil conformation, while the spectra of the other 
peptides (2-5) indicated a β-turn conformation. 
Asymmetric lipopeptides 6-9 were also first incorporated in vesicles of phospholipid 
DSPC. There was no difference in observed conformation between the various asymmetric 
lipopeptides or between the symmetric and asymmetric peptides. In all cases β-turn 
characteristics were observed. Incorporation of the asymmetric peptides in DPPC or DMPC 
liposomes did not influence the folding of the peptides either. In case of peptide 1 the two C6 
tails did not interact with liposomes and the β-turn of the peptide was not stabilized. Peptide 6 
containing a C-terminal C18 and an N-terminal C6 chain, however did show stabilization of 
the β-turn, as indicated by the CD spectrum. Interaction between the C-terminal C18 tail and 
the phospholipid vesicle places the C6 tail close enough to the bilayer to allow hydrophobic 
interaction and folding to take place.  
No effect was observed of alkyl tail length on the stabilization of peptide structure at 
room temperature, as long as the tails were longer than C6. Therefore, the vesicles of 
phospholipids with incorporated lipopeptides were heated in the CD-spectrophotometer in 
order to determine whether the stabilization of the peptide could be influenced by 
temperature.  Still, there was little change in the CD spectrum on heating the sample to 90 ºC, 
the intensity of the minimum at 200 nm lowered by 10 percent, but this change was rapidly 
and completely reversible on cooling. 
 
 
5.4 Conclusion 
Introduction of alkyl tails longer than C12 at both termini of the β-turn forming 
GANPNAAG peptide sequence stabilizes these turns in monolayers at an air-water interface. 
Furthermore, incorporation of the peptides in a dynamic phospholipid scaffold is a robust way 
to stabilize the conformation of this peptide sequence in a β-turn. The scaffold stabilizes the 
β-turn fold of peptides even when the tails are not hydrophobic enough to stabilize these 
structures in a monolayer. No effect was observed of the matching of hydrophobic domains of 
peptide and liposome on the stabilization of the turn. However, the peptide is short and the 
presence of the proline results in a predisposition for a turn.  Furthermore, incorporation of the 
tails of both termini in the bilayer scaffold will result in the close proximity of both endgroups 
in the bilayer. This means that the peptides are pre-organized to form the β-sheet hydrogen-
bonding pattern which in turn stabilizes the β-turn conformation. The influence of both 
Chapter 5 
 106 
hydrophobic and hydrogen bond interactions probably contributes to the robustness of the 
stabilization. 
 
5.5 Experimental 
1H-NMR spectra were measured on a Varian Inova 400 MHz NMR spectrometer. MALDI-TOF spectra 
were measured on a Bruker Biflex II mass spectrometer, 2,5-dihydroxybenzoic acid (DHB) was used as a matrix. 
Peptides were synthesized on a Labortec SP4000 or a Labortec SP640 semi-automatic peptide synthesizer. 
Peptide couplings were followed to completion using the Kaiser test42. 
 
CnH2n+1CO-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-NCmH2m+1 1-9 
Peptides were synthesized using a standard Fmoc solid phase synthesis protocol on an aldehyde resin, the C-
terminal alkyl tail was introduced as described in chapter 2. Acylation of the N-terminus was achieved by a 
standard peptide coupling of the corresponding n-alkylcarboxylic acid. The resin was washed using DMF, DCM, 
methanol, DCM and diethylether. After drying, the products were cleaved from the resin by treatment with 
TFA/H2O (95/5) during three hours. After cleavage the peptides were purified by precipitation in diethylether, 
followed by silica column chromatography (chloroform/methanol/water; 65/24/4). The peptides were 
characterized using 1H-NMR spectroscopy and MALDI-TOF mass spectrometry. 
Typical analysis: 1 C5H11CO-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-NC6H13   
Resin loading: 0.48 mmol g-1 (65 %). 1H-NMR (DMSO-d6) δ (ppm):  8.25 (d, 1H)  7.95 (t, 1H),  7.87 (t, 1H),  
7.87 (d, 1H),  7.87 (d, 1H),  7.75 (d, 1H),  7.64 (s, 1H),  7.57 (d, 1H),  7.54 (t, 1H),  7.23 (s, 1H),  7.11 (s, 1H),  
6.94 (s, 1H),  4.72 (q, 1H),  4.39 (q, 1H),  4.26 (qu, 1H),  4.22 (dd, 1H),  4.14 (qu, 1H),  4.12 (qu, 1H), 3.70 (m, 
4H),  3.60 (m, 2H),  3.00 (q, 2H),  2.66 (d, 1H),  2.54 (d, 1H),  2.41 (d, 1H),  2.40 (d, 1H),  2.10 (t, 2H), 2.07 (m, 
2H),  1.82 (m, 2H),  1.44 (qu, 2H),  1.35 (t, 2H),  1.22 (d, 6H),  1.20 (m, 18H), 1.12 (d, 3H),  0.82 (t, 6H) 
 
Maldi-TOF mass spectra of peptides 1-9 
 
Compound (M)+ 
calc 
(M+Na)+ 
observed 
(M+K)+ 
observed 
1 851.49 873.91  
2 1019.67 1042.10  
3 1075.74 1098.09  
4 1131.80 1154.40  
5 1187.86 1200.42  
6 1019.67 1042.12 1058.17 
7 1103.77 1126.49 1152.55 
8 1131.80 1155.21 1170.20 
9 1159.83 1182.55 1198.70 
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Langmuir monolayer experiments 
Langmuir-trough monolayer experiments were performed at room temperature on a thermostated (20.0 °C 
Lauda RM6) double barrier R&K trough (6 × 25 cm). Peptides were dissolved to a final concentration of 1 mg 
mL-1 in a mixture of chloroform and methanol (9/1 v/v), heated and sonicated in a closed vial. The solution (10-
50µL) was spread on the water subphase and the compression isotherm was recorded after 15 minutes.  
 
Liposome preparation 
Peptides 1-10 were dissolved in a mixture of chloroform and methanol (9/1) to a final concentration of 1 mg 
mL-1. Solutions were prepared of di-alkyl-phosphatidylcholine (DMPC, DPPC or DSPC) in the same solvent 
mixture to a concentration of 10 mg mL-1. Mixtures were made of the peptide and phospholipid solutions in glass 
vials to a final concentration of 10% lipopeptide by weight. The solutions were dried by a slow nitrogen-flow 
and subsequent exposure to vacuum.  
The samples were suspended in water to a total amphiphile concentration of 1 mg mL-1 (i.e. a lipopeptide 
concentration of 0.1 mg mL-1) by heating to 60 °C for 1 hour with intermittent vortexing. The suspensions were 
homogenized by sonication at 60 °C for an hour. 
 
CD measurements 
CD spectra were measured in a jasco 810 spectrophotometer fitted with a peltier temperature control unit 
(jasco PT-423 s/1). Samples were measured at 25 °C in a 1 mm quartz cell. Soluble peptides were dissolved in 
water to a concentration of 0.1 mg mL-1. Liposomes with lipopeptides were used as prepared.  
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Amphiphilic peptides in a biologically 
active conformation 
 
 
Alkyl functionalized Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly (GANPNAAG) peptides based 
on the CS protein of the malaria parasite were either bound in the lipid bilayer of a liposome 
or conjugated to a KLH carrier protein. The alkyl tails were introduced with the aim of using 
hydrophobic interactions to stabilize the sequence in the native β-turn conformation while 
being presented to the immune system. The stabilized β-turn peptide presented at the surface 
of a liposome induced the formation of antibodies when injected into rabbits, albeit at a low 
titer. Conjugates to KLH induced the formation of antibodies recognizing the peptide 
sequence as well. However, selectivity of the antibodies for the β-turn conformation could not 
be demonstrated 
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6.1 Introduction 
In this chapter the biological activity is examined of amphiphilic derivatives of the 
Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly (GANPNAAG) peptide sequence, by way of their 
immunogenic capabilities. This peptide sequence is derived from the circumsporozoite (CS) 
surface protein of the malaria parasite Plasmodium falciparum.1,2 The CS protein is one of the 
main surface proteins of the sporozoite stage of this malaria parasite and contains 43 repeats 
of the Asn-Ala-Asn-Pro (NPNA) sequence.  
In order to mimic biologically active domains of the native protein a model system not 
only has to encompass the amino acid sequence, but also the folding of the peptide has to be 
established.3,4 Furthermore, haptens, immunogenic small molecules such as peptides, usually 
do not cause an efficient response of the immune system, although they are capable of 
interacting with antibodies. In order to elicit a response these small molecules need to be 
connected to a larger structure. For this purpose haptens are often conjugated to a carrier 
structure, such as polymers,5 proteins6,7 or liposomes.8 
Robinson and coworkers have shown that the GANPNAAG peptide turn can be 
stabilized by introducing a covalent scaffold. This stabilized turn is the biologically 
significant structure, as antibodies raised against the stabilized turn sequence also recognized 
the sporozoite.19,10 The cyclized epitope was functionalized with hydrophobic tails and 
incorporated in so-called immunopotentiating reconstituted influenza virosomes (IRIV) to 
present efficiently multiple copies of the epitope to the immune system.11  
Instead of using a covalent approach to stabilize the hairpin structure of NPNA, as 
described by Robinson, a non-covalent method using hydrophobic interactions was envisaged, 
since in the previous chapter we demonstrated that the GANPNAAG peptide can be stabilized 
in a β-turn conformation via the attachment of hydrophobic tails to the N-terminus and C-
terminus.  
Two carrier options for the presentation of the non-covalently stabilized peptide were 
selected: liposomes and a carrier protein. The liposomal system described in Chapter 5 not 
only stabilized the conformation of the Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly sequence in a 
biologically relevant β-turn, but also resulted in a multivalent presentation of the peptides. 
The ligation of haptens to proteins is a common tool to prepare immunogenic samples, 
and the ligation chemistry is well studied and readily compatible with peptide synthesis. 
Therefore, it was interesting to examine whether the stabilizing effect of hydrophobic tails 
could be used in conjunction with a carrier protein. As a scaffold Keyhole Limpet 
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hemocyanin (KLH) was selected, a widely used commercially available carrier protein.14,15 
This non-mammalian protein is highly immunogenic, and provides many lysine residues that 
can be readily functionalized.  
The preparation of GANPNAAG containing immunogenic liposomal solutions and 
peptide-KLH conjugates is described in this chapter. Moreover, the interaction between 
antibodies raised against these systems and model peptides containing the GANPNAAG 
sequence is examined. An immunoblotting technique is used to evaluate the level and 
specificity of antibodies in serum. The interactions are further examined using surface 
plasmon resonance (SPR). 
 
 
6.2 Synthesis 
6.2.1 Peptides 
Two sets of peptides were synthesized for the examination of the biological activity of 
the hydrophobically modified GANPNAAG sequence. The first set (1 and 2, figure 1) was 
used for insertion of amphiphilic peptides into the bilayer membrane of a liposome. As 
previously published and described in chapter 5, incorporation of the GANPNAAG sequence 
functionalized with two hydrophobic tails in a liposome stabilized the peptide in a β-turn 
conformation.16 In contrast, the interaction between a singly alkylated amphiphile and a 
liposome resulted in a random coil conformation for the peptide. The system with C18 
functionalized peptides and the C18 distearoyl phosphatidylcholine (DSPC) liposomal 
scaffold was chosen for the immunogenicity tests of these amphiphilic peptide structures. 
These peptides were synthesized on a solid phase support. Monoacylated peptide C18-
GANPNAAG 1 was synthesized on a Wang resin as earlier described in chapter 4. The 
dialkyl C18-GANPNAAG-C18 2 was synthesized on an aldehyde resin as described in 
chapter 5. 
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Figure 1 Structure of the peptides which were incorporated in DSPC liposomes in 
order to form an immunogenic system. 
 
For the second approach peptides needed to be synthesized that contained a thiol 
moiety for coupling to the KLH carrier protein (figure 2). Two peptides were synthesized, one 
with a tail at the N-terminus of the peptide (3); the second with alkyl tails on both N- and C-
termini (4), which were expected to stabilize the peptide in a β-turn conformation. In both 
cases the alkyl tail at the N-terminus was ω-aminododecanoic acid, which allowed for the 
introduction of a protected sulfhydril group at the end of the alkyl tail. Peptide 4 contained a 
C16 tail on the C-terminus, which in combination with the C12 tail should be able to stabilize 
the β-turn conformation as was shown in chapter 5. 
Peptides 3 and 4 were prepared on the solid phase as described previously. Peptide 3 
was prepared on a Breipohl resin as described in chapter 4, while peptide 4 was synthesized 
on an aldehyde resin after introduction of hexadecyl-amine following the procedure in chapter 
5. After the deprotection of the final glycine, Fmoc-aminododecanoic acid was introduced to 
the N-terminus using standard peptide coupling chemistry. Finally, a protected thiol was 
introduced using the NHS activated ester of aceto-thioacetic acid (SATA, figure 3). This 
moiety can be readily deprotected before use yielding a free sulfhydride, which can be quickly 
used before oxidation results in dimerization. 
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Figure 2. Peptides synthesized for conjugation with a carrier protein. The N-terminal 
tail is modified with a protected sulfhydril (SATA) group  
 
In order to be able to observe whether the hydrophobic doubly alkylated peptide is 
effectively coupled to the carrier protein a model peptide was synthesized containing a 
fluorescent label (5). After the introduction of the final glycine an Fmoc protected β-(1-
naphtyl)-alanine was introduced. Subsequently, the synthesis was completed as described 
above. 
 
Figure 3. Conjugation of SATA to the free N-terminus of a peptide on a solid phase.  
 
In addition, model peptides were synthesized with a fixed conformation (figure 4). 
These peptides were necessary to check the presence and selectivity of raised antibodies. The 
linear water soluble GANPNAAG 6 attains a random conformation, and was synthesized as 
described in chapter 4. Conformationally constrained peptides were obtained by introducing a 
cystine disulfide bridge. Cysteines were introduced in the GANPNAAG sequence, resulting 
in two stabilized structures. Firstly, cysteines replaced the glycines in the peptide, yielding a 
stabilized β-turn (7, 9). Secondly, cysteines were introduced flanking the GANPNAAG 
sequence, resulting in a loop with some more conformational freedom (8). 
The cysteine containing peptides were synthesized and cyclized on the solid support. 
Peptides 7 and 8 were synthesized on a Wang resin, standard Fmoc protocols were followed. 
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The first cysteine introduced was protected with a trityl group while the second was protected 
with an acetamidomethyl moiety which has been found to promote intramolecular 
cyclization.17 After the final acylation, the resin was suspended in DMF and nitrogen was led 
through the suspension. Subsequently, the resin was treated with iodine resulting in 
deprotection of the cysteines and subsequent ring-closure. Finally, the peptides were cleaved 
from the resin using TFA/water (95/5), lyophilized from water and characterized using NMR 
and mass spectrometry. Peptide 9 with an amide C-terminus was synthesized on a Breipohl 
resin, which allowed us to make use of the free N-terminal amine to introduce the peptide to 
the surface of an SPR chip. Also this peptide was treated with iodine after removal of the final 
Fmoc protecting group, before its subsequent cleavage from the resin.  
Figure 4. Peptides with various stabilized conformations that were synthesized as model 
compounds for binding studies. Linear peptide 6, peptide 7 with a stabilized β-turn, 
peptide 8 with a stabilized loop and peptide 9 with a stabilized β-turn and a free amine for 
conjugation to a surface. 
 
 
6.2.2 Preparation of liposomes 
The general procedure to obtain functionalized liposomes described in chapter 5 was 
also employed to prepare DSPC liposomes containing 1 and 2 for the immunogenicity 
experiments. The samples were prepared to a final concentration of 10 percent of peptide by 
weight containing 0.2 mg peptide in 500 µL of physiological PBS buffer. To minimize the 
effect of any residual organic solvents the mixture of peptide amphiphile and phospholipid 
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was dried thoroughly in vacuo for at least 18 hours. Furthermore, the liposomes were freshly 
prepared shortly before each injection.  
Since the buffer was a new component for the liposomal system, the conformation of 
the peptides in the liposomes was checked using CD spectroscopy. Liposome solutions were 
diluted to a final peptide concentration of 0.2 mg·mL-1. The CD spectra showed that the 
conformation of the peptides in PBS was identical to the conformation in pure water as has 
been described in chapter 5. 
 
6.2.3 Ligation to KLH 
Keyhole limpet hemocyanin (KLH) was used as the carrier protein for conjugation of 
the amphiphilic peptides 3-5.14 This widely used large carrier protein stimulates a response by 
the immune system and can be readily functionalized. The peptides were coupled using an 
established protocol (scheme 1). First the amines of KLH were functionalized using 6-
(maleimido)hexanoyl-N-hydroxysuccinimide (MHS) introducing maleimides on the protein. 
Subsequently, the acetyl protecting group of the thiol moiety of peptides 3-5 was removed by 
treatment with a concentrated NaOH solution. After quenching this reaction via the addition 
of acetic acid, the peptide was immediately added to the protein solution and allowed to react 
at room temperature. Finally, the reaction mixture was purified by dialysis, resulting in 10 mL 
of buffer containing 4 mg of protein. This solution was divided in aliquots for immuno-
injection. For the initial injections the concentration of protein was doubled by lyophilization 
and subsequent re-dissolution. Care had to be taken not to mix the KLH protein solution too 
violently since this could lead to precipitation.   
Chapter 6 
 116 
NH2
N
N
O
OO
O
O
O
N
H
O N
O
O
H
N
O
S
O
5
R
O
H
N
O
HS
5
R
O
N
H
O N
O
O
S
O
H
N
R
O
5
16 33
16 33
 
Scheme 1. Conjugation procedure of ATA labeled peptides to KLH, by 
functionalization of KLH with maleimide and subsequent coupling with a free thiol on 
the peptide. At room temperature; i) pH 7.2, 5 min subsequent 2 times dilution with 
pH 6.0 Phosphate Buffer; ii) DMF, methanol and 8M NaOH, 0.5 min; iii) quenching 
with acetic acid; iv) 4 hours reaction. Subsequent twofold dilution and dialysis against 
pH 6.9 50 mM PBS. 
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Since the alkyl modified hydrophobic peptides 3-5 were insoluble in water they were 
dissolved in DMF for the first steps of the ligation procedure. Although no precipitation was 
observed after addition of the peptides to the KLH solution it was conceivable that the ligation 
reaction could be hindered by their hydrophobicity. To investigate this, peptide 5 containing a 
fluorescent probe was ligated to KLH using the procedure described above. After dialysis UV 
and fluorescence spectra were recorded in order to determine the presence of peptide. The 
measurements showed a fluorescent signal, confirming the effectiveness of the ligation 
reaction. Since the naphtyl containing model peptide 5 is more hydrophobic than peptides 3 
and 4, it was expected that the ligation of these peptides to KLH had also proceeded 
efficiently. 
 
 
6.3 Biological activity procedures 
 
6.3.1 Liposomes 
In order to evaluate the immunogenicity of the liposomal systems rabbits were 
injected (in duplo) with DSPC liposomes containing either C18-GANPNAAG-C18 (2) or 
C18-GANPNAAG-OH (1). Sera of these rabbits were tested for the presence of antibodies 
that could recognize linear GANPNAAG 6 or the cyclic model peptides 7 or 8 (vide infra). 
Because the tests showed that after the first injections no immediate immune response was 
elicited. Therefore, booster injections were injected with an interval of 3 weeks up to a total of 
10 times. 
 
6.3.2 KLH conjugates 
KLH conjugates were injected following a two phase protocol. In the first step 
conjugates were injected into the lymph nodes, with addition of Freund’s adjuvant. 
Subsequent booster injections served to stimulate the immune system further.  
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6.4 Analysis of immune response 
 
6.4.1 Spot test 
The first evaluation of the sera for the presence of antibodies recognizing the 
GANPNAAG hapten was based on a spot test (figure 5). Model peptides for different 
GANPNAAG conformations (6-8) were non-covalently immobilized at a range of densities 
on a nitrocellulose strip (i).  Aspecific binding was prevented by blocking the remaining 
surface with milk-powder. These treated strips were incubated with diluted crude serum, and 
excess material was subsequently washed away (ii). The strips were subsequently developed 
by incubation with general HRP-labeled anti-rabbit antibodies (iii). Finally, reagents were 
added in order to visualize the antibodies using chemiluminescent detection (iv).  
 
Figure 5. Spot test for the determination of the presence of antibodies. i) 
immobilization of model peptides and subsequent blocking by milk; ii) incubation 
with crude serum, followed by washing; iii) incubation of HRP-labeled antibody, 
followed by washing; iv) addition of reagents, followed by detection on film. 
 
This methodology yielded preliminary information on the presence and selectivity of 
antibodies in the serum. Furthermore, serum dilution and exposure during the 
chemiluminescent detection phase could be varied to detect differences in antibody 
concentration or binding strength. 
 
6.4.2 SPR 
To further examine the properties of the raised antibodies their interactions with model 
peptides were investigated using a surface plasmon resonance based biosensor (SPR), 
specifically a Biacore 2000 system. The principle of SPR can be described as follows (figure 
6): a thin layer of gold reflects light, but at a specific angle the interaction between the light 
and surface plasmons results in absorption.18 The absorption angle is dependent on the 
dielectric constant of the material above the gold surface. Binding of a molecule to an 
immobilized substrate on the gold surface changes the dielectric constant and is therefore 
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detectable as a change in the absorption angle. The change in dielectric constant is correlated 
to the mass of the binding species. In a flow cell, such as used in the Biacore system, this 
binding process can be monitored in time.  
 
 
Figure 6. Schematic overview of SPR. A) Monochromatic polarized light is reflected 
from a gold film on the interface between the chip substrate and the analysis channel, 
resulting in an absorbance at a specific angle. B) Upon binding to the surface, a 
refractive index change leads to a change in the absorption angle. C) The change in 
angle can be followed in time, which is correlated to the amount of molecules bound 
to the surface. 
 
The Biacore system uses standardized chips, functionalized with carboxymethylated 
dextran. A single chip contains multiple, simultaneously addressable channels.  This allows 
for an immediate correction of non-specific interactions between chip surface and solutes. 
Cystine stabilized peptide 9 was immobilized on the chip surface through its free amine at the 
N terminus, using a standard EDC – NHS mediated coupling. A reference channel was 
obtained by functionalization of the surface with amino-ethanol. This channel allowed for 
correction of the effects of aspecific interactions between solute and surface. 
In two approaches the interactions between the antibodies in the sera and the 
immobilized peptide 9 were examined. In the first the effect of the concentration of the 
antibodies on binding was investigated (figure 7). The maximum response of the binding 
curves was expected to yield some more information on antibody concentration, while on- 
and off curves should give some data on selectivity and kinetics. Since SPR is capable of 
distinguishing between specific and aspecific interactions crude serum was used. The serum 
was diluted with PBS to a concentration at which a binding curve could be readily observed.  
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Figure 7. Schematic representation of an SPR binding curve, the shape of the curve is 
determined by association (A), reaching equilibrium (B) and finally dissociation (C) of 
antibodies to an immobilized hapten. 
 
In a second approach the competitive effect of the presence of peptides in solution on 
the binding of antibodies was examined (figure 8). It is possible to introduce different 
peptides on the SPR chip, but variation in functionalization introduces further uncertainties in 
our system. Therefore, in order to obtain information on the specificity of the antibodies in the 
sera competition experiments were performed using a singly modified chip and different 
peptides in solution. Antibodies bound to a hapten in solution no longer bind to the surface, 
and varying concentrations of inhibitor in solution should reveal the differences in affinity to 
different conformations of the peptide of interest (figure 8). The surface was functionalized 
with a cystine stabilized loop 9, as used before in the dilution experiments described above. 
Serum was diluted using PBS and from stock solutions either linear peptide 6 or cyclic 
peptide 9 were added. The resulting solutions contained serum with peptide at concentrations 
of 1 mM, 0.1 mM, 0.01 mM and no peptide at all.  
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Figure 8. Schematic overview of an SPR binding competition experiment. Upon 
addition of a competing peptide to the serum the interaction with the immobilized 
hapten diminishes.  
 
 
6.5 Results 
6.5.1 Spot test 
Using the spot test on the sera raised by exposure to the liposomes, antibodies were 
detected only in case of the DSPC vesicles functionalized with the stabilized β-turn of di-
alkylated GANPNAAG (2) (figure 9). These antibodies specifically recognized the stabilized 
β-turn of model peptide 7. However, the response was very weak and only observed for one 
of the two sera. Neither linear sequence 6 nor the more open loop of 8 was recognized by 
antibodies in this serum. No response was observed in either of the samples raised against the 
liposomes containing monoalkylated peptide 1.  
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Figure 9. Spot-tests for the sera raised against liposomes containing GANPNAAG, the 
sera were tested for antibodies recognizing GANPNAAG in a β-turn (7), a loop (8) 
and as linear peptide (6) A) Response to the sera of liposomes containing singly 
alkylated 1. B) Response to the sera of liposomes containing doubly alkylated 2. 
Antibodies recognizing β-turn model peptide 7 are indicated with arrows. 
 
Sera raised against KLH conjugates KLH-3, with the singly alkylated peptide, and 
KLH-4, with two hydrophobic tails on the peptide were tested against the stabilized β-turn of 
model peptide 7 and the more open loop of 8. The serum raised against linear peptide 
conjugate KLH-3 (figure 10) contained mostly antibodies that recognized the open loop of 
cyclized peptide 8. The stabilized β-turn of peptide 7 was also recognized, but this response 
was significantly lower. The response of both samples raised against KLH-3 was not 
identical. The response for the open loop (8) was similar, but one sample showed a markedly 
lower response to β-turn 7. 
The titer of the sera raised against the conjugated di-alkyl peptide KLH-4 was much 
lower than for the sera obtained from the experiment with KLH-3. Only antibodies were 
present that recognized model peptide 8. This response was only observed for one of the two 
sera, the titer of the second serum was too low to be observed using this test. 
 
Amphiphilic peptides in a biologically active conformation 
 
 123 
 
Figure 10. Results for spot-tests for the sera raised against KLH conjugates containing 
GANPNAAG. The sera were tested for antibodies recognizing GANPNAAG in a β-
turn (7) or a loop (8) (figure 4). A) Antibodies recognizing the open loop of 8 were 
prevalent in the serum raised against KLH-3, B) Antibodies recognizing 8 were 
present at a low titer in the serum raised against KLH-4 (indicated with arrows). 
 
6.5.2 SPR 
Of the liposomal sera only the spot-test positive sample raised against the stabilized β-
turn (2) was tested using SPR (figure 11). Selective binding to the surface was only observed 
at high concentrations of serum. Upon increasing the dilution of the serum the shape of the 
binding curve indicated a slower binding process, i.e. the slope of the curve became less steep. 
At the same time the absolute response increased, indicating more specific binding. This 
apparent contradiction indicated an influence, possibly competition, of non-specific 
interactions of compounds in the serum. Competitive binding curves for this serum showed a 
higher inhibition by the cyclic peptide (9) than by the linear peptide (6) (figure 13). 
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Figure 11. SPR curves demonstrating binding of antibodies in crude serum raised 
against liposome stabilized β-turn peptide 2. Cyclic peptide 9 was immobilized on the 
chip surface and the serum was diluted with PBS. 
 
Sera raised against conjugate KLH-3, with the singly alkylated peptide, resulted in 
slightly different responses depending on the exact serum that was tested. This was consistent 
with the spot tests which indicated a difference in titer in the two responses. Binding to the 
functionalized surface was lower in the presence of linear model peptide 6 than in the 
presence of cyclic 9. 
The sera raised against conjugate KLH-4 had a lower response than was observed for 
KLH-3, which was consistent with the spot test. Both sera for KLH-4 showed a similar 
response, this was unexpected since the spot-tests showed different titers. Competition 
experiments showed some influence of the presence of linear peptide 6 on the binding to the 
surface, while the effect of cyclic model peptide 9 in solution was negligible. The influence of 
either peptide was much lower for the sera of KLH-4 than for either the sera of KLH-3 or the 
liposomal sample. 
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Figure 12. SPR binding curves. Binding of antibodies in crude serum raised against 
conjugates KLH-3 (A) and KLH-4 (B). Cyclic peptide 9 was immobilized on the chip 
surface and the serum was diluted with PBS. 
 
 
Figure 13. Schematic summary of the influence of peptides 9 or 6 in solution on 
binding of antibodies raised against liposomally stabilized β-turn 2, and conjugates 
KLH-3 and KLH-4. Competitive effect of peptides added in solution is qualitatively 
expressed by the signs, from (+++) for a strong competitive effect to (-) for no 
observed competitive effect. 
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6.6 Discussion 
A clear difference is observed in the immunogenic response depending on peptide 
functionalization and carrier system. The spot test and SPR results indicate that the response 
to the KLH conjugates is higher than for the liposomal system. For the liposomal system both 
the long induction time before antibodies were detected and the low titer indicate a low 
immunogenicity. This can in part be explained by the fact that the immune system was not 
further stimulated by use of an adjuvant in conjunction with the liposome injections, due to 
incompatibility of standard adjuvants with liposomal systems. Furthermore, the stability and 
lifetime of the liposomes in vivo could have been low. It is conceivable they are rapidly 
cleared from the blood stream, resulting in only a short effective window of action.19 
The instability of the liposomal system could also have been the reason for the 
difference in response to the mono-alkylated GANPNAAG 1 and the di-functionalized 
peptide 2 in the liposomal system. In chapter 4 it was shown that the singly alkylated 
C18-GANPNAAG 1 can form soluble fibrils in solution, while as observed in chapter 5 2 is 
not soluble in water. It can be argued that this difference in solubility can have an effect on 
the dissolution of the liposomes in vivo. This can render the singly alkylated peptide 1 
inactive while C18-GANPNAAG-C18 2 retains some activity. The titer of the antibodies 
raised against the stabilized β-turn of 2 was low as was shown by both the spot test and the 
SPR studies; however, the selectivity of the binding was good.  
In contrast to the liposomal system containing singly alkylated peptide 1 the analogous 
KLH conjugate KLH-3 did show a response. This shows that in the right environment the 
conformationally free GANPNAAG sequence can stimulate the immune system. The spot test 
of the sera raised against KLH-3 showed a decidedly larger response for the open loop of 8 
than for the β-turn of model peptide 7 (figure 10). This difference was expected for the non-
stabilized peptide. However, the SPR competition binding experiments showed a small 
difference in selectivity between the linear model peptide 6 and the β-turn of 9 (figure 14). 
However, since the chip surface was functionalized with a stabilized β-turn it is conceivable 
that mostly the antibodies in the serum that specifically recognize this conformation bind to 
the chip surface. This would be a specific subset of the antibodies present in the polyclonal 
mixture in the serum, resulting in a bias in the competition experiment. Since in this case the 
antibodies bound to the chip already readily recognize the β-turn conformation the 
competitive effect of β-turn peptide 9 would be larger than expected solely based on the spot 
test that tests the whole population.  
Amphiphilic peptides in a biologically active conformation 
 
 127 
The response of antibodies raised against di-functionalized conjugate KLH-4 as 
determined using the spot test was low and the antibodies present recognized the open loop 
and not the β-turn (figure 10). However, SPR measurements showed that antibodies were 
present; moreover the competition experiments show that these antibodies bind better to an 
immobilized peptide on the chip than to a peptide in solution. The low titer and unexpected 
selectivity of the antibodies in these sera, especially in contrast to those raised against KLH-
3, possibly indicate that in this conjugate the peptide is presented less effectively to the 
environment compared with the more hydrophilic conjugate KLH-3. It is conceivable that the 
increased hydrophobicity of the peptide at the terminus of the GANPNAAG sequence 
resulted in an interaction with the core of the carrier protein. Such an interaction could fold 
the hapten in a badly accessible conformation, which is not likely to be the desired stabilized 
β-turn. This could explain why the antibodies that were raised had specificity for the open 
loop of model peptide 8. Furthermore, the low competitive effect of either model peptide on 
the binding of the antibodies in the serum raised against KLH-4 could indicate that these 
antibodies were influenced by the close proximity of the protein surface to the epitope.  
 
6.7 Conclusion 
In this chapter it is shown that immunogenic constructs can be readily synthesized 
using peptides functionalized with hydrophobic tails. Peptide 2, stabilized in a β-turn 
conformation by incorporation in DSPC liposomes, induced the formation of antibodies that 
preferably recognize the stabilized β-turn of the Asn-Pro-Asn-Ala sequence. This shows the 
effective presentation of this conformation to the immune system. However, the immune 
response was low. The non-stabilized peptide 1, anchored to DSPC liposome through a single 
N-terminal C18 tail did not induce an observable immune response. 
Hydrophobically modified peptides could be coupled to a carrier protein using 
standard bio-conjugation methodologies. The resulting conjugates gave rise to a response of 
the immune system. However, there was no strong correlation between conjugated peptide 
and the selectivity of the antibodies raised against the peptide. Moreover, the immune 
response of conjugate KLH-4, containing peptide 4b with hydrophobic moieties at both C- 
and N-terminus was lower than for KLH-3. This, joined with the observed selectivity of the 
antibodies raises doubts on the usefulness of hydrophobic stabilization of peptide secondary 
structure in conjunction with a carrier protein. 
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6.9 Experimental 
Materials and  Methods 
Synthesis of peptides 1 and 6 is described in Chapters 4, synthesis of peptide 2 is described in Chapter  5.  
MHS (N-succinidyl 6- maleidocaproate) was obtained from Pierce, KLH (imject KLH) was obtained from Pierce 
in the form of ampoules containing 20mg of KLH lyophilized from PBS buffer. CM5 chips and HBS-EP buffer 
for the SPR measurements were obtained from Biacore. Cyclic model peptides 7 and 8 were synthesized by 
Dennis Löwik, and analyzed by mass spectroscopy and TLC before use. SPR measurements were performed on 
a Biacore 2000. 1H-NMR spectra were measured on a Varian Inova 400 MHz NMR spectrometer. MALDI-TOF 
spectra were measured on a Bruker Biflex II mass spectrometer, 2,5-dihydroxybenzoic acid (DHB) was used as a 
matrix. Peptides were synthesized on a Labortec SP4000 or a Labortec SP640 semi-automatic peptide 
synthesizer. Peptide couplings were followed to completion using the Kaiser test20.  
 
ATA-C12-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-NH2  3 
The peptide was synthesized using standard Fmoc peptide synthesis on a Breipohl resin.21,22 Peptide 
coupling was achieved using 3 equivalents of Fmoc amino acid and diisopropylcarbodiimide (DIPCDI, 3.3 eq.) 
with N-hydroxy benzotriazole (HOBt, 3.6 eq.) in DMF. The resin was swollen in DMF for 20 minutes prior to 
use. The Fmoc-group was removed using piperidine in DMF (20% v/v, 3 times 6 minutes). Three equivalents of 
Fmoc-protected ω-aminododecanoic acid were dissolved in dichloromethane and 3.6 equivalents of HOBt (1M 
in DMF) were added. After mixing, 3.3 equivalents of neat DIPCDI were added. The solution was added to the 
resin and the resin was agitated for 18 hours; subsequently, the Fmoc group was removed. A solution of 2 
equivalents aceto-thioacetic acid (SATA) in DMF was added to the resin, the suspension was agitated for 3 
hours. After washing with methanol, dichloromethane and ether the resin was dried in vacuo.  The peptide was 
cleaved from the resin by treatment with trifluoroacetic acid/water/triisopropylsilane/ethanedithiol 
(92.5/2.5/2.5/2.5, by volume) for 4 hours. After precipitation in diethyl ether the peptide was lyophilized from 
acetic acid.  
1H-NMR (DMSO-d6) δ (ppm): 8.25 (d, 1 H)  8.01 (m, 3H), 7.94 (q, 1H), 7.87 (m, 4H), 7.75 (d, 1H),  7.64 (s, 
1H) 7.57 (d, 1H), 7.44 (2, 1H), 7.24 (s, 1H), 7.12 (m, 5H), 6.95 (d, 2H), 4.72 (q, 1H), 4.55 (m, 1H), 4.39 (q, 1H), 
4.26 (m, 1H), 4.22 (m, 1H), 4.14 (q, 2H),  3.70 (m, 2H),  3.64 (m, 2H), 3.60 (m, 3H), 3.52 (s, 3H), 3.14 (m, 1H), 
2.9 (m, 3H),  2.66 (m, 1H),  2.54 (m, 1H),  2.41 (m, 2H), 2.05 (m, 4H), 1.95 (t, 1H),  1.82 (m, 4H),  1.44 (m, 2H),  
1.35 (m, 2H),,  1.20 (m, 18H). Maldi TOF Mass (C42H70N12O13S) (calc) 982.49 (M); (obs) 1004.78 ([M+Na]+), 
1020.75 ([M+K]+) 
 
ATA-C12-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-NHC16 4 
The C-terminal n-hexadecylamine tail for peptide 4 was introduced through reductive amination of 4-(4-
formyl-3-methoxyphenoxy)butyryl aminomethyl resin,23 as described in Chapter 2. This was followed by a 
standard Fmoc solid phase peptide protocol as described above for peptide 3.  
1H-NMR (DMSO-d6) δ (ppm): 8.28 (d, 1H), 8.05 (t, 1H), 7.95 (t, 1H), 7.85 (m, 2H), 7.75 (d, 1H), 7.65 (s, 
1H), 7.55 (m, 2H), 7.24 (s, 1H), 7.12 (s 1H), 6. 95 (s, 1H). 4.54 (s, 1H), 4.48 (q, 1H), 4.27 (t, 1H), 4.20 (m, 1H), 
4.10 (m, 2H), 3.75-3.55 (m, 4H), 3.50 (s, 1H), 2.95 (qu, 3H), 2.65 (m, 1H), 2.55-2.45 (m, 5H), 2.05 (m, 2H), 
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1.95 (m, 1H), 1.85 (s, 1H), 1.80 (m, 2H), 1.45 (m, 2H), 1.35 (m, 4H), 1.25 (m, 44H), 1.20 (m, 4H), 0.8 (t, 3H). 
Maldi TOF Mass (C58H102N12O13S) (calc) 1206.74 (M); (obs) 1229.22 ([M+Na]+), 1245.20 ([M+K]+) 
 
ATA-C12-1-Nal-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-NHC16  5 
The C-terminal n-hexadecylamine tail for peptide 4 was introduced through reductive amination of 4-(4-
formyl-3-methoxyphenoxy)butyryl aminomethyl resin,23 as described in Chapter 2. This was followed by a 
standard Fmoc solid phase peptide protocol as described above for peptide 3.  
1H-NMR (DMSO-d6) δ (ppm):  8.28-8.15 (m, 2 H)  8.12 (d, 0.5H), 8.01 (m, 1H), 7.94 (d, 0.5H), 7.87 (m, 
3H), 7.75 (m, 2H),  7.64 (s, 1H) 7.60-7.5 (m, 3H), 7.35 (m, 1H), 7.22 (s, 1H), 7.12 (s, 1H), 6.95 (s, 1H), 4.72 (q, 
1H), 4.55 (m, 1H), 4.39 (q, 1H), 4.26 (m, 1H), 4.22 (m, 1H), 4.14 (q, 2H),  3.70 (m, 2H),  3.64 (m, 2H),  3.60 (t, 
3H), 3.52 (s, 1H), 3.14 (m, 1H), 3.00 (m, 3H),  2.66 (m, 1H),  2.54 (m, 1H),  2.41 (m, 2H), 2.05 (m, 1H), 1.95 (t, 
1H),  1.82 (m, 4H),  1.34 (qu, 2H),  1.20 (m, 32H),  1.15 (m, 6H), 0.82 (t, 3H). Maldi TOF Mass 
(C71H113N13O14S ) (calc) 1403.83; (obs) 1427.20 ([M+Na]+), 1443.16 ([M+K]+) 
 
 
Cyclic H-Cys-Ala-Asn-Pro-Asn-Ala-Ala-Cys-Gly-NH2  9 
The peptide was synthesized on 1g of breipohl resin (0.52 mmol) using standard Fmoc solid phase synthesis 
protocols. For the first cysteine on the resin acetamidomethyl (Acm) was used as protecting group, the second 
cysteine was protected with a trityl (Trt) protecting group. Cyclization was performed after the removal of the 
final Fmoc protecting group. After the linear synthesis the resin was washed with DMF, DCM, methanol, DCM 
and diethylether and finally resuspended in DMF. Nitrogen was bubbled through the suspension for half an hour. 
Subsequently 3 grams of iodine dissolved in DMF was added and the mixture was agitated under a nitrogen flow 
for one hour. The resin was washed using DMF, a solution of ascorbic acid in aqueous DMF, methanol, DCM 
and diethylether. After drying, the peptide was cleaved from the resin by treatment with TFA/H2O (95/5) during 
three hours. After cleavage the peptide was purified by precipitation in diethylether, followed by silica column 
chromatography (chloroform methanol water; 65/24/4). The peptide was characterized using 1H-NMR 
spectroscopy and MALDI-TOF mass spectrometry. 1H-NMR (DMSO-d6) δ (ppm): 8.7 (1H), 8.4 (1H), 8.15 
(1H), 7.9 (3H), 7.7 (1H), 7.5 (1H), 7.4 (2H), 7.2 (2H), 7.1 (1H), 6.9 (1H), 4.8 (1H), 4.4 (2H), 4.2 (3H), 4.0 (1H), 
3.6 (3H), 2.8 (1H), 2.6 (1H), 2.0 (2H), 1.8 (3H), 1.2 (9H)Maldi TOF Mass (C30H48N12O11S2) (calc) 816.30; (obs) 
817.55 ([M+H]+), 839.53 ([M+Na]+), 855.52 ([M+K]+) 
 
Cyclic Ac-Cys-Ala-Asn-Pro-Asn-Ala-Ala-Cys-Gly-OH  7 
Maldi TOF Mass (C32H49N11O13S2) (calc) 859.30; (obs) 860.49 ([M+H]+), 882.48 ([M+Na]+), 898.42 
([M+K]+). 
Cyclic Ac-Cys-Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly-Cys-Gly-OH  8 
Maldi TOF Mass (C36H55N13O15S2) (calc) 973.34; (obs) 996.49 ([M+Na]+) 
 
Conjugation protocol (KLH-3, KLH-4) 
A buffered (0.1 M phosphate, 0.15 M NaCl, pH 7.2) solution of KLH (10 mg mL-1) was obtained by 
dissolving an ampoule of lyophilized KLH (20 mg) in 2 mL of MilliQ. To the slightly opaque KLH solution 4.6 
mg N-succinimidyl 6- maleidocaproate (MHS) dissolved in 125 µL DMF was added. After mixing gently the 
reaction mixture was left at room temperature for 5 minutes. Subsequently, the activated KLH was diluted to 5 
mL using a pH 6 phosphate buffer (0.05 M), resulting in a 4 mg mL-1 protein solution.  
Ata-conjugated peptide was deprotected immediately before coupling to the activated KLH to yield a free 
sulfhydryl group. First, 6 mg of peptide was dissolved in 140 µL DMF. Next, 50 µL methanol and 8 µL of an 8M 
NaOH solution were added and the mixture was vortexed well. Finally, after 30 seconds 10 µL of acetic acid was 
added to quench the reaction mixture.  
The deprotected peptide was slowly added to 4 mg of the activated KLH, the reaction mixture was left for 4 
hours at room temperature. Subsequently, the reaction mixture was diluted to 10 mL using a 0.05 M phosphate 
buffer at pH 6.9. The diluted reaction mixture was dialyzed for 2 hours, and again twice for 8 hours against a 
0.05 M phosphate buffer (pH 6.9). A 500 µL aliquot of the dialyzed solution was freeze dried and redissolved in 
250 µL MilliQ water for the initial injection in the immunization procedure. The remainder of the conjugate 
solution was divided in 900 µL aliquots, stored at -20 °C and used for booster injections. 
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Preparation of liposome-solutions 
Solutions of liposomes were freshly prepared for inoculation of the rabbits. Peptide (C18-GANPNAAG-OH 
(1) or C18-GANPNAAG-C18 (2)) was dissolved in chloroform/methanol mixture (9:1, v/v) at a concentration of 
1 mg mL-1, and DSPC was dissolved in the same solvent to a concentration of 10 mg mL-1. The amphiphiles 
were mixed by adding 500 µL of the peptide solution and 45 µL of the DSPC solution in a vial. The solvent was 
first dried using a nitrogen flow, subsequently followed by exposure to vacuum for at least 16 hours. The dry 
material was hydrated by adding 0.5 mL PBS, heated to 60 °C for 1 hour with intermittent vortexing, leading to 
liposomes with a final concentration of 500 µg peptide per 1 mL of PBS. Finally, the suspensions were 
homogenized by sonication at 60 °C for an hour. 
 
Spot-test to determine the presence of specific antibodies in serum. 
Solutions were prepared of peptides 6, 7 and 8 in milliQ water to a final concentration of 0.5 mg mL-1. These 
solutions were diluted 2, 4, 8, 16 and 32 times. Nitrocellulose strips were cut from a sheet. On a strip a dilution 
series was applied by spotting with 1 µL of each of the solutions in the series, the spot was allowed to dry in air. 
The strips were placed in a vessel which isolated each strip in a separate chamber. To each chamber 2 mL of 
blocking buffer (5% milk powder in a PBS buffer containing 0.2% Tween-20 (PBST)) was added, the vessel was 
agitated for 1 hour at RT. Subsequently the strips were washed 3 times for 5 minutes using PBST, in which they 
were kept moist until the next step. 
To each vessel 2 mL of incubation buffer (2.5% milk powder in PBST) was added, and to the buffer 5 µL of 
serum was added (500 times diluted). The strips were incubated overnight in the diluted serum at 4 °C. The 
strips were subsequently washed 3 times for 5 minutes with PBST, in which they were kept moist until the next 
step. To the strips 2mL solution of an anti-rabbit antibody labeled with horsradish peroxidase (HRP) 3000 times 
diluted in PBST milk (2.5 %) was added. Following 1 hour of incubation at room temperature the strips were 
washed again 3 times for 5 minutes using PBST. The washing buffer was removed and the strips were put on a 
glass plate. A freshly mixed solution of the HRP detection reagent mixture for the specific antibody was added to 
the strips and after 1 minute of incubation excess reagents were removed. The glass plate with the strips was 
covered with plastic foil and the whole set-up was quickly moved to a dark room. Photographic film was put on 
top of the glass plate and was developed after exposure. Films for the KLH sera were exposed for 1 minute, 
films for the liposomal sera were exposed for 5 minutes. 
 
 
SPR protocols  
The Biacore 2000 was fitted with a carboxymethyldextran-derivatized CM5 research grade chip, following 
implemented protocols, priming the chip using HBS-EP running buffer (0.01 M HEPES [pH 7.4], 0.15 M NaCl, 
3 mM EDTA, 0.005% surfactant P20).  Cyclic peptide 9 was dissolved in MilliQ to a concentration of 4 mg mL-1 
and subsequently diluted to 0.2 mg mL-1 pH 5.0 using an acetate buffer. The peptide was immobilized on the 
chip using EDC (N-ethyl-N'-(dimethylaminopropyl)carbodiimide) and NHS (N-hydroxysuccinimide), both 1M 
aqueous solutions, in a standard coupling procedure.24 Excess reactive groups were finally reacted with 
ethanolamine. A reference channel was coated with ethanolamine after EDC-NHS activation. 
Binding of antibodies was determined at a HPB-EP buffer flow of 20 µL/min. Serum was diluted with PBS 
and injected, and both peptide-functionalized and reference channels were monitored. The initial dilution factor 
of 50 was varied to obtain a binding curve. 
Serums raised against KLH-3 and KLH-4 were diluted 12.5 times using PBS, serum raised against 
liposomes containing 2 was diluted 5 times in PBS. Solutions were prepared of peptides 6 and 9 in PBS to a 
concentration of 2, 0.2 and 0.02 mM. Serum dilutions and peptide solutions were mixed 1:1. These mixtures 
were injected and both peptide-functionalized and reference channels were monitored. 
 
Amphiphilic peptides in a biologically active conformation 
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Summary 
 
Proteins attain their specific properties by a three-dimensional folding and assembly 
process, which leads to the correct positioning of amino acids at for example recognition sites 
and active sites. In principle small peptides can be synthesized which mimic the amino acid 
sequence of a functional site of a protein, basically by cutting a piece out of the protein., 
However, these peptides lack the stabilizing effect of their spatial structure by the remainder 
of the protein, via e.g. hydrogen bonds, electrostatic interactions and hydrophobic 
interactions. In order to restore biological activity in these peptide fragments, numerous 
methods have been developed that ensure peptides to fold in the desired conformation, for 
example via the use of non-covalent interactions. 
In this thesis it is examined whether peptide assembly and folding can be influenced 
by the introduction of additional hydrophobic interactions. The moieties used to increase the 
hydrophobicity were alkyl tails, which were introduced specifically at the peptide termini. 
Lipopeptides like these are a subset of peptide amphiphiles, and this set currently forms an 
important class of protein mimics and model systems as a result of their assembly behavior. In 
Chapter 1 an overview is presented on lipopeptide amphiphiles with a focus on their assembly 
behavior and resulting properties.  
In Chapter 2 the influence of the introduction of alkyl tails to a self-assembling fibril 
forming peptide with the sequence Lys-Thr-Val-Ile-Ile-Glu is examined. The addition of a 
hydrophobic tail at the N-terminus of the peptide did not influence the morphology of the 
assemblies formed by the peptides in aqueous solution, as determined primarily using 
Circular Dichroism spectroscopy and Transmission Electron Microscopy. The stability of the 
assemblies was however increased by the introduction of the alkyl tail. Whereas fibrils 
formed by the acetylated peptide disassembled above 40ºC and at a concentration below 60 
µM, peptides with a tail of C12 or longer formed stable assemblies up to at least 90ºC.  
Since the introduction of hydrophobic interactions increased the stability of the 
peptide assemblies of Lys-Thr-Val-Ile-Ile-Glu, it was envisaged that increasing the solubility 
of the peptide in water should hinder the formation of fibrils. This was demonstrated in 
Chapter 3 through the synthesis of a peptide with a water-soluble polyethylene glycol (PEG) 
polymer at its C-terminus. Moreover, the introduction of a C16-tail to the N-terminus in 
conjunction with the C-terminal PEG resulted in a peptide that forms fibrils, since the 
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additional hydrophobic interactions were able to overcome the solubilizing effect of the PEG 
chain. Interestingly, a minimum alkyl length was required to achieve stabilization, since tails 
up to C10 all resulted in non-assembling peptides, while the introduction of a C12 tail and 
longer resulted in the formation of fibrils that were stable up to at least 90 ºC. 
The presence of the two states, i.e. molecularly dissolved or in a fibrillar assembly, 
depending on hydrophobicity, opened the possibility to switch from assembled to dissolved 
peptides by specifically removing the hydrophobic tail. This was achieved by the introduction 
of a UV-cleavable linker between the pegylated peptide and the alkyl tail (C18). This 
molecule formed fibres in solution, which were, as expected, disassembled by exposure to UV 
light. 
In Chapter 4, alkyl tails were introduced to the N-terminus of a peptide that does not 
self-assemble by itself but has a preferred fold in its native protein. This peptide, with the 
sequence Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly (GANPNAAG), is based on a sequence found 
in the malaria coat protein and is thought to be present in a β-turn conformation. The 
acetylated peptide did not have a preferred fold in solution, and the same was true for peptides 
with tails up to C12. In contrast, a tail of C14 or longer induced a β-sheet like conformation, 
which was concurrent with the appearance of fibrillar assemblies. These assemblies could be 
influenced by increasing the temperature, with a critical temperature of approximately 50 ºC 
for the C14 and 80 ºC for the C16 compound. The latter did retain some stabilization of the β-
sheet-like conformation at these high temperatures, while the C18 compound still shows 
fibrils at this temperature. Also for these amphiphilic peptides a UV cleavable group was 
introduced between the stabilizing hydrophobic tail and the peptide, and the removal of the 
tail did result in the disassembly of fibrils. 
Peptide amphiphiles can be co-assembled with phospholipids into liposomes. This was 
shown before for the C18-functionalized Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly peptide in DSPC 
liposomes (also containing C18 hydrophobic tails). In that case the peptide adopted a random 
coil structure. However, when the peptide was functionalized with C18 tails on both N- and 
C-terminus a β-turn conformation was obtained upon insertion in the DSPC liposome bilayer. 
In Chapter 5 this methodology to stabilize the β-turn conformation of the peptide was 
further investigated, with the aim of tuning the stabilization. To this goal a series of peptides 
was synthesized with varying alkyl tail lengths, and to ensure anchoring, a second series was 
synthesized in which the C-terminal was always modified with a C18 tail and tails of varying 
length were coupled at the N-terminus. These peptides were first applied at the air-water 
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interface of a Langmuir through. This showed that the presence of tails longer than C12 was 
needed to form a stable monolayer with the amphiphile in a β-turn conformation. Tails of C12 
and shorter were forced into the aqueous subphase. The peptides were incorporated in 
liposomes composed of either DMPC, DPPC or DSPC (with C14, C16 and C18 tails 
respectively), in this case all peptides with at least one alkyl tail of C12 or longer were 
stabilized in a β-turn like structure. The stabilization was not influenced by the match between 
the peptide hydrophobic region and the liposomal bilayer. 
As mentioned before the GANPNAAG sequence adopts a  β-turn conformation in the 
native Malaria protein. Since GANPNAAG peptides incorporated in liposomes are forced to 
obtain a similar fold, it was of interest to investigate if this conformation resembled the native 
structure. This was tested in Chapter 6 by raising anti-bodies against the bifunctionalized C18 
peptide in DSPC. The response against these liposomes was low, although the selectivity of 
the antibodies that were present was good. In order to increase the response a conjugate was 
made of the peptide functionalized with two hydrophobic tails and the carrier protein KLH. 
The hydrophobic tails were hoped to induce a stable β-turn to the peptide. Although the 
response was improved when compared to the liposomal system, the antibodies raised showed 
however low selectivity, probably as a result of a competing interaction between the 
hydrophobic tails and the carrier with the stabilization of the turn. 
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Eiwitten verkrijgen hun specifieke eigenschappen als gevolg van drie-dimensionale 
vouwing en complexatie, deze processen leiden tot de juiste positionering en oriëntatie van 
aminozuren bij bijvoorbeeld actieve sites en herkenning sites. In principe is het mogelijk om 
peptiden te maken die de aminozuurvolgorde van een functionele locatie kopiëren, 
vergelijkbaar met het knippen van dit stuk uit het eiwit. Maar bij deze peptiden ontbreekt de 
stabilisatie van een driedimensionale structuur door de rest van het eiwit, door o.a. 
waterstofbruggen, elektrostatische en hydrofobe interacties. Om de biologische activiteit van 
deze peptide fragmenten te behouden zijn er vele methodes ontwikkeld die er voor zorgen dat 
ze in de juiste conformatie vouwen, bijvoorbeeld door het gebruik van niet-covalente 
interacties. 
In dit proefschrift wordt onderzocht of de vouwing en pakking van peptiden kan 
worden beïnvloed door de introductie van extra hydrofobe interacties. De functionele groepen 
die werden toegepast om het hydrofobe karakter te verhogen waren alkyl staarten, deze 
werden specifiek op het uiteinde van het peptide geïntroduceerd. Er zijn aanverwante peptide 
amfifielen bekend, en deze vormen als gevolg van hun aggregatie gedrag tegenwoordig een 
belangrijke klasse van eiwit-mimetica en modelsystemen. In Hoofdstuk 1 wordt een overzicht 
gegeven van lipopeptide amfifielen, voornamelijk gericht de structuren die ze vormen en de 
eigenschappen die daaruit volgen. 
In Hoofdstuk 2 wordt de invloed van de introductie van een alkyl staart op de 
eigenschappen van een zelf-assemblerend, vezel vormend, peptide (Lys-Thr-Val-Ile-Ile-Glu) 
onderzocht. De morfologie van de structuren die door het peptide worden gevormd in een 
waterige oplossing werd niet beïnvloed door alkyl staarten die aan de N-terminus waren 
gekoppeld. Dit werd met name bepaald met behulp van Circulair Dichroïsme spectroscopie en 
electronenmicroscopie. De stabiliteit van de gestructureerde aggregaten werd daarentegen wel 
beïnvloed door de introductie van de alkyl staart. Waar de structuren van het peptide zelf 
boven de 40 ºC en bij concentraties lager dan 60 mM uit elkaar vielen bleven de structuren 
van het peptide met een C12 staart (of langer) heel tot minstens 90 ºC. 
Aangezien de introductie van extra hydrofobe interacties de stabiliteit van de 
structuren die werden gevormd door Lys-Thr-Val-Ile-Ile-Glu, leek het aannemelijk dat de 
introductie van een meer wateroplosbare groep de aggregatie zou remmen. Dit werd 
gedemonstreerd in Hoofdstuk 3 door een peptide te synthetiseren met een water-oplosbaar 
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polyethyleenglycol (PEG) staart aan de C-terminus. Wanneer naast de C terminale PEG ook 
nog een C16 staart werd geïntroduceerd op de N-terminus vormde het resulterende peptide 
echter weer structuren, omdat de extra hydrofobe interacties sterk genoeg waren om de 
wateroplosbaarheid van de PEG te overwinnen. Interessant genoeg bleek een minimum lengte 
van de alkyl staart nodig om stabilisatie te bewerkstelligen, want staarten tot en met C10 
leverden water-oplosbare peptiden op. Echter, zodra de lengte C12 of langer was werden 
structuren gevormd die zelf bij 90 ºC nog stabiel waren. 
Een klein verschil in een molecuul, een hydrofobe staart, kan dus een groot verschil in 
structuur opleveren, namelijk een oplosbaar molecuul of een gestructureerd aggregaat. Dit 
opent de mogelijkheid om van aggregaat naar opgelost molecuul te schakelen door de 
hydrofobe staart te verwijderen. Dit werd bewerkstelligd door tussen het PEG 
gefunctionaliseerde peptide en de alkyl staart (C18) een UV gevoelige schakel te 
introduceren. Het molecuul vormde gestructureerde aggregaten in oplossing, welke naar 
verwachting verdwenen onder invloed van UV licht. 
In Hoofdstuk 4 wordt de introductie beschreven van alkylstaarten bij een peptide dat 
in water niet uit zichzelf aggregeert, maar in het eiwit waar het op gebaseerd is wel een 
voorkeursvouwing heeft. Dit peptide, met de sequentie Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly 
(GANPNAAG), is gebaseerd op een sequentie uit een oppervlakte-eiwit van malaria, waarin 
het waarschijnlijk een β-turn vouwing heeft. Het geacetyleerde peptide zelf had in oplossing 
geen specifieke vouwing, en hetzelfde gold wanneer staarten met een lengte tot en met C12 
werd geïntroduceerd. Voor langere staarten werd daarentegen een β sheet achtige vouwing 
waargenomen, en in dezelfde samples liet electronenmicroscopie fibers zien. Deze structuren 
konden worden beïnvloed door de temperatuur te verhogen. Bij een C14 staart was een 
temperatuur van 50 ºC nodig en bij een C16 staart 80 ºC, dit laatste molecuul hield zelfs bij 
deze hoge temperaturen echter nog een β sheet karakter. Tot slot behield het peptide met een 
C18 staart zelfs nog fibrillen bij 90 ºC. Ook bij deze peptide amfifielen werd een UV 
gevoelige schakel ingebouwd tussen peptide en alkyl staart. Dit peptide vormde structuren, 
welke onder UV belichting verdwenen.  
Peptide amfifielen kunnen samen met fosfolipiden co-assembleren in liposomen. Dit 
was aangetoond voor het Gly-Ala-Asn-Pro-Asn-Ala-Ala-Gly peptide gefunctionaliseerd met 
een C18 staart, en DSPC (C18 staarten). In dit geval liet het ingebouwde peptide een 
willekeurige vouwing zien. Daarentegen werd, als het peptide aan beide termini met een C18 
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staart werd gefunctionaliseerd, het peptide na incorporatie in de bilaag van een DSPC 
liposoom gestabiliseerd in een β turn. 
Deze methode om een β turn te stabiliseren werd in Hoofdstuk 5 verder uitgewerkt, 
met als doel de stabilisatie beter te kunnen sturen. Hiertoe werden peptiden gesynthetiseerd 
met in lengte variërende alkyl staarten. Verder werd, om zeker te zijn van ankering in het 
liposoom, een serie peptiden gemaakt waarbij de C-terminus altijd met een C18 staart was 
gefunctionaliseerd terwijl staarten met een variatie aan lengtes werd gekoppeld aan de N-
terminus werd gevarieerd. Deze peptiden werden aangebracht op de water-lucht grens in een 
Langmuir-trog. Hieruit bleek dat beide staarten langer dan C12 moesten zijn om een stabiele 
monolaag te vormen waarin het peptide in een β turn conformatie was gevouwen. Staarten 
met een lengte van C12 of korter werden tijdens compressie in de waterfase gedwongen. De 
peptiden werden ingebouwd in liposomen van DMPC, DPPC dan wel DSPC (met C14, C16 
of C18 staarten), en hierbij werden alle peptiden met minstens een staart van C12 of langer 
gestabiliseerd in een β turn achtige vouwing. De stabilisatie werd niet beïnvloed door (gebrek 
aan) overeenkomst tussen de hydrofobe staart van het peptide en de lipide bilaag. 
Zoals hierboven staat beschreven is de GANPNAAG sequentie in het natuurlijke eiwit 
in een β turn conformatie aanwezig. Omdat de GANPNAAG peptiden in een liposoom in 
deze zelfde conformatie worden gedwongen was het interessant om te bepalen of deze 
conformatie de natuurlijke vouwing benaderde. Dit werd in Hoofdstuk 6 getest door 
antilichamen op te wekken tegen het liposomen van DSPC waarin het peptide met twee C18 
staarten was ingebouwd. De imuunrespons tegen dit systeem was laag, maar de opgewekte 
antilichamen waren wel specifiek. Om de respons te verhogen werd een peptide met twee 
hydrofobe staarten geconjugeerd aan KLH, een drager eiwit, waarbij de hydrofobe staarten de 
β turn zouden moeten stabilizeren. Hoewel de respons hoger was dan bij het liposomale 
systeem werd er een lagere specificiteit waargenomen. Vermoedelijk was dit een gevolg van 
competitieve interactie tussen de hydrofobe staarten met het drager eiwit. 
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Na de jaren van een promotieonderzoek en in mijn geval van schrijven rest nog een 
belangrijk deel van ieder proefschrift. Want gedurende al die jaren waren er mensen die 
steunen, motiveren, afleiden, helpen... en zonder hen was het voltooien van dit proefschrift 
onmogelijk geweest. Natuurlijk wil je daarvoor iedereen bedanken, en bij deze wil dat ook 
zeker doen, maar het is niet altijd makkelijk om goed onder woorden te brengen, en om het 
goed te doen zou het aantal pagina's in dit proefschrift makkelijk kunnen verdubbelen. Toch 
zal ik hier een poging wagen, hoewel ik natuurlijk hier en daar dingen en zelfs mensen zal 
vergeten te noemen, sorry maar in ieder geval heel erg bedankt.  
In eerste instantie ben ik natuurlijk mijn promotor Jan van Hest dankbaar voor de 
begeleiding tijdens mijn onderzoek en zeker tijdens het schrijven dat er ook bij hoort. Je hebt 
me toch iedere keer weer weten te motiveren en interesseren, en ik ben nog steeds onder de 
indruk van de manier waarop je de juiste woorden weet te vinden om orde te brengen in een 
relatieve chaos aan resultaten en ideeën. Ook wil ik Bert Meijer bedanken, vanzelfsprekend 
voor de samenwerking die mijn promotie mogelijk maakte, ik blijf het jammer vinden dat ik 
daar niet meer mee heb kunnen doen. Maar ook voor de tijd die ik tijdens mijn afstuderen in 
je groep heb doorgebracht. 
In de dagelijkse begeleiding was daar Dennis Löwik, een bron van inspiratie en ideeën 
en aangenaam snel als het op nakijken aankomt. Ik kan ondertussen binnen 20 minuten een 
reactie inzetten, maar helaas moet ik nog wel de truc leren om daar niet eerst dagen over na te 
denken. In het algemeen geldt dat ik gezegend ben geweest met begeleiders en collega's 
waarbij de deur altijd openstaat en dat geldt zeker voor jou. 
Toen ik begon aan deze promotie wist ik nauwelijks iets van peptide-chemie, gelukkig 
was daar Hans Adams. Niet alleen vond ik in het begin een plek in je kantoor, maar je hebt 
me ook de ontspannen houding bijgebracht die in ieder geval synthese van peptiden tot een 
goed einde brengt. Ik vermoed dat ik maar een fractie van je kennis en trucs heb kunnen 
overnemen, maar dat is al voldoende om een heel eind te komen. Een brainstormsessie met 
jou en Dennis was vaak voldoende voor 5 strategieën die horen te werken en 10 routes die in 
ieder geval hopeloos zijn. Ik zal in ieder geval in mijn achterhoofd houden dat heel veel 
dingen eigenlijk al jaren geleden zijn uitgezocht en dat je in ieder geval dingen gewoon moet 
uitproberen. 
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Iemand die hier niet mag ontbreken is Marjolijn Roeters, die de basis heeft gelegd 
onder een belangrijk deel van dit proefschrift. De reden dat dit heeft kunnen gebeuren is dat je 
de dappere keuze hebt gemaakt om je eigen promotie te staken om je geluk elders te vinden. 
Jouw werk, en dat van je studenten, vormt de kern van de resultaten in hoofdstuk 2 en 
daarmee de inspiratie voor het werk beschreven in hoofdstuk 3.  
Het werk beschreven in hoofdstuk 6 had niet kunnen plaatsvinden zonder de hulp van 
prof. Stunnenberg en van zijn afdeling Moleculaire Biologie. Met name de hulp van Josephine 
Jansen, Anita Kaan en Adriana Salcedo was groot en zo nu en dan onmisbaar. In hetzelfde 
project was de samenwerking met Hinke Malda van de TU Eindhoven belangrijk, haar 
antilichamen tegen vergelijkbare peptiden werkten zo nu en dan beter dan die van mij en 
hebben een flink aantal tests mogelijk gemaakt die dit boek helaas niet hebben gehaald. 
Het werk in het lab kan niet zonder de nodige ondersteuning. Binnen de afdeling is er 
natuurlijk het secretariaat met Jacky (bedankt voor de motivatie, die nu en dan nodig was) en 
ook Désirée en Paula. Voor apparatuur, bestellingen en onderhoud waren Peter, Pieter, Peter, 
Ad en Helene altijd bereikbaar. Hoewel we veel hebben is toch niet alles aanwezig, dus wil ik 
ook Huub op den Camp (Maldi-TOF), Liesbeth, Rien, Geert-Jan (algemeen instrumentarium) 
Will Roefen en Meta Roestenberg bedanken voor de hulp bij verscheidene metingen.  
Natuurlijk alle collega's die de afgelopen jaren zowel tijdens mijn promotie als daarna 
het deel uitmaken van de groep van Jan zo'n plezier maken. Met name Dennis, Jurgen, Lee, 
Henri, Joost, Marjolijn, Eric, Mark, Pieter, Kaspar, Rosalie, Linda, Hefziba, Stijn, Luiz, 
Sanne, Maddi, TuHa, Maaike, Ruud, Dennis, Morten, René, K.T., Sander en bovendien alle 
studenten. 
Tijdens mijn promotie heb ik een aantal studenten mogen begeleiden, waarbij niet 
iedereen technisch gesproken voor mij werkte, maar dat wil niet zeggen dat ik er niet van heb 
genoten. Bovendien heb er veel van geleerd, wat wel als nadeel moet hebben gehad dat mijn 
begeleiding niet altijd even helder moet zijn geweest daarvoor (nogmaals) mijn 
verontschuldigingen. Jaime en Loes hebben sterk bijgedragen aan het ontdekken van de 
eigenschappen van de GANPNAAG vezels. Remon en Inge hebben in aparte projecten de 
basis gelegd voor het gebruik alhier van de UV-kliefbare linkers voor het schakelen van 
peptide eigenschappen en structuren, waarbij moet worden aangemerkt dat hun eigen 
resultaten hoewel ze niet in dit proefschrift voorkomen nu de basis vormen voor het 
onderzoek van een promovendus. Een groot deel van de begeleiding van jullie stages lag dan 
wel bij Dennis, maar ik ben toch erg dankbaar voor jullie bijdragen.  
Dankwoord 
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Evelyn heeft veel werk verricht aan de validering van de ligatie van lipopeptiden aan 
KLH, het blijft toch eng om te zien hoe kort dat kan worden opgeschreven. Maar de 
gemoedsrust die je resultaten gaven is niet in woorden te omvatten. Valentina, you suddenly 
(to me) appeared fom Italy, and your efforts were an important contribution to the publication 
of the results in Chapter 2. I enjoyed your presence and suspect you had a nice time here. 
Marloes, je hebt in ieder geval hier geleerd dat organische chemie je ding niet is, en ik hoop 
nog steeds dat die conclusie niet aan mij ligt. Maar je inspanningen en resultaten hebben toch 
bijgedragen aan Hoofdstuk 3, dus je kunt het in ieder geval wel. Iris en Wouter hebben 
kortere stages doorgebracht en hebben wat zijwegen getest die helaas nergens op zijn 
uitgelopen. Naast de reguliere studenten waren er ook nog de MLW practica, het blijft 
verbijsterend hoe efficiënt je dingen kunt uitzoeken als alles strak is gepland, Peter, Inez, 
Lisa, Kwinten hebben met Henri zelfs een gepubliceerd deel bijgedragen aan hoofdstuk 4.  
In in de loop der jaren ben ik in contact gekomen met velen binnen de (an)organische 
afdelingen. In eerste instantie begonnen op het peptiden-lab op de 1e verdieping, met alle 
interessante contacten met de personen in de andere labs die daar bij zaten en natuurlijk de 
hele Nolte-groep waarmee koffie werd gedronken. Koffie boven drinken en samen lunchen 
was belangrijk in het contact met de rest van de groep van Jan, en ook met de groep van Floris 
en de mensen van Chiralix. De verhuizing van het UL naar het Huygensgebouw veranderde 
wat interacties en versterkte velen. Zoals mensen misschien is opgevallen ben ik ben redelijk 
nieuwsgierig, ook in het lab, waardoor ik bij vele mensen over de schouder heb meegekeken, 
en hen vaak ook heb proberen te helpen. Zelf heb ik en veel plezier aan beleefd en en een en 
ander geleerd. Ik hoop dat een deel van mijn bemoeienis uiteindelijk nuttig is geweest.  
Onstpanning was ook belangrijk. Bij koffie, lunch, conferenties, borrels, impromptu 
kantoorgesprekken heb ik veel geleerd, over van alles en nog wat, boeken, kunst, films, 
muziek, eten, techniek, auto's etc. en nog veel meer dingen waarvan ik een deel eigenlijk niet 
eens wilde weten. En door de groepinteractie word je ook gestimuleerd om van alles te doen. 
Bijvoorbeeld sport (voetbal, volleybal, zwemmen), maar ook uitgaan, zeilen, eten, optredens 
of een film bezoeken, en zelfs boeken lezen. Zo ongeveer iedereen die ik gedurende de laatste 
jaren hier heb ontmoet heeft hier aan bijgedragen, en ik daarvoor iedereen bedanken, sowieso 
de mensen al genoemd. Maar ook net name, maar niet alleen, Mark, Hans, Johan, Paul, Pili, 
Marga, Onno, Jaap, Femke, Suzanne, Bram, Stan, Inge, Dennis, Bas, Sjef, Richard, Corneel, 
Nico, René, Maria, Jasper, Margot, Ribera, Marta, Heather, Nikos, Marco, Inma, Erik, 
Marloes, Dani, Richard, Carmen, Gerald, Roy, Victor en .......... . 
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Familie is er altijd, en ik ben iedereen erg dankbaar voor alle steun. Ik hoop dat ik nu 
duidelijk kan uitleggen wat ik nu eigenlijk de afgelopen jaren heb gedaan, hoewel jullie de 
juiste termen ondertussen al lijken te kennen. Mieke, bedankt voor alles, de afgelopen jaren 
altijd klaarstaand, zeker voor de morele ondersteuning. Han, bedankt, je laat me mijn eigen 
weg volgen maar hebt hem zeker ook mogelijk gemaakt. Janne, Femke en Gijs en Olga, 
bedankt voor afleiding, er gewoon zijn en alle gesprekken en leuke dingen die we hebben 
gedaan. 
 
Joris 
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